<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>eh1901248_ex0201.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Paul Weiss
         Document created using EDGARfilings PROfile 6.4.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div style="text-align: right;"><font style="font-weight: bold;">EXHIBIT 2.1</font><br>
  </div>
  <div><br>
  </div>
  <div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">AGREEMENT AND PLAN OF MERGER</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">by and among</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">THE MEDICINES COMPANY,</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">NOVARTIS AG</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">and</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">MEDUSA MERGER CORPORATION</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">November 23, 2019</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%%%-->
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>TABLE OF CONTENTS</u></div>
    <div style="line-height: 1.25; font-weight: 400;">
      <div style="text-align: right; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Page</u></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> </u>
      <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z4ad6836f6ecf4ddcadd0042bbce9147f" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> ARTICLE&#160;1 DEFINITIONS</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 1.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Definitions</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 1.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Other Definitional and Interpretative Provisions</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">15</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;2 THE OFFER AND THE MERGER</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">The Offer</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Actions</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.03.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">The Closing</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">20</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.04.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">The Merger</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">21</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.05.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Conversion of Shares</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">21</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.06.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Surrender and Payment</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">22</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.07.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Dissenting Shares</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">24</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.08.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Stock Options; Company Restricted Shares; Company ESPP</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">24</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.09.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Adjustments</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">26</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.10.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Withholding Rights</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">26</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.11.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">No Liability</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">26</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.12.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Lost Certificates</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">26</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.13.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Closing of Transfer Books</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.14.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Further Action</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">27</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;3 THE SURVIVING CORPORATION</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Certificate of Incorporation</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Bylaws</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.03.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Directors and Officers</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">27</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;4 REPRESENTATIONS AND WARRANTIES OF THE COMPANY</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Corporate Existence and Power</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Organizational Documents</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.03.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Corporate Authorization</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.04.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Governmental Authorization</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">29</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.05.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Non-contravention</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">30</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.06.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Capitalization</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">30</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.07.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Subsidiaries</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">32</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.08.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SEC Filings and the Sarbanes-Oxley Act</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">33</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.09.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Financial Statements; Internal Controls</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">34</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.10.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Disclosure Documents</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.11.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Absence of Certain Changes</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.12.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">No Undisclosed Liabilities</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.13.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Litigation</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.14.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Compliance with Applicable Law</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">37</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.15.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Anticorruption Matters</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">37</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.16.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Specified Contracts</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">37</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.17.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Taxes</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">39</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">i</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: right;"><u>Page</u> </div>
      <div><br>
      </div>
      <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.18.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Employee Benefit Plans</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">41</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.19.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Labor and Employment Matters</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">43</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.20.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Insurance Policies</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">44</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.21.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Environmental Matters</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">44</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.22.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Intellectual Property</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">45</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.23.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Real Property</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">47</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.24.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Health Regulatory Matters</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">48</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.25.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Sanctions Laws</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">51</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.26.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Critical Technology</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">51</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.27.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Interested Party Transactions</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">52</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.28.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Brokers&#8217; Fees</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">52</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.29.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Opinion of Financial Advisor</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">52</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.30.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">No Other Representations or Warranties</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">52</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;5 REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">53</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Corporate Existence and Power</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">53</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Authorization; Enforceability</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">53</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.03.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Governmental Authorization</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">54</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.04.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Non-contravention</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">54</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.05.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Capitalization and Operation of Merger Sub</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">54</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.06.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">No Vote of Parent Stockholders; Required Approval</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">54</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.07.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Disclosure Documents</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">55</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.08.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Litigation</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">55</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.09.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Available Funds</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">55</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.10.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Ownership of Company Common Stock</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">55</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.11.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Broker&#8217;s Fees</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">55</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 5.12.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">No Other Representations or Warranties</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">56</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;6 COVENANTS</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">56</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Conduct of the Company</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">56</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Acquisition Proposals; Change in Recommendation</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">61</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.03.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Approval of Merger</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">64</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.04.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Access to Information</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">65</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.05.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Employee Benefit Plan Matters</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">66</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.06.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">State Takeover Laws</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">67</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.07.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Obligations of Parent</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">68</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.08.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director and Officer Liability</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">68</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.09.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Best Efforts</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">69</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.10.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Transaction Litigation</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">72</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.11.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public Announcements</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">73</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.12.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Convertible Senior Notes; Capped Call Transaction</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">73</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.13.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 16 Matters</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">76</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.14.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Rule 14d-10 Matters</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">76</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.15.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Stock Exchange De-listing</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">76</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">ii</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: right;"><u>Page</u> </div>
      <div><u> <br>
        </u></div>
      <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;7 CONDITIONS TO THE MERGER</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">76</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 7.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Conditions to the Obligations of Each Party</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">76</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;8 TERMINATION</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">77</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 8.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Termination</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">77</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 8.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Effect of Termination</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">78</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">ARTICLE&#160;9 MISCELLANEOUS</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">79</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.01.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Notices</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">79</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.02.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Survival of Representations and Warranties</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">80</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.03.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Amendments and Waivers</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">80</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.04.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Fees; Expenses</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">80</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.05.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Assignment; Benefit</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">82</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.06.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Governing Law</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">82</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.07.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Jurisdiction</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">82</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.08.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Waiver of Jury Trial</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">83</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.09.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Specific Performance; Remedies</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">83</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.10.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Severability</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">83</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.11.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Entire Agreement</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">84</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.12.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Rules of Construction</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">84</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="margin-left: 14.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.13.</div>
            </td>
            <td style="width: 70%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Counterparts; Effectiveness</div>
            </td>
            <td style="width: 15%; vertical-align: top; background-color: rgb(198, 244, 249);">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">84</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-weight: 400;"> Annex A &#8211; Conditions to the Offer </div>
    <div style="line-height: 1.25;"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">iii</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">AGREEMENT AND PLAN OF MERGER</div>
    <br>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">THIS AGREEMENT AND PLAN OF MERGER (this &#8220;<u>Agreement</u>&#8221;), dated as of November 23, 2019, is entered into by and among The Medicines
      Company, a Delaware corporation (the &#8220;<u>Company</u>&#8221;), Novartis AG, a company organized under the laws of Switzerland (&#8220;<u>Parent</u>&#8221;), and Medusa Merger Corporation, a Delaware corporation and an indirect, wholly owned subsidiary of Parent (&#8220;<u>Merger











        Sub</u>&#8221;).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">WHEREAS, the respective boards of directors of each of the Company and Merger Sub have approved and declared advisable, and the board
      of directors of Parent has approved, this Agreement and the Transactions, including the Offer and the Merger, on the terms and conditions set forth in this Agreement, and Parent shall cause the sole stockholder of Merger Sub to approve and adopt this
      Agreement by written consent immediately following its execution;</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">WHEREAS, pursuant to this Agreement, Merger Sub has agreed to commence, and Parent has agreed to cause Merger Sub to commence, a
      tender offer (as it may be amended from time to time as permitted under this Agreement, the &#8220;<u>Offer</u>&#8221;) to purchase any and all of the shares of common stock, par value $0.001 per share, of the Company (the &#8220;<u>Company Common Stock</u>&#8221;) issued
      and outstanding (each, a &#8220;<u>Share</u>&#8221;), at a price per Share of $85.00 (such amount, or any other amount per Share paid pursuant to the Offer or the Merger in accordance with this Agreement, the &#8220;<u>Per Share Amount</u>&#8221;), to the holder of such
      Share, in cash, without interest, on the terms and subject to the conditions set forth in this Agreement;</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">WHEREAS, following consummation of the Offer, subject to the terms and conditions of this Agreement and in accordance with Section
      251(h) of the Delaware General Corporation Law (the &#8220;<u>DGCL</u>&#8221;), Merger Sub will be merged with and into the Company (the &#8220;<u>Merger</u>&#8221; and, together with the Offer and the other transactions contemplated by this Agreement, the &#8220;<u>Transactions</u>&#8221;),











      with the Company surviving the Merger as an indirect, wholly owned Subsidiary of Parent in accordance with the DGCL, and each Share that is not (a) validly tendered and irrevocably accepted for purchase pursuant to the Offer, (b) a Dissenting Share
      or (c) to be canceled pursuant to <u>Section 2.05(b)</u>, <u>Section 2.05(c)</u> and <u>Section 2.05(d)</u> will thereupon be converted into the right to receive cash in an amount equal to the Per Share Amount, on the terms and subject to the
      conditions set forth in this Agreement;</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">WHEREAS, Parent, Merger Sub and the Company acknowledge and agree that the Merger shall be governed by and effected pursuant to
      Section 251(h) of the DGCL and shall be consummated as soon as practicable following the consummation of the Offer upon the terms and subject to the conditions set forth in this Agreement; and</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">WHEREAS, the board of directors of the Company (the &#8220;<u>Company Board</u>&#8221;) has unanimously (a) determined and declared that this
      Agreement and the Transactions, including the Offer and the Merger, are advisable and in the best interests of the Company and the Company&#8217;s stockholders, (b)&#160;approved the execution, delivery and performance by the Company of this Agreement and the
      consummation of the Transactions, including the Offer and the Merger, (c) resolved to recommend that the stockholders of the Company accept the Offer and </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">tender their shares to Merger Sub pursuant to the Offer and (d) agreed and authorized that the Merger be governed by Section 251(h) of the DGCL.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth
      below, the parties hereto agree as follows:</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;1</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">DEFINITIONS</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 1.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Definitions</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As used in this Agreement, the
        following terms have the following meanings:</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Acceptable Confidentiality Agreement</u>&#8221; means a confidentiality agreement (i)&#160;containing terms as to confidentiality that are,
      in the aggregate, no less restrictive of the Third Party that is party to such agreement and its Affiliates and Representatives than the terms as to confidentiality set forth in the Confidentiality Agreement are to Parent and its Affiliates and
      Representatives and (ii) that does not prohibit the Company from providing any information to Parent in accordance with <u>Section 6.02</u>.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Acquired Companies</u>&#8221; means the Company and the Company Subsidiaries, collectively.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Acquisition Proposal</u>&#8221; means any indication of interest, inquiry, offer or proposal, including any amendment or modification to
      any existing indication of interest, inquiry, offer or proposal (other than, in each case, any indication of interest, inquiry, offer or proposal made or submitted by or on behalf of Parent, Merger Sub or one or more of their Subsidiaries), relating
      to an Acquisition Transaction.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">
      <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;">&#8220;<u>Acquisition Transaction</u>&#8221; means, other than the Transactions, (a)&#160;any merger, joint venture, partnership, consolidation, dissolution, liquidation, tender offer,
        recapitalization, reorganization, spin-off, share exchange, business combination or similar transaction involving any Acquired Company that, if consummated, would result in any Person or &#8220;group&#8221; (as defined in the Exchange Act) owning, directly or
        indirectly, twenty percent (20%) or more of the total voting power of or any class of equity securities of the Company or of the surviving entity or the resulting direct or indirect parent of the Company or such surviving entity; or (b) any
        transaction (including any single- or multi-step transaction) or series of related transactions directly or indirectly involving (i) the acquisition or purchase of twenty percent (20%) or more of the total voting power of or any class of equity
        securities of the Company, (ii) the acquisition or purchase of tangible or intangible assets of the Acquired Companies representing twenty percent (20%) or more of the consolidated total assets (<u>it</u>&#160;<u>being</u>&#160;<u>understood</u> that total
        assets include equity securities of Subsidiaries) of the Acquired Companies, taken as a whole, or (iii) the sale, lease, license, transfer, lapse or abandonment of twenty percent (20%) or more of the total tangible or intangible assets of the
        Acquired Companies relating to the Product or any Intellectual Property embodied therein or relating thereto.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">2</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Affiliate</u>&#8221; means, with respect to any Person, any other Person that, directly or indirectly, including through one or more
      intermediaries, controls, is controlled by or is under common control with such Person.&#160; As used in this definition, the term &#8220;<u>controls</u>&#8221; (including the terms &#8220;<u>controlled by</u>&#8221; and &#8220;<u>under </u><u>common control with</u>&#8221;) means
      possession, directly or indirectly, including through one or more intermediaries, of the power to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by Contract or otherwise. </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Alnylam License Agreement</u>&#8221; means the License and Collaboration Agreement, dated as of February 3, 2013, by and between Alnylam
      Pharmaceuticals, Inc. and the Company.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Anticorruption Laws</u>&#8221; means the U.S. Foreign Corrupt Practices Act of 1977, or any other anticorruption or anti-bribery
      Applicable Law applicable to the Company or any of the Company Subsidiaries.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Antitrust Laws</u>&#8221; means the HSR Act, the Federal Trade Commission Act, the Sherman Act, the Clayton Act, and any applicable
      foreign antitrust laws and all other Applicable Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of competition through merger or
      acquisition.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Applicable Law</u>&#8221; means any international, national, federal, state or local law, constitution, treaty, convention, statute,
      ordinance, decree, order, code, rule, regulation or common law or other similar requirement enacted, adopted, promulgated or applied by any Governmental Authority.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Audited Balance Sheet</u>&#8221; means the audited consolidated balance sheet of the Company, as of December 31, 2018, included in the
      Company SEC Documents.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Audited Balance Sheet Date</u>&#8221; means the date of the Audited Balance Sheet.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Audited Financial Statements</u>&#8221; means the audited consolidated financial statements consisting of the consolidated balance
      sheets and the related consolidated statements of operations, comprehensive loss, stockholders&#8217; (deficit) equity and cash flows of the Acquired Companies, as of and for the fiscal years ended December 31, 2018 and December 31, 2017 (including, in
      each case, any related notes thereto and the related reports of the independent public accountants) included in the Company SEC Documents prior to the date of this Agreement.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Board of Directors</u>&#8221; means, with respect to any entity, the board of directors of such entity.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#160;&#8220;<u>Business Day</u>&#8221; has the meaning set forth in Rule 14d-1(g)(3) of the Exchange Act; <u>provided</u>, <u>however</u>, that, in
      the case of determining a date when any payment is due, a day on which commercial banks in the County of New York, New York or the City of Zurich, Switzerland are authorized or required by Applicable Law to be closed shall not be a &#8220;Business Day&#8221;.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Capped Call Documentation</u>&#8221; means (i) the letter agreement re: Base Call Option Transaction, dated as of June 6, 2016, between
      the Company and Goldman, Sachs &amp; Co., (ii) the </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">letter agreement re: Base Call Option Transaction, dated as of June 6, 2016, between the Company and Bank of America, N.A., (iii) the letter agreement re:
      Base Call Option Transaction, dated as of June 6, 2016, between the Company and JPMorgan Chase Bank, National Association, (iv) the letter agreement re: Additional Call Option Transaction, dated as of June 7, 2016, between the Company and Goldman,
      Sachs &amp; Co., (v) the letter agreement re: Additional Call Option Transaction, dated as of June 7, 2016, between the Company and Bank of America, N.A. and (vi) the letter agreement re: Additional Call Option Transaction, dated as of June 7, 2016,
      between the Company and JPMorgan Chase Bank, National Association, in each case, as amended, restated, supplemented or otherwise modified&#160; from time to time prior to the date hereof.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Capped Call Transaction</u>&#8221; means the capped call transactions evidenced by the Capped Call Documentation.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Closing Date</u>&#8221; means the date of the Closing.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Code</u>&#8221; means the Internal Revenue Code of 1986.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Equity Awards</u>&#8221; means the Company Stock Options and the Company Restricted Shares.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Intellectual Property</u>&#8221; means all Intellectual Property owned by the Acquired Companies and all Intellectual Property
      used or licensed for use by the Acquired Companies in the conduct of their respective businesses, including the Company Owned IP and the Exclusively Licensed IP.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Material Adverse Effect</u>&#8221; means any state of facts, circumstance, condition, event, change, development, occurrence,
      result or effect (each, an &#8220;<u>Effect</u>&#8221;) that, individually or in the aggregate with any one or more other Effects, (i) has a material adverse effect on the business, assets, financial condition or results of operations of the Acquired Companies,
      taken as a whole or (ii) prevents, materially impairs or materially delays the consummation of the Transactions on a timely basis and in any event on or before the End Date; <u>provided</u>, <u>however</u>, that with respect to clause (i) only, no
      Effect to the extent relating to or resulting or arising from any of the following, shall be deemed to constitute a Company Material Adverse Effect or shall be taken into account in determining whether there has been, or would reasonably be expected
      to be, a Company Material Adverse Effect: (A) general economic, regulatory, political, business, financial or market conditions in the United States or elsewhere in the world; (B) Effects relating to the credit, debt, financial or capital markets or
      in interest or exchange rates, in each case, in the United States or elsewhere in the world; (C) conditions generally affecting the industries in which the Acquired Companies operate; (D) geopolitical conditions, any outbreak, continuation or
      escalation of any military conflict, declared or undeclared war, armed hostilities, or acts of foreign or domestic terrorism (including cyber-terrorism); (E) any epidemic, plague, or other outbreak of illness or public health event, hurricane, flood,
      tornado, earthquake or other natural disaster or act of God or changes resulting from weather conditions; (F) any failure by the Company or any of the Company Subsidiaries to </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">meet any internal or external projections or forecasts or any decline in the price of Company Common Stock or other Company Securities (but excluding, in
      each case, the underlying causes of such failure or decline, as applicable, unless such underlying causes would otherwise be excepted from this definition); (G) the public announcement or pendency of the Transactions, including, in any such case, the
      impact thereof on relationships, contractual or otherwise, with customers, suppliers, vendors, lenders, investors, licensors, licensees, Collaboration Partners, venture partners or employees (other than, in each case, for purposes of any
      representation or warranty set forth in <u>Section 4.03</u> or <u>Section 4.05</u>); (H) changes in Applicable Laws or the interpretation thereof; (I) changes in GAAP or any other applicable accounting standards or the interpretation thereof; (J)
      any action required to be taken by the Company pursuant to the terms of this Agreement or at the direction of Parent or Merger Sub; (K) any breach of this Agreement by Parent or Merger Sub; (L) any change, event, occurrence or development relating to
      the products or product candidates of any Person (other than the Acquired Companies); or (M) any determination or development relating to coverage, reimbursement or payor rules or policies applicable to, or pricing of, the Product or any products or
      product candidates of any competitors of the Company (except to the extent that such determination or development results from fraud by the Company or any of the Company Subsidiaries (in which case the Effect of such determination or development, to
      the extent resulting from fraud by the Company or any of the Company Subsidiaries, may be taken into account in determining the occurrence of a Company Material Adverse Effect)); <u>provided</u>, <u>further</u>, that any Effect relating to or
      arising out of or resulting from any change or event referred to in clause (A), (B), (C), (D), (E), (H) or (I) above may constitute, and be taken into account in determining the occurrence of, a Company Material Adverse Effect if and only to the
      extent that such change or event has a disproportionate adverse impact on the Acquired Companies as compared generally to other participants that operate in the industries in which the Acquired Companies operate. </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Owned IP</u>&#8221; means any Intellectual Property owned or purported to be owned by any of the Acquired Companies.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Regulatory Authority</u>&#8221; means the FDA and any other applicable Governmental Authority that has regulatory authority over
      the nonclinical and clinical testing, development, design, quality, identity, safety, efficacy, reliability, manufacturing, storing, packaging labeling, marketing, promotion, distribution, handling, commercialization, sale, pricing, import or export
      of the Product.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Regulatory Permits</u>&#8221; means Permits required by the FDA under the FDCA and all Permits of any other applicable Company
      Regulatory Authority, in each case, as necessary for the lawful operation of the businesses of the Acquired Companies as currently conducted in each jurisdiction in which such entity operates.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Restricted Share</u>&#8221; means a share of restricted Company Common Stock granted pursuant to one of the Company Stock Plans.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Stock Option</u>&#8221; means an option to acquire shares of Company Common Stock granted pursuant to one of the Company Stock
      Plans.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company Subsidiary</u>&#8221; means each Subsidiary of the Company.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Company&#8217;s Knowledge</u>&#8221; means, as to a particular matter, the actual knowledge of any one or more of the individuals listed on <u>Section














        1.01(b)</u> of the Company Disclosure Letter.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Confidentiality Agreement</u>&#8221; means the confidentiality agreement, dated as of August 21, 2019, between Novartis Pharmaceuticals
      Corporation and the Company.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>consummate</u>&#8221; (and with its correlative meanings &#8220;<u>consummation</u>&#8221; and &#8220;<u>consummating</u>&#8221;), as such term is used with
      respect to the Offer, has the meaning ascribed to it in Section 251(h) of the DGCL.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Continuing Employees</u>&#8221; means Company Employees immediately before the Effective Time who are employed by the Surviving
      Corporation or any Subsidiary of the Surviving Corporation immediately following the Effective Time.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Contract</u>&#8221; means any written, oral or other agreement, contract, binding contractual arrangement, subcontract, lease, binding
      understanding, instrument, bond, debenture, note, loan or credit agreement, indenture, option, warrant, warranty, purchase order, license, sublicense, insurance policy, or other legally binding commitment, obligation or undertaking of any nature,
      other than any Company Employee Plan.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Convertible Senior Notes</u>&#8221; means the Company&#8217;s (i) 2.50% Convertible Senior Notes due 2022, (ii) 2.75% Convertible Senior Notes
      due 2023 and (iii) 3.50% Convertible Senior Notes due 2024.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Convertible Senior Notes Indenture</u>&#8221; means (i) with respect to the Company&#8217;s 2.50% Convertible Senior Notes due 2022, the
      Indenture dated as of January 13, 2015, by and between the Company and Wells Fargo Bank, National Association (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof); (ii) with respect to the Company&#8217;s
      2.75% Convertible Senior Notes due 2023, the Indenture dated as of June 10, 2016, by and between the Company and Wells Fargo Bank, National Association (as amended, restated, supplemented or otherwise modified from time to time prior to the date
      hereof); and (iii) with respect to the Company&#8217;s 3.50% Convertible Senior Notes due 2024, the Indenture dated as of December 18, 2018, by and between the Company and Wells Fargo Bank, National Association (as amended, restated, supplemented or
      otherwise modified from time to time prior to the date hereof).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Critical Technology</u>&#8221; means any of the following:&#160; (a) defense articles or defense services included on the United States
      Munitions List set forth in the International Traffic in Arms Regulations (ITAR) (22 CFR parts 120&#8211;130); (b) items included on the Commerce Control List set forth in Supplement No. 1 to part 774 of the Export Administration Regulations (EAR) (15 CFR
      Parts 730&#8211;774) and controlled (i) pursuant to multilateral regimes, including for reasons relating to national security, chemical and biological weapons proliferation, nuclear nonproliferation, or missile technology, or (ii) for reasons relating to
      regional stability or surreptitious listening; (c) specially designed and prepared nuclear equipment, parts and components, materials, software, and technology covered by 10 CFR part 810 (relating to assistance to foreign atomic energy activities);
      (d) nuclear facilities, equipment, and material </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">covered by 10 CFR part 110 (relating to export and import of nuclear equipment and material); (e) select agents and toxins covered by 7 CFR part 331, 9 CFR
      part 121, or 42 CFR part 73; or (f) emerging and foundational technologies controlled pursuant to section 1758 of the Export Control Reform Act of 2018.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Data Room</u>&#8221; means the electronic data site established for Project Football by Merrill Corporation on behalf of the Company and
      to which Parent and its Representatives have been given access in connection with the Transactions.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>DOJ</u>&#8221; means the U.S. Department of Justice.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Effect</u>&#8221; has the meaning set forth in the definition of &#8220;Company Material Adverse Effect.&#8221;</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Environmental Law</u>&#8221; means any Applicable Law relating to (i) pollution, (ii) the protection of the environment or natural
      resources or (iii) Releases, management or presence of, or exposure to, Hazardous Substances.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>ERISA</u>&#8221; means the Employee Retirement Income Security Act of 1974, as amended.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>ERISA Affiliate</u>&#8221; of any entity means any other entity that, together with such entity, would be treated as a single employer
      within the meaning of Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Exclusively Licensed IP</u>&#8221; means any issued patents or pending patent applications or other Intellectual Property that are owned
      by a Third Party and are exclusively licensed to an Acquired Company.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>FDA</u>&#8221; means the U.S. Food and Drug Administration.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>FDCA</u>&#8221; means the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167; 301 et seq.) and the rules promulgated thereunder.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Financial Statements</u>&#8221; means the Audited Financial Statements and the Unaudited Financial Statements.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>FTC</u>&#8221; means the U.S. Federal Trade Commission.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>GAAP</u>&#8221; means generally accepted accounting principles in the United States.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Governmental Authority</u>&#8221; means any U.S. or non-U.S. federal, state, provincial, local or other government department,
      authority, court, tribunal, commission, instrumentality, regulatory body or self-regulatory body (including any securities exchange), or any political or other subdivision, department, agency or branch of any of the foregoing.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Hazardous Substance</u>&#8221; means any pollutant, contaminant, chemical, petroleum or any fraction thereof, asbestos or
      asbestos-containing material, polychlorinated biphenyls, or industrial, solid, toxic, radioactive, infectious, disease-causing or hazardous substance, material, waste or agent, including all substances, materials, wastes or agents which are
      identified or regulated by, the subject of liability or requirements for investigation or remediation under, or otherwise subject to, any Environmental Law.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>HSR Act</u>&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and any rules and regulations promulgated thereunder.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Indebtedness</u>&#8221; of any Person at any date means, without duplication, all obligations of such Person under the applicable
      governing documentation to pay principal, interest, penalties, fees, guarantees, reimbursements, damages, &#8220;make-whole&#8221; amounts, costs of unwinding and other liabilities with respect to (i) indebtedness for borrowed money, whether current or funded,
      fixed or contingent, secured or unsecured, (ii) indebtedness evidenced by bonds, debentures, notes, mortgages or similar instruments or debt securities, (iii) leases that are required to be capitalized in accordance with GAAP under which such Person
      is the lessee, (iv)&#160;the deferred purchase price of goods or services (other than trade payables or accruals in the ordinary course of business consistent with past practice), (v) obligations under interest rate, currency swap, hedging, cap, collar or
      futures Contracts or other derivative instruments or agreements, (vi) obligations in respect of letters of credit and bankers&#8217; acceptances (other than letters of credit used as security for leases) and (vii) direct or indirect guarantees or other
      forms of credit support of obligations described in clauses (i) through (vi) above of any Person.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Intellectual Property</u>&#8221; means all intellectual property rights and other similar proprietary rights in any jurisdiction,
      whether registered or unregistered, including any: (i)&#160;patent, patentable invention, or other patent right (including all reissues, divisions, continuations, continuations-in-part, and extensions thereof), (ii) trademark, service mark, trade name,
      business name, brand name, slogan, logo, trade dress, social media identifier and all other indicia of origin, together with all common law rights and goodwill associated therewith, (iii)&#160;copyright or work of authorship (whether or not
      copyrightable), together with all moral rights and common law rights thereto, (iv)&#160;computer software (&#8220;<u>Software</u>&#8221;), (v)&#160;Internet domain names, (vi)&#160;trade secrets, proprietary know-how, formulae, inventions (whether patentable or not) and other
      proprietary rights and (vii) application, registration, issuance, extension or renewal of any of the foregoing with any Governmental Authority.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Intervening Event</u>&#8221; means an event, occurrence or fact occurring or arising after the date hereof that was not known to or
      reasonably foreseeable by the Company Board as of the date of this Agreement (or, if known, the magnitude or consequences of which were not known or reasonably foreseeable by the Company Board as of the date of this Agreement), other than (i) any
      event, occurrence or fact that relates to an Acquisition Proposal or (ii) changes in the market price of Company Common Stock (it being understood that the underlying causes of any such changes may, if they are not otherwise excluded from the
      definition of &#8220;Intervening Event&#8221;, be taken into account in determining whether an Intervening Event has occurred).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>IRS</u>&#8221; means the Internal Revenue Service.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>IT Assets</u>&#8221; means computers, Software, middleware, servers, workstations, routers, hubs, switches, data communications lines
      and other information technology equipment, and all associated documentation, in each case, that is either owned by the Acquired Companies or used and controlled by the Acquired Companies.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Liabilities</u>&#8221; means any and all Indebtedness, liabilities, commitments or obligations, whether accrued or fixed, known or
      unknown, absolute or contingent, matured or unmatured, liquidated or unliquidated, determined or determinable, on- or off-balance sheet, and whether arising in the past, present or future, and including those arising under any Contract, Proceeding or
      Order.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Lien</u>&#8221; means, with respect to any property or asset, any charge, claim, adverse interest, community property interest, pledge,
      hypothecation, condition, lien (statutory or other), option, security interest, mortgage, deed of trust, encumbrance, easement, encroachment, lease, sublease, license, sublicense, right of way, right of first refusal, or restriction of any kind,
      including any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership or any interest or restriction similar in substance to any of the foregoing.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#160;&#8220;<u>Made Available</u>&#8221; means that, prior to the execution of this Agreement, such information, document or material was (i) made
      publicly available by the Company in unredacted form on the SEC&#8217;s EDGAR database with respect to the Acquired Companies or (ii)&#160;made available for review by Parent or Parent&#8217;s Representatives in the Data Room or otherwise provided in writing to
      Parent or Parent&#8217;s Representatives by or on behalf of the Company (including in any &#8220;clean room&#8221; or on an &#8220;outside counsel only&#8221; basis).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Nasdaq</u>&#8221; means the NASDAQ Global Select Market.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Non-Minimum Tender Offer Conditions</u>&#8221; means the Offer Conditions other than the Minimum Tender Condition.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Option Consideration</u>&#8221; means, with respect to any Company Stock Option, an amount equal to the product of (x) the number of
      Shares issuable under such Company Stock Option <u>multiplied</u> by (y) the excess (if any) of (i) the Per Share Amount <u>over</u> (ii) the exercise price payable in respect of each Share issuable under such Company Stock Option, <u>less</u>
      applicable Taxes required to be withheld.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Order</u>&#8221; means, with respect to any Person, any order, injunction, judgment, decision, determination, award, writ, ruling,
      stipulation, assessment or decree or other similar requirement of, or entered, enacted, adopted, promulgated or applied by, with or under the supervision of, a Governmental Authority or arbitrator.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Organizational Documents</u>&#8221; means, with respect to any Person that is not a natural person, the articles of incorporation,
      certificate of incorporation, charter, certificates of designations, bylaws, stockholders&#8217; agreement, articles of formation, certificate of formation, operating agreement, partnership agreement, certificate of limited partnership and all other
      similar documents, instruments or certificates executed, adopted or filed in connection with the creation, formation or organization of such Person, including any amendments thereto or restatements thereof.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Parent Material Adverse Effect</u>&#8221; means any Effect that, individually or in the aggregate with one or more other Effects, does
      or would reasonably be expected to prevent, materially delay or materially impair Merger Sub or Parent from consummating the Offer or the Merger, on a timely basis and in any event on or before the End Date.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Permits</u>&#8221; means all permits, licenses, consents, franchises, approvals, privileges, immunities, authorizations, exemptions,
      registrations, certificates, variances and similar rights obtained from a Governmental Authority.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Permitted Liens</u>&#8221; means (i) Liens for Taxes that (A) are not yet due and payable or (B) are being contested in good faith by
      appropriate proceedings, in each case only if adequate reserves with respect thereto have specifically been established in the Financial Statements, to the extent required by GAAP, (ii) Liens of carriers, warehousemen, mechanics, materialmen,
      repairmen and other similar common law or statutory Liens arising or incurred in the ordinary course of business consistent with past practice that (A) relate to obligations that are not delinquent or (B) the Company or any of the Company
      Subsidiaries is contesting in good faith by appropriate proceedings and for which adequate reserves have specifically been established in the Audited Balance Sheet, to the extent required by GAAP, (iii) Liens arising under original purchase price
      conditional sales Contracts and equipment leases with third parties entered into in the ordinary course of business consistent with past practice that are not, individually or in the aggregate, material to the business of the Acquired Companies,
      taken as a whole, (iv) zoning, entitlement, building and land use ordinances, codes and regulations imposed by any Governmental Authority that are not materially violated by or do not place any material restrictions or limitations on any current use,
      occupancy or activity conducted by the Company or any of the Company Subsidiaries, (v) in the case of the Leased Property, any Lien to which the fee simple interest (or any superior leasehold interest) is subject, (vi) Liens in favor of the lessors
      on any personal property located at the demised premises under the Lease Agreements, (vii) real property easements, rights-of-way, encroachments, restrictions, conditions or imperfections of title or other similar Liens that have arisen in the
      ordinary course of business which, individually and in the aggregate, do not and would not materially impair the use (or contemplated use), utility or value of the applicable real property or otherwise materially impair the present or contemplated
      business operations at such location, (viii) non-exclusive licenses of Intellectual Property granted in the ordinary course of business, (ix) any Liens which are disclosed on the Financial Statements, (x) Liens discharged prior to the consummation of
      the Offer and (xi) any Liens that are not, individually or in the aggregate, material to the business or operations of the Acquired Companies, taken as a whole.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Person</u>&#8221; means any individual, general or limited partnership, corporation, limited liability company, business trust, joint
      stock company, trust, unincorporated organization, joint venture, firm, association or other entity or organization (whether or not a legal entity), including any Governmental Authority (or any department, agency or political subdivision thereof) and
      any syndicate or group that would be deemed to be a person under Section 13(d)(3) of the Exchange Act.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Pilot Program Industry</u>&#8221; means any industry identified in Annex A to part 801 of Title 31 of the Code of Federal Regulations by
      reference to the North American Industry Classification System (NAICS).</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Proceeding</u>&#8221; means any suit (whether civil, criminal, administrative, or judicial), action, litigation, arbitration, proceeding
      (including any civil, criminal, administrative or appellate proceeding), hearing, criminal prosecution, investigation (but only to the extent that the Company has been notified in writing by the investigating Governmental Authority of such
      investigation) or SEC &#8220;Wells&#8221; process, in each case, whether at law or in equity, commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Authority or any arbitrator or arbitration panel (and, in
      each case, including if resulting from a claim, charge, complaint, citation or demand).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Product</u>&#8221; means any form or dosage of <font style="background-color: #FFFFFF;">inclisiran</font>.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Release</u>&#8221; means any actual or threatened release, spilling, leaking, pumping, pouring, emitting, emptying, discharging,
      injecting, escaping, leaching, dumping, abandonment, disposing or allowing to escape or migrate into or through the environment (including ambient air (indoor or outdoor), surface water, groundwater, land surface or subsurface strata).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Representatives</u>&#8221; means, with respect to any Person, the directors, officers, employees, financial advisors, attorneys,
      accountants (other than independent public accountants), consultants, agents and other authorized representatives and advisors of such Person.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Sanctioned Country</u>&#8221; means any country or region subject to economic sanctions or trade restrictions of the United States,
      Japan, the United Kingdom, the European Union or the United Nations that broadly prohibit or restrict dealings with such country or region (currently Cuba, Iran, North Korea, the Crimea and Syria).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Sanctioned Person</u>&#8221; means any Person subject to economic sanctions, trade restrictions, or similar restrictions under any
      Sanctions Laws, including (i) any Person identified in any sanctions list maintained by (A) the U.S. government, including the U.S. Department of Treasury, Office of Foreign Assets Control, the U.S. Department of Commerce, Bureau of Industry and
      Security, and the U.S. Department of State; (B) the government of Japan; (C)&#160;the government of the United Kingdom, including HM Treasury; (D) the European Union; or (E)&#160;the United Nations Security Council; (ii) any Person located, organized, or
      resident in, or a government instrumentality of, any Sanctioned Country; and (iii) any Person directly or indirectly owned or controlled by or acting for the benefit or on behalf of a Person described in clause (i) or (ii).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Sanctions Laws</u>&#8221; means all Applicable Laws concerning embargoes, economic sanctions, export or import controls or restrictions,
      the ability to make or receive international payments, the ability to engage in international transactions, or the ability to take an ownership interest in assets located in a foreign country, including those administered by Office of Foreign Assets
      Control of the U.S. Department of Treasury, the Bureau of Industry and Security of the U.S. Department of Commerce, and the U.S. Department of State, the United Nations Security Council, the European Union or HM Treasury and any other similar laws of
      any other jurisdiction.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Sarbanes-Oxley Act</u>&#8221; means the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated thereunder.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>SEC</u>&#8221; means the U.S. Securities and Exchange Commission.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, and the rules and regulations promulgated thereunder.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Software</u>&#8221; has the meaning set forth in the definition of &#8220;Intellectual Property.&#8221;</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Subsidiary</u>&#8221; means, with respect to any Person, any other Person with respect to which the first Person (alone or in
      combination with any of such first Person&#8217;s other Subsidiaries) owns (i) capital stock or other equity interests having the ordinary voting power to elect a majority of the board of directors or other governing body of such other Person or (ii) a
      majority of the outstanding voting securities of such other Person.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Substantial Detriment</u>&#8221; means any sale, divestiture, license or disposition of any assets, properties or businesses, or any
      other action, concession or undertaking, with respect to or relating to (i) any tangible or intangible assets (including Contracts and Intellectual Property) or personnel embodied in or relating to the Product, or (ii) any relationships,
      arrangements, Contracts or obligations relating to the development, manufacturing, commercialization or other exploitation of the Product or any Intellectual Property embodied in or relating thereto, that, in each case, would be materially
      detrimental to the benefits expected to be derived by Parent and its Affiliates from the Transactions.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Superior Proposal</u>&#8221; means a bona fide written Acquisition Proposal (<u>provided</u> that for this purpose the references to
      &#8220;twenty percent (20%)&#8221; in the definition of Acquisition Transaction shall be deemed to be references to &#8220;fifty percent (50%)&#8221;) that did not result from a material breach of <u>Section 6.02</u> and that the Company Board determines in its good faith
      judgment (after consultation with its financial advisors and outside legal counsel) (i) is reasonably likely to be consummated in accordance with its terms and (ii) would, if consummated, result in a transaction that is more favorable to the
      Company&#8217;s stockholders from a financial point of view than the Transactions.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Tax</u>&#8221; means any tax or other similar governmental assessment or charge of any kind whatsoever including income, franchise,
      profits, corporations, gross receipts, transfer, excise, property, sales, use, value-added, ad valorem, license, capital, wage, employment, payroll, withholding, social security, severance, occupation, import, custom, stamp, alternative, add-on
      minimum, environmental or other governmental taxes or charges (including taxes, charges, or other assessments which are imposed upon or incurred under Treasury Regulation &#167;1.1502-6 (or any similar provision of state, local or foreign law) as a result
      of membership in an affiliated, consolidated, combined or unitary group for Tax purposes, or as transferee or successor, by contract or otherwise), together with any interest, penalty, or addition to tax with respect thereto, whether disputed or not
      and including any obligations to indemnify or otherwise assume or succeed to the Tax liability of any other Person (other than any such obligations arising under commercial agreements or arrangements entered into in the ordinary course of business).</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Tax Return</u>&#8221; means any report, return, document, declaration or information return required to be filed with or supplied to a
      Taxing Authority (including any amendments thereto and including any schedule or statement thereto).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Taxing Authority</u>&#8221; means any Governmental Authority exercising any authority to determine, impose, regulate, collect, levy,
      assess, enforce or administer any Tax.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Third Party</u>&#8221; means any Person or &#8220;group&#8221; (as defined under Section 13(d) of the Exchange Act) of Persons, other than Parent,
      Merger Sub, the Company or any of their respective Affiliates or Representatives (solely in their capacity as such).</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Transaction Litigation</u>&#8221; means any claim or Proceeding against the Company or any of its directors or officers (including any
      class action or derivative litigation) relating, directly or indirectly, to this Agreement, the Merger, the Offer or the other Transactions, including disclosures made under securities laws and regulations related thereto.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Treasury Regulations</u>&#8221; means the regulations promulgated under the Code by the United States Department of Treasury.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Unaudited Balance Sheet</u>&#8221; means the unaudited condensed consolidated balance sheet of the Acquired Companies, as of September
      30, 2019, included in the Company SEC Documents prior to the date of this Agreement.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Unaudited Financial Statements</u>&#8221; means the unaudited condensed consolidated financial statements of the Acquired Companies
      consisting of the Unaudited Balance Sheet and all of the related condensed consolidated statements of income and comprehensive income, cash flows and equity of the Acquired Companies as of and for the nine (9) months ended September 30, 2019
      (including, in each case, any related notes thereto), included in the Company SEC Documents prior to the date of this Agreement.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">&#8220;<u>Willful Breach</u>&#8221; means, with respect to any representation, warranty, agreement or covenant in this Agreement, an intentional
      act or omission (including a failure to cure circumstances) where the breaching party knows such action or omission is or would reasonably be expected to result in a breach of this Agreement, <u>it</u>&#160;<u>being</u>&#160;<u>understood</u> that such term
      shall include, in any event, the failure to consummate the Offer or the Closing when required to do so by this Agreement or the failure to take actions required by this Agreement the failure of which to be taken would reasonably be expected to result
      in a failure of any of the Offer Conditions or a failure of the Closing to occur.</div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Each of the following terms is defined
        in the Section set forth opposite such term:</font></div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze03e4fc12c734d04bd14d2a8ec9593ac" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 79.81%; vertical-align: top;">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Term</u></div>
          </td>
          <td style="width: 20.19%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Section</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Agreement&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Alternative Acquisition Agreement&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.02(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Bankruptcy and Equity Exceptions&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.03(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Board Recommendation&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.03(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Capitalization Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.06(a)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

        <tr>
          <td rowspan="1" style="width: 79.81%; vertical-align: top; font-weight: bold;"><u>Term</u></td>
          <td rowspan="1" style="width: 20.19%; vertical-align: top; font-weight: bold;"><u>Section</u></td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Certificate of Merger&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.04(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Certificates&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.06(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Change in Recommendation&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.02(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Closing&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.03</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Collaboration Partner&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.24(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company 401(k) Plan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.05(f)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Board&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Common Stock&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Disclosure Letter&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Article 4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Employee Plan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.18(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Employees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.18(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company ESPP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.08(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Preferred Stock&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.06(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Related Parties&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">9.04(h)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company SEC Documents&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.08(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Securities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.06(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Stock Plans&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.06(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Current Policy&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.08(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Current Premium&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.08(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Delaware Secretary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.04(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Depository Agent&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.06(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">DGCL&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Dissenting Shares&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.07</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Effect&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1.01(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Effective Time&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.04(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">EMA&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.24(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">End Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">8.01(b)(i)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Environmental Permits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.21(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Exclusive Rights&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.16(b)(iii)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Filed Company Contract&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.16(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">GDPR&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.22(h)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Health Care Laws&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.24(j)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Health Care Submissions&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.24(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Indemnified Party&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.08(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Lease Agreement&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.23(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Leased Property&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.23(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Merger&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Merger Agreement&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Annex A</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Merger Consideration&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.05(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Merger Sub&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Minimum Tender Condition&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Annex A</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Offer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Offer Conditions&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.01(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Offer Documents&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.01(f)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

        <tr>
          <td rowspan="1" style="width: 79.81%; vertical-align: top; font-weight: bold;"><u>Term</u></td>
          <td rowspan="1" style="width: 20.19%; vertical-align: top; font-weight: bold;"><u>Section</u></td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Offer Expiration Time&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.01(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Parent&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Parent 401(k) Plan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.05(f)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Parent Benefit Plans&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.05(d)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Parent Disclosure Letter&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Article 5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Paying Agent&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.06(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Payment Fund&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.06(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Per Share Amount&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Personal Data&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.22(h)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Pre-Closing Period&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.01(a)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">prohibited transaction&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.18(e)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Privacy Requirements&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.22(h)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Schedule 14D-9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.02(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Share&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Specified Contract&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.16(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Stockholder List Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.02(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Superior Proposal Notice&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6.02(e)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Surviving Corporation&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.04(c)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Surviving Corporation Common Stock&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2.05(e)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Termination Condition&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Annex A</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Termination Fee&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(198, 244, 249);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">9.04(b)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79.81%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="margin-right: 8.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Transactions&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td style="width: 20.19%; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Recitals</div>
          </td>
        </tr>

    </table>
    <div style="margin-right: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 1.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Other
          Definitional and Interpretative Provisions</u>.&#160; The words &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereto&#8221; and &#8220;hereunder&#8221; and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this
        Agreement.&#160; The headings and captions contained herein are included for convenience of reference only and shall be ignored in the construction or interpretation hereof.&#160; References to Articles, Sections, Exhibits, Annexes and Schedules are to
        Articles, Sections, Exhibits, Annexes and Schedules of this Agreement unless otherwise specified and references to clauses without a cross-reference to a Section or subsection are references to clauses within the same Section or subsection.&#160; All
        Exhibits, Annexes and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein.&#160; Any capitalized terms used in any Exhibit, Annex or Schedule but not otherwise
        defined therein shall have the meaning as defined in this Agreement.&#160; Any singular term in this Agreement shall be deemed to include the plural, and any plural term the singular.&#160; Whenever the words &#8220;include,&#8221; &#8220;includes&#8221; or &#8220;including&#8221; are used in
        this Agreement, they shall be deemed to be followed by the words &#8220;without limitation,&#8221; whether or not they are in fact followed by those words or words of like import.&#160; &#8220;Writing,&#8221; &#8220;written&#8221; and comparable terms refer to printing, typing and other
        means of reproducing words (including electronic media) in a visible form.&#160; References (i) to &#8220;$&#8221; and &#8220;dollars&#8221; are to the currency of the United States and (ii) to &#8220;days&#8221; shall be to calendar days unless otherwise indicated.&#160; References to &#8220;from&#8221;
        or &#8220;through&#8221; any date mean, unless otherwise specified, from and including or through and including such date, respectively. &#160;No summary of this Agreement or any Exhibit, Annex, Schedule or other document delivered herewith prepared by or on behalf
        of any party will affect the meaning or interpretation of this Agreement or such </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">Exhibit, Annex&#160;or Schedule.&#160; Any reference in this Agreement to a date or time shall be deemed to be such date or time in the City of New
        York, New York, U.S.A., unless otherwise specified.&#160; Any Contract, instrument or law defined or referred to herein means such Contract, instrument or law as from time to time amended, modified or supplemented (<u>provided</u> that for purposes of
        any representations and warranties contained in this Agreement that are made as of a specific date or dates, references to (x)&#160;any Contract, instrument or statute shall be deemed to refer to such Contract, instrument or statute, as amended, as of
        such date, and (y)&#160;any rules&#160;or regulations promulgated under any such statute, in each case, as of such date). &#160;Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter
        forms.</font></div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;2</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">THE OFFER AND THE MERGER</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>The Offer</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Commencement of the Offer</u>.&#160; As
        promptly as practicable after the execution and delivery of this Agreement and in no event later than December 5, 2019, Merger Sub shall, and Parent shall cause Merger Sub to, commence (within the meaning of Rule 14d-2 promulgated by the SEC under
        the Exchange Act) the Offer to purchase any and all of the Shares at a price per Share equal to the Per Share Amount to the holder of the Share in cash, without interest.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Terms and Conditions of the Offer</u>.&#160;














        The obligations of Merger Sub to, and of Parent to cause Merger Sub to, accept for payment, and pay for, any Shares tendered pursuant to the Offer are subject only to the terms and conditions set forth in this Agreement, including the prior
        satisfaction or waiver of the Minimum Tender Condition, the Termination Condition and the other conditions set forth in <u>Annex A</u> (collectively, the &#8220;<u>Offer Conditions</u>&#8221;).&#160; Merger Sub expressly reserves the right (but is not obligated
        to) at any time and from time to time in its sole discretion to waive, in whole or in part, any Offer Condition or modify the terms of the Offer (including by increasing the Per Share Amount), in each case only (and Merger Sub shall not do so
        except) in a manner not inconsistent with the terms of this Agreement, except that, for the avoidance of doubt, without the prior written consent of the Company, Merger Sub shall not (i) reduce the number of Shares subject to the Offer, (ii) reduce
        the Per Share Amount, (iii) directly or indirectly amend, modify, supplement or waive the Minimum Tender Condition or the Termination Condition, (iv) add to or directly or indirectly amend, modify or supplement any Offer Condition, (v) directly or
        indirectly amend, modify or supplement any other term of the Offer in any individual case in any manner adverse to the holders of Shares or that would, individually or in the aggregate, reasonably be expected to prevent or materially delay the
        consummation of the Offer or the Merger or impair the ability of Parent or Merger Sub to consummate the Offer, (vi) extend or otherwise change the Offer Expiration Time (except as expressly required or permitted by the other provisions of this <u>Section














          2.01</u>), (vii) change the form of consideration payable in the Offer or (viii) provide for any &#8220;subsequent offering period&#8221; (or any extension of any thereof) within the meaning of Rule 14d-11 under the Exchange Act.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Expiration and Extension of the
          Offer</u>.&#160; The expiration date and time for the Offer, as the same may be extended from time to time, is hereinafter referred to as the &#8220;<u>Offer Expiration Time</u>.&#8221;&#160; The initial Offer Expiration Time shall be 11:59 p.m. (New York City time)
        on the twentieth (20th) Business Day following (and including the day of) commencement of the Offer (determined pursuant to Exchange Act Rule 14d-1(g)(3)).&#160; Subject to the parties&#8217; respective rights to terminate the Agreement pursuant to <u>Section














          8.01</u> and notwithstanding anything to the contrary in this Agreement, Merger Sub shall (and Parent shall cause Merger Sub to):</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">extend the Offer for any period
        required by any applicable rule, regulation, interpretation or position of the SEC or the staff thereof or Nasdaq (including in order to comply with Exchange Act Rule 14e-1(b) in respect of any change in the Per Share Amount) or as may be necessary
        to resolve any comments of the SEC or the staff or Nasdaq, in each case, as applicable to the Offer, the Schedule 14D-9 or the Offer Documents; and</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">if, as of any then-scheduled Offer
        Expiration Time, any Offer Condition is not satisfied and has not been waived by Parent or Merger Sub (to the extent permitted hereunder), extend the Offer (x) on one or more occasions in consecutive increments of up to five (5) Business Days each
        (or such longer or shorter period as the parties hereto may agree) or (y) if any then-scheduled Offer Expiration Time is five (5) or less Business Days before the End Date, until 11:59 p.m., New York City Time, on the day before the End Date (or
        such other date and time as the parties hereto may agree);</font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u> that, without the Company&#8217;s written consent, Merger Sub shall not extend the Offer, and without Parent&#8217;s prior written consent, Merger
      Sub shall not be required to extend the Offer, in each case, beyond the earlier of the End Date or the valid termination of this Agreement in accordance with <u>Section 8.01</u>.</div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Consummation of the Offer; Payment</u>.&#160;














        On the terms and subject to the conditions of the Offer and this Agreement, Merger Sub shall (and Parent shall cause Merger Sub to) (i) consummate the Offer and accept for payment all Shares validly tendered and not withdrawn pursuant to the Offer
        promptly after (in any event, no later than the first (1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>) Business Day after) the Offer Expiration Time and (ii) promptly after (in any event, no more than the
        second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) Business Days after) the Offer Expiration Time, pay for such Shares.&#160; Parent shall provide or cause to be provided to Merger Sub on a timely basis the
        funds necessary to purchase any Shares that Merger Sub becomes obligated to purchase pursuant to the Offer.&#160; The Per Share Amount shall be paid to the holder of the Share in cash, without interest, upon the terms and subject to the conditions of
        the Offer.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Termination of the Offer</u>.&#160;
        Parent and Merger Sub shall not terminate the Offer or permit the Offer to be terminated prior to the Offer Expiration Time (as it may be extended and re-extended in accordance with this Agreement), unless and until this Agreement is validly
        terminated in accordance with <u>Section 8.01</u>.&#160; In the event that this Agreement is validly terminated pursuant to <u>Section 8.01</u> prior to any scheduled expiration of the Offer, Merger Sub shall, and Parent shall cause Merger Sub to,
        promptly (but in any event not more than one (1) Business Day after such termination) irrevocably and unconditionally terminate the Offer.&#160; If the Offer is terminated or withdrawn by Merger Sub, Merger Sub shall </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">promptly return, and shall cause any depository acting on behalf of Merger Sub to return, all tendered Shares to the record holders thereof
        in accordance with Applicable Law.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Offer Documents</u>.&#160; On the date of
        commencement of the Offer (determined pursuant to Exchange Act Rule 14d-2), Parent and Merger Sub shall (i) file with the SEC, in accordance with Exchange Act Rule 14d-3, a Tender Offer Statement on Schedule TO with respect to the Offer, which
        Tender Offer Statement shall contain an offer to purchase and a related letter of transmittal, summary advertisement, notice of guaranteed delivery and other ancillary offer documents pursuant to which the Offer will be made (such Schedule TO and
        documents, together with any exhibits, supplements or amendments thereto, the &#8220;<u>Offer Documents</u>&#8221;) and (ii) cause the Offer Documents to be disseminated to holders of Shares, in each case, as and to the extent required by Applicable Law.&#160; The
        Company shall promptly furnish Parent and Merger Sub with all information concerning the Company and its stockholders required by the Exchange Act or other Applicable Law to be set forth in the Offer Documents and all other information concerning
        the Company and its stockholders as reasonably requested by Parent and Merger Sub for inclusion in the Offer Documents and, unless previously withdrawn in accordance with <u>Section 6.02(d)</u> or <u>Section 6.02(e)</u>, shall allow Parent and
        Merger Sub to include the Board Recommendation in the Offer Documents.&#160; Parent and Merger Sub shall cause the Offer Documents to comply in all material respects with the requirements of Applicable Law and, on the date first filed with the SEC and
        on the date first published, sent or given to the holders of Shares, not to contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in
        light of the circumstances under which they were made, not misleading, except that no covenant is made by Parent or Merger Sub with respect to information supplied by the Company in writing specifically for inclusion or incorporation by reference
        in the Offer Documents.&#160; Each of Parent, Merger Sub and the Company shall promptly correct any information provided by it for use in the Offer Documents if and to the extent that such information is or shall have become false or misleading in any
        material respect, and each of Parent and Merger Sub shall take all steps necessary to amend or supplement the Offer Documents and to cause the Offer Documents as so amended or supplemented to be filed with the SEC and disseminated to the holders of
        Shares, in each case, as and to the extent required by Applicable Law.&#160; The Company and its counsel shall be given a reasonable opportunity to review and comment upon the Offer Documents and any amendments and supplements thereto prior to filing
        such documents with the SEC or dissemination of such documents to the stockholders of the Company and Parent and Merger Sub shall give reasonable and good faith consideration to any comments made by the Company and its counsel.&#160; Parent and Merger
        Sub shall (A) provide the Company and its counsel any written comments that Parent, Merger Sub or their counsel may receive from the SEC or its staff with respect to the Offer Documents promptly after the receipt of such comments (and shall give
        the Company and its counsel prompt telephonic notice of any material discussions with or oral comments received from the SEC staff), (B) provide the Company and its counsel a reasonable opportunity to review and comment upon the proposed responses
        to any such comments and a copy of any proposed written responses thereto prior to the filing thereof, and (C) give reasonable and good faith consideration to any comments made by the Company and its counsel on any such proposed responses.&#160; Parent
        and Merger Sub shall respond promptly to any comments of the SEC or its staff with respect to the Offer Documents.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">18</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Guaranteed Delivery</u>.&#160; For
        purposes of this Agreement and the Offer, unless mutually agreed by Parent and the Company, any Shares subject to notices of guaranteed delivery shall be deemed not to be validly tendered into the Offer unless and until the Shares underlying such
        notices of guaranteed delivery are &#8220;received&#8221; (as defined by Section 251(h) of the DGCL) by Merger Sub or by an agent of Merger Sub.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Notification of Offer Status</u>.&#160;
        Parent shall keep the Company reasonably informed on a reasonably current basis of the status of the Offer, including with respect to the number of Shares that have been validly tendered and not validly withdrawn in accordance with the terms of the
        Offer, and with respect to any material developments with respect thereto and, upon the Company&#8217;s written request, provide the Company as soon as practicable with the most recent report then available from the Depository Agent detailing the number
        of Shares that have been validly tendered and not validly withdrawn in accordance with the terms of the Offer.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Company
          Actions</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Approval</u>.&#160; The Company hereby
        approves of and consents to the Transactions.&#160; The Company agrees that no Shares held by the Company or any of the Company Subsidiaries (other than any such shares held on behalf of third parties) will be tendered pursuant to the Offer.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Schedule 14D-9</u>.&#160; Concurrently
        with or as soon as reasonably practicable following the filing of the Schedule TO with the SEC, the Company shall (i) file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the Offer (such Schedule 14D-9, as
        amended or supplemented from time to time and including any exhibits thereto, the &#8220;<u>Schedule 14D-9</u>&#8221;) and, unless previously withdrawn in accordance with <u>Section 6.02(d)</u> or <u>Section 6.02(e), shall include in the Schedule 14D-9, </u>the














        Board Recommendation.&#160; The Company shall (i) include in the Schedule 14D-9 a notice of appraisal rights and (ii) cause the Schedule 14D-9 to be disseminated to holders of Shares as and to the extent required by Rule 14d-9 promulgated under the
        Exchange Act and any other Applicable Law, including by setting the Stockholder List Date as the record date for purposes of receiving the notice required by Section 262(d)(2) of the DGCL.&#160; Parent and Merger Sub shall promptly furnish the Company
        with all information concerning Parent and Merger Sub required by the Exchange Act to be set forth in the Schedule 14D-9, and all other information concerning Parent and Merger Sub as reasonably requested by the Company for inclusion in the
        Schedule 14D-9.&#160; The Company shall cause the Schedule 14D-9 to comply in all material respects with the requirements of Applicable Law and, on the date first filed with the SEC and on the date first published, sent or given to the holders of
        Shares, not to contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
        misleading, except that no covenant is made by the Company with respect to information supplied by Parent or Merger Sub in writing specifically for inclusion or incorporation by reference in the Schedule 14D-9.&#160; Each of the Company, Parent and
        Merger Sub shall promptly correct any information provided by it for use in the Schedule 14D-9 if and to the extent that such information shall have become false or misleading in any material respect, and the Company shall take all steps necessary
        to amend or supplement the Schedule 14D-9 and to cause </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">19</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">the Schedule 14D-9 as so amended or supplemented to be filed with the SEC and disseminated to the holders of Shares, in each case as and to
        the extent required by Applicable Law.&#160; Parent and its counsel shall be given a reasonable opportunity to review and comment upon the Schedule 14D-9 and any amendments and supplements thereto prior to filing such documents with the SEC or
        dissemination of such documents to the stockholders of the Company and the Company shall give reasonable and good faith consideration to any comments made by Parent and its counsel.&#160; The Company shall (A) provide Parent and its counsel any written
        comments that the Company or its counsel may receive from the SEC or its staff with respect to the Schedule 14D-9 promptly after the receipt of such comments (and shall give Parent and its counsel prompt telephonic notice of any oral comments
        received from the SEC staff), (B) provide Parent and its counsel a reasonable opportunity to review and comment upon the proposed responses to any such comments and a copy of any proposed written responses thereto prior to the filing thereof and
        (C) give reasonable and good faith consideration to any comments made by Parent and its counsel on any such proposed responses.&#160; The Company shall respond promptly to any comments of the SEC or its staff with respect to the Schedule 14D-9.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Stockholder Lists</u>.&#160; In
        connection with the Offer, the Company shall instruct its transfer agent to furnish Merger Sub (x) promptly after the date of this Agreement and (y) from time to time thereafter as requested by Parent, with a list of its stockholders and mailing
        labels containing the names and addresses of the record holders of Shares as of the most recent practicable date and of those persons becoming record holders subsequent to such date, together with copies of all lists of stockholders, security
        position listings and computer files and all other information in the Company&#8217;s possession regarding the beneficial owners of the Shares, and shall furnish to Merger Sub such information and assistance (including updated lists of stockholders,
        security position listings and computer files) as Parent may reasonably request in communicating the Offer to the holders of Shares (the date of the list used to determine the Persons to whom the Offer Documents and the Schedule 14D-9 are first
        disseminated, the &#8220;<u>Stockholder List Date</u>&#8221;).&#160; Subject to Applicable Law, and except for such steps as are necessary to communicate the Offer to the holders of Shares, Parent and Merger Sub and their Representatives shall (i) hold in
        confidence such lists, files and information and will use such information only in connection with the Offer and the Merger and (ii) if this Agreement is terminated, promptly either deliver to the Company or destroy, and shall cause their
        Representatives to deliver to the Company or destroy, all copies and any extracts or summaries of such information then in their possession or control and notify the Company that all such material has been so returned or destroyed.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.03.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>The Closing</u>.&#160;














        Upon the terms and subject to the conditions set forth in this Agreement, the closing of the Merger (the &#8220;<u>Closing</u>&#8221;) will take place as soon as practicable after (but in any event on the same day as) the consummation of the Offer, subject to
        satisfaction or, to the extent permitted hereunder and by Applicable Law, waiver of all conditions set forth in <u>Article&#160;7</u> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction
        or waiver (to the extent permitted hereunder and by Applicable Law) of such conditions), unless this Agreement has been terminated pursuant to its terms or unless another time or date is agreed to in writing by the parties hereto.&#160; The Closing
        shall be held at the offices of Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP, 1285 Avenue of the Americas, New York, New York 10019, or remotely by exchange of documents and </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">20</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">signatures (or their electronic counterparts), unless another place is agreed upon in writing by the parties hereto.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.04.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>The Merger</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Effecting the Merger</u>.&#160; Upon the
        terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, as promptly as practicable on the Closing Date, Parent, Merger Sub and the Company shall (i) cause a certificate of merger (the &#8220;<u>Certificate of
          Merger</u>&#8221;), to be executed and delivered to the Office of the Secretary of State of the State of Delaware (the &#8220;<u>Delaware Secretary</u>&#8221;) for filing in such form as required by and in accordance with the applicable provisions of the DGCL and
        (ii) take all other necessary or appropriate action to cause the Merger to be effected under Section 251(h) of the DGCL without the adoption of this Agreement by the stockholders of the Company.&#160; The Merger shall be governed by and effected
        pursuant to Section 251(h) of the DGCL.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Effective Time</u>.&#160; The Merger
        shall become effective on such date and at such time as when the Certificate of Merger has been duly filed with the Delaware Secretary or at such later time and date as may be agreed by the parties in writing and specified in the Certificate of
        Merger in accordance with the DGCL (the &#8220;<u>Effective Time</u>&#8221;).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Surviving Corporation</u>.&#160; At the
        Effective Time, Merger Sub shall be merged with and into the Company in accordance with the DGCL, including Section 251(h) thereof, whereupon the separate existence of Merger Sub shall cease, and the Company shall be the surviving corporation in
        the Merger (the &#8220;<u>Surviving Corporation</u>&#8221;) and shall become a wholly owned Subsidiary of Parent, and the separate corporate existence of the Company, with all its rights, privileges, immunities, powers and franchises, shall continue unaffected
        by the Merger.&#160; Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all of the properties, rights, privileges, immunities, powers and franchises of the Company and Merger Sub shall vest in the Surviving
        Corporation, and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Effects of the Merger</u>.&#160; The
        Merger shall have the effects set forth in the applicable provisions of the DGCL, this Agreement and the Certificate of Merger.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.05.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Conversion of
          Shares</u>.&#160; At the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or any stockholder thereof or any other Person:</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">except as otherwise provided in <u>Section














          2.05(b)</u>, <u>Section 2.05(c)</u>, <u>Section 2.05(d)</u>, or <u>Section 2.07</u>, each Share outstanding immediately prior to the Effective Time shall (i) be converted automatically into the right to receive the Per Share Amount (the &#8220;<u>Merger














          Consideration</u>&#8221;) in cash, without interest and (ii) cease to be outstanding and shall automatically be canceled and cease to exist and each holder of a Certificate representing any such Shares shall have only the right to receive the Per Share
        Amount with respect thereto in accordance with <u>Section 2.06</u> or <u>Section 2.08(e)</u>, as applicable;</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">21</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each Share owned by Parent, Merger Sub
        or any other direct or indirect wholly owned subsidiary of Parent immediately prior to the Effective Time (other than Shares tendered and accepted for payment by Merger Sub in connection with the Offer) shall be canceled and cease to exist, and no
        payment shall be made with respect thereto and each holder of a Certificate representing any such Shares shall cease to have any rights with respect thereto;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each Share owned by the Company or held
        in the Company&#8217;s treasury immediately prior to the Effective Time shall be canceled and cease to exist, and no payment shall be made with respect thereto and each holder of a Certificate representing any such Shares shall cease to have any rights
        with respect thereto;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each Share owned by any direct or
        indirect wholly owned Subsidiary of the Company immediately prior to the Effective Time shall be canceled and cease to exist, and no payment shall be made with respect thereto and each holder of a Certificate representing any such Shares shall
        cease to have any rights with respect thereto; and</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each share of common stock of Merger
        Sub outstanding immediately prior to the Effective Time shall be converted into and become one fully paid, nonassessable share of common stock, par value $0.001 per share, of the Surviving Corporation (the &#8220;<u>Surviving Corporation Common Stock</u>&#8221;),














        which shall constitute the only outstanding shares of capital stock of the Surviving Corporation as of immediately following the Effective Time.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.06.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Surrender and
          Payment</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Depository Agent, Paying Agent and
          Payment Fund</u>.&#160; Prior to the expiration of the Offer, Parent shall appoint a paying agent reasonably acceptable to the Company to act as agent (the &#8220;<u>Depository Agent</u>&#8221;) for the holders of Shares to receive the aggregate Per Share Amount
        to which holders of such Shares shall become entitled pursuant to <u>Section 2.01(d)</u> and to act as agent (the &#8220;<u>Paying Agent</u>&#8221;) for the holders of Shares to receive the aggregate Merger Consideration to which holders of such Shares
        (excluding Company Restricted Shares) shall become entitled pursuant to <u>Section 2.05(a)</u>.&#160; Promptly after the expiration of the Offer, Parent shall deposit, or shall cause to be deposited, (i) with the Depository Agent cash sufficient to
        make the payment of the aggregate Per Share Amount payable pursuant to <u>Section 2.01(d)</u> and (ii) with the Paying Agent cash sufficient to pay the aggregate Merger Consideration payable pursuant to <u>Section 2.05</u>, excluding the
        aggregate Merger Consideration payable with respect to Company Restricted Shares (together with the amount deposited pursuant to clause (i), the &#8220;<u>Payment Fund</u>&#8221;).&#160; To the extent such fund diminishes for any reason below the level required to
        make prompt payment of any outstanding Per Share Amounts to be paid in exchange for Shares accepted for payment pursuant to <u>Section 2.01(d)</u> or converted in the Merger pursuant to <u>Section 2.05(a)</u>, Parent and the Surviving Corporation
        shall promptly replace or restore the lost portion of such fund so as to ensure that it is, at all times, maintained at a level sufficient to make such payments.&#160; The Payment Fund shall not be used for any purpose other than to pay the aggregate
        Per Share Amount in the Offer and the Merger.&#160; The Payment Fund shall be invested by the Paying Agent as directed by the Surviving Corporation; <u>provided</u> that such investments shall be in obligations of or guaranteed by the United States of
        America in commercial paper obligations rated A-1 or P-1 or better by Moody&#8217;s Investors Service, Inc. or Standard &amp; Poor&#8217;s Corporation, respectively, in certificates of deposit, bank repurchase agreements or banker&#8217;s </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">22</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">acceptances of commercial banks with capital exceeding $1 billion, or in money market funds having a rating in the highest investment
        category granted by a recognized credit rating agency at the time of acquisition or a combination of the foregoing and, in any such case, no such instrument shall have a maturity exceeding three (3) months.&#160; Promptly after the Effective Time and in
        any event no later than five (5) Business Days after the Effective Time, Parent shall send, or shall cause the Paying Agent to send, to each record holder of Shares at the Effective Time, in each case whose Shares were converted into the right to
        receive the Per Share Amount pursuant to <u>Section 2.05(a)</u>, a letter of transmittal and instructions (which shall specify that delivery of the Shares shall be effected, and risk of loss and title shall pass, only upon proper delivery or
        transfer of the certificate representing the Shares (the &#8220;<u>Certificates</u>&#8221;; <u>provided</u>, <u>however</u>, that any references herein to &#8220;Certificates&#8221; are deemed to include references to effective affidavits of loss in accordance with <u>Section












          2.12</u> or to book-entry account statements relating to the ownership of Shares, as applicable) to the Paying Agent and shall be in such form and have such other provisions as Parent may reasonably specify (after due consultation with the
        Company) prior to the consummation of the Offer) for use in effecting the surrender of Certificates in exchange for payment of the Per Share Amount for each Share.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Surrender of Shares</u>.&#160; Each
        holder of Shares that have been converted into the right to receive the Per Share Amount shall be entitled to receive the Per Share Amount in respect of the Shares represented by a Certificate promptly upon (i) surrender to the Paying Agent of the
        Certificate (<u>provided</u>, <u>however</u>, that delivery of a book-entry statement shall not be required in respect of any uncertificated Shares held of record in book-entry), together with a duly completed and validly executed letter of
        transmittal and such other documents as may reasonably be requested by the Paying Agent, or (ii) receipt of an &#8220;agent&#8217;s message&#8221; by the Paying Agent (or such other evidence, if any, of transfer as the Paying Agent may reasonably request) in the
        case of the exchange of book-entry Shares.&#160; Until so surrendered or transferred each such Certificate shall represent after the Effective Time for all purposes only the right to receive such Per Share Amount.&#160; No interest shall be paid or accrued
        on the cash payable upon the surrender or transfer of such Certificate.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Unregistered Transferees</u>.&#160; If
        any portion of the aggregate Per Share Amount to be paid in respect of any Certificate is to be paid to a Person other than the Person in whose name the surrendered Certificate is registered, it shall be a condition to such payment that (i) either
        such Certificate shall be properly endorsed or shall otherwise be in proper form for transfer and (ii) the Person requesting such payment shall either pay to the Paying Agent any transfer or other Tax required as a result of such payment being made
        to a Person other than the registered holder of such Certificate or otherwise establish to the satisfaction of the Paying Agent that such Tax has been paid or is not payable.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>No Other Rights</u>.&#160; The Per Share
        Amount paid upon the surrender of Certificates or book-entry Shares in accordance with the terms hereof shall be deemed to have been paid in full satisfaction of all rights pertaining to the Shares formerly represented by such Certificate or
        book-entry Share and from and after the Effective Time, the Surviving Corporation shall not permit any further registration of transfers of Shares on the stock transfer books of the Surviving Corporation.&#160; If, after the Effective Time, any
        Certificate is presented to the Surviving Corporation, Parent or the Paying Agent for transfer, the holder of such Certificates shall be given a copy of a letter of transmittal and instructed to comply with the instructions therein in </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">23</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">order to receive the Per Share Amount to which such holder is entitled pursuant to the Merger.&#160; From and after the Effective Time, the
        holders of the Shares outstanding immediately prior to the Effective Time shall cease to have any rights with respect to such Shares except to receive, upon surrender of a Certificate or book-entry Share pursuant to and in accordance with this <u>Section












          2.06</u>, the Per Share Amount in respect of each Share represented thereby, except as otherwise provided herein or by Applicable Law.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Termination of the Payment Fund</u>.&#160;














        Any portion of the Payment Fund that remains unclaimed by the holders of Shares at any time following the date that is twelve (12) months after the Effective Time shall be delivered to Parent, upon demand, and any such holder who has not exchanged
        Shares for the Per Share Amount in accordance with this <u>Section 2.06</u> prior to that time shall, subject to abandoned property, escheat or other Applicable Laws, thereafter look only to the Surviving Corporation (subject to <u>Section 2.11</u>)
        as general creditors thereof for payment of the Per Share Amount.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.07.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Dissenting
          Shares</u>.&#160; Notwithstanding <u>Section 2.06</u> or any other provision of this Agreement to the contrary, Shares issued and outstanding immediately prior to the Effective Time and held by a holder who is entitled to demand appraisal and who has
        properly exercised and perfected a demand for appraisal of such Shares in accordance with Section 262 of the DGCL and, as of the Effective Time, has neither effectively withdrawn nor lost such holder&#8217;s right to appraisal and payment under the DGCL
        with respect to such Shares (any such Shares, &#8220;<u>Dissenting Shares</u>&#8221;) shall not be converted into a right to receive the Per Share Amount but instead shall be entitled only to such rights as are granted by the DGCL to a holder of Dissenting
        Shares; <u>provided</u>, <u>however</u>, that, if, after the Effective Time, such holder fails to perfect, withdraws, waives or otherwise loses such holder&#8217;s right to appraisal pursuant to Section 262 of the DGCL or if a court of competent
        jurisdiction shall determine that such holder is not entitled to the relief provided by Section 262 of the DGCL, such Shares shall immediately cease to be Dissenting Shares and shall be treated as if they had been Shares converted as of the
        Effective Time into the right to receive the Per Share Amount in accordance with <u>Section 2.05(a)</u>, without interest thereon, upon surrender of such Certificate formerly representing such Shares.&#160; The Company shall provide Parent with prompt
        written notice of any demands received by the Company for appraisal of any Shares, any withdrawal of any such demand and any other demand, notice and/or instrument delivered to the Company prior to the Effective Time pursuant to Section 262 of the
        DGCL that relates to such demand, and Parent shall have the opportunity and right to direct all negotiations and proceedings with respect to such demands.&#160; Except with the prior written consent of Parent, or if required by Applicable Law, the
        Company shall not make any payment with respect to, or offer to settle or settle, any such demands.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.08.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Company Stock
          Options; Company Restricted Shares; Company ESPP</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Company Stock Options</u>.&#160; Each
        Company Stock Option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, shall become fully vested and shall be canceled as of immediately prior to, and contingent upon, the Effective Time (without regard to
        the exercise price of such Company Stock Option) in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, with respect to such Company Stock Option; <u>provided</u>, <u>however</u>, that if
        the </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">24</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">per-share exercise price of any such Company Stock Option is equal to or greater than the Per Share Amount, such Company Stock Option shall
        be canceled and terminated without any cash payment being made in respect thereof.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Restricted Shares</u>.&#160; Each Company
        Restricted Share outstanding immediately prior to the consummation of the Offer shall, automatically and without any required action on the part of the holder thereof, become fully vested as of immediately prior to, and contingent upon, the
        Effective Time, and shall be treated in accordance with <u>Section 2.05</u> above, subject to <u>Section 2.08(e)</u> and <u>Section 2.10</u> below.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Company ESPP</u>.&#160; As soon as
        practicable following the date of this Agreement, the Company shall take all reasonable actions, including adopting any necessary resolution, to (i) terminate the Company&#8217;s 2010 Employee Stock Purchase Plan, as amended (the&#160;&#8220;<u>Company ESPP</u>&#8221;),
        as of immediately prior to the Closing Date, (ii) ensure that no offering period under the Company ESPP shall commence on or after the date of this Agreement, (iii)&#160;if the Closing shall occur prior to the end of any offering period in existence
        under the Company ESPP on the date of this Agreement, cause a new exercise date to be set under the Company ESPP, which date shall be ten (10) Business Days prior to the initial Offer Expiration Time, for the automatic exercise of such options on
        such date, (iv)&#160;prohibit participants in the Company ESPP from altering their payroll deductions from those in effect on the date of this Agreement (other than to discontinue their participation in the Company ESPP in accordance with the terms and
        conditions of the Company ESPP) and (v)&#160;provide that the amount of the accumulated contributions of each participant under the Company ESPP as of immediately prior to the Offer Expiration Time shall, to the extent not used to purchase shares of
        Company Common Stock in accordance with the terms and conditions of the Company ESPP (as amended pursuant to this <u>Section 2.08(c)</u>), be refunded to such participant as promptly as practicable following the Effective Time (without interest).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">At or prior to the consummation of the
        Offer, the Company, the Company Board and the Compensation Committee of the Company Board, as applicable, shall adopt any resolutions and take any actions that are necessary to effectuate the provisions of this <u>Section 2.08</u>.&#160; The Company
        shall take all actions necessary to ensure that from and after the Effective Time, neither Parent nor the Surviving Corporation will be required to deliver Shares or other capital stock of the Company to any Person pursuant to or in settlement of
        Company Equity Awards.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As soon as reasonably practicable after
        the Effective Time (but no later than ten (10) calendar days after the Effective Time), the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, pay the amounts provided for in <u>Section 2.08(a)</u> - <u>Section
          2.08(b)</u> that are payable with respect to Company Stock Options and Company Restricted Shares through, to the extent applicable, the Surviving Corporation&#8217;s payroll to the holders of Company Stock Options and Company Restricted Shares.&#160; As of
        the consummation of the Offer, each holder of a Company Stock Option or Company Restricted Share shall cease to have any rights with respect thereto, except the right to receive the payments provided for under this <u>Section 2.08</u>.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">25</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">To the extent a payment pursuant in
        this <u>Section 2.08</u> would trigger a Tax or penalty under Section&#160;409A of the Code, such payment shall be made on the earliest date that payment would not trigger such Tax or penalty.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.09.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Adjustments</u>.&#160;














        If, during the period between the date of this Agreement and the Effective Time, any change in the outstanding shares of capital stock of the Company shall occur, including by reason of any reclassification, recapitalization, consolidation, stock
        split (including reverse stock split) or combination, exchange or readjustment of shares, or any stock dividend or similar transaction, all references herein to a specified number of shares affected thereby, and any calculations that are based upon
        such numbers of shares affected thereby, including the Per Share Amount, the Merger Consideration and any other amounts payable pursuant to this Agreement, shall be appropriately adjusted.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Withholding
          Rights</u>.&#160; Notwithstanding any other provision of this Agreement, each of Parent, Merger Sub, the Surviving Corporation and the Paying Agent shall be entitled (i) to deduct and withhold (or cause to be deducted or withheld) from the
        consideration otherwise payable to any Person pursuant to this Agreement such amounts as may be required to be deducted or withheld from such payment under any provision of any applicable Tax law and (ii) to request any necessary Tax forms,
        including Form W-9 or the appropriate series of Form W-8, as applicable, or any similar information, from any Person to whom a payment is required to be made pursuant to this Agreement.&#160; To the extent that amounts are so deducted and withheld by
        Parent, Merger Sub, the Surviving Corporation or the Paying Agent, as the case may be, such amounts shall (i) be paid to the appropriate Taxing Authorities and (ii) to the extent paid to the appropriate Taxing Authorities, be treated for all
        purposes of this Agreement as having been paid to the Person in respect of which Parent, Merger Sub, the Surviving Corporation or the Paying Agent, as the case may be, made such deduction and withholding.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>No Liability</u>.&#160;














        None of Parent, Merger Sub, the Company, the Surviving Corporation or the Paying Agent shall be liable to any Person in respect of any cash from the Payment Fund delivered to a public official pursuant to and in accordance with any applicable
        abandoned property, escheat or similar Applicable Law.&#160; If any Certificate shall not have been surrendered immediately prior to such date on which any amounts payable pursuant to this <u>Article&#160;2</u> would otherwise escheat to or become the
        property of any Governmental Authority, any such amounts shall, to the extent permitted by Applicable Law, become the property of the Surviving Corporation, free and clear of all claims or interest of any Person previously entitled thereto.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Lost
          Certificates</u>.&#160; If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if reasonably required by Parent or the
        Paying Agent, the posting by such Person of a bond, in such customary amount as Parent or the Paying Agent may direct, as indemnity against any claim that may be made against it with respect to such Certificate, the Paying Agent will issue, in
        exchange for such lost, stolen or destroyed Certificate, the Per Share Amount to be paid in respect of the Shares formerly represented by such Certificate, as contemplated under this <u>Article&#160;2</u>.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">26</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Closing of
          Transfer Books</u>.&#160; At the Effective Time, the stock transfer books of the Company shall be closed and no transfer of Shares shall thereafter be made.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 2.14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Further
          Action</u>.&#160; If, at any time after the Effective Time, any further action is necessary or desirable to carry out the purposes of this Article 2, the officers and directors of the Surviving Corporation and Parent shall be fully authorized (in the
        name of Merger Sub, in the name of the Company or otherwise) to take, and shall take, all such action.</font></div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;3</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">THE SURVIVING CORPORATION</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 3.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Certificate
          of Incorporation</u>.&#160; At the Effective Time and without any further action on the part of the Company and Merger Sub, the certificate of incorporation of the Company as in effect immediately prior to the Effective Time shall be amended and
        restated in its entirety as of the Effective Time to be in the form of the certificate of incorporation of Merger Sub as in effect immediately prior to the Effective Time (except (i) that all references to the name, date of incorporation,
        registered office and registered agent of Merger Sub therein may be changed to refer to the name, date of incorporation, registered office and registered agent, respectively, of the Company, (ii) that any references naming the incorporator(s),
        original board of directors or original subscribers for shares of Merger Sub may be omitted and (iii) for any changes as shall be necessary to comply with <u>Section 6.08</u>) and, as so amended and restated, will be the certificate of
        incorporation of the Surviving Corporation until thereafter amended in accordance its terms and Applicable Law (but subject to <u>Section 6.08</u>).</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 3.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Bylaws</u>.&#160;
        The parties hereto shall take all necessary action such that the bylaws of the Company, as in effect immediately prior to the Effective Time, shall be amended and restated as of the Effective Time to be in the form of the bylaws of Merger Sub as in
        effect immediately prior to the Effective Time (except (i) that all references therein to Merger Sub shall be amended to become references to the Surviving Corporation and (ii) for any changes as shall be necessary to comply with <u>Section 6.08</u>)
        and, as so amended and restated, will be the bylaws of the Surviving Corporation until thereafter amended in accordance with its terms, the certificate of incorporation of the Surviving Corporation and Applicable Law (but subject to <u>Section
          6.08</u>).</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 3.03.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Directors and
          Officers</u>.&#160; From and after the Effective Time, until successors are duly elected or appointed and qualified in accordance with Applicable Law, or until their earlier death, resignation or removal in accordance with the Organizational Documents
        of the Surviving Corporation, (i) the directors of Merger Sub immediately prior to the Effective Time shall be the directors of the Surviving Corporation and (ii) the officers of the Company immediately prior to the Effective Time shall be the
        officers of the Surviving Corporation.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">27</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;4</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Except (a) as disclosed in the Company SEC Documents filed with the SEC on or after January 1, 2018 and prior to the date of this
      Agreement (other than as set forth in the forward-looking statements or the &#8220;risk factors&#8221; contained therein or other disclosures that are predictive, cautionary or forward-looking in nature) or (b)&#160;as set forth in the Company Disclosure Letter (each
      section or subsection of which qualifies the correspondingly numbered and lettered representation and warranty in this <u>Article&#160;4</u> to the extent specified therein and the representations and warranties in such other applicable sections or
      subsections of this Agreement to the extent that the disclosure on its face is reasonably apparent upon reading the disclosure contained in such section or subsection of the Company Disclosure Letter that such disclosure is responsive to such other
      numbered and lettered Section or subsection of this <u>Article&#160;4</u>) delivered by the Company to Parent and Merger Sub prior to the execution of this Agreement (the &#8220;<u>Company Disclosure Letter</u>&#8221;), the Company hereby represents and warrants to
      Parent and Merger Sub as follows:</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Corporate
          Existence and Power</u>.&#160; The Company is a corporation duly incorporated, validly existing and in good standing under the Applicable Law of the State of Delaware.&#160; The Company has full power and authority required to carry on its business
        conducted as of the date of this Agreement.&#160; The Company is duly licensed and qualified to do business as a foreign corporation and is in good standing (to the extent a concept of &#8220;good standing&#8221; is applicable) in each jurisdiction where such
        qualification is necessary, except for those jurisdictions where the failure to be so licensed, qualified or in good standing have not had, and would not reasonably be expected to have, a Company Material Adverse Effect.&#160; The Company has full power
        and authority required to own, lease and operate the assets and properties that it purports to own, lease and operate, except where any failure thereof has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Organizational














          Documents</u>.&#160; The Organizational Documents that are incorporated by reference as exhibits to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 are true, correct and complete copies of the Organizational
        Documents of the Company as of the date of this Agreement, and contain and reflect any and all amendments thereto, and (i) the Organizational Documents of the Company are in full force and effect and (ii) the Company is not in violation of any
        provision of such Organizational Documents.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.03.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Corporate
          Authorization</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Authority; Enforceability</u>.&#160; (i)
        The Company has all requisite power and authority to enter into this Agreement and, assuming the accuracy of the representations and warranties of Parent and Merger Sub set forth in <u>Section 5.10</u>, to consummate the Transactions and (ii) the
        execution, delivery and performance by the Company of this Agreement and, assuming the accuracy of the representations and warranties of Parent and Merger Sub set forth in <u>Section 5.10</u>, the consummation by the Company of the Transactions
        have been duly authorized by all necessary action on the part of the Company subject, in the case </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">28</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">of the Merger, to the filing with the Delaware Secretary of the Certificate of Merger as required by the DGCL.&#160; The Company has duly executed
        and delivered this Agreement, and, assuming due authorization, execution and delivery by Parent and Merger Sub, this Agreement constitutes a valid and binding agreement of the Company enforceable against the Company in accordance with its terms,
        except as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium and other similar laws of general applicability relating to or affecting creditors&#8217; rights, and by general principles of equity (the &#8220;<u>Bankruptcy












          and Equity Exceptions</u>&#8221;).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Company Board Approval and Board
          Recommendation</u>.&#160; At a meeting duly called and held, prior to the execution of this Agreement, at which all directors of the Company were present and voting in favor, the Company Board duly and unanimously adopted resolutions (which, as of the
        execution and delivery of this Agreement by the parties hereto, have not been rescinded, modified or withdrawn in any way) (i) declaring that this Agreement and the Transactions, including the Offer and the Merger, are advisable and in the best
        interests of the Company and the Company&#8217;s stockholders, (ii) approving the execution, delivery and performance by the Company of this Agreement and the consummation of the Transactions, including the Offer and the Merger, on the terms and subject
        to the conditions set forth herein, (iii)&#160;determining to recommend that the stockholders of the Company (other than Parent and its Subsidiaries) accept the Offer and tender their Shares to Merger Sub pursuant to the Offer, (iv)&#160;assuming the
        accuracy of the representations and warranties of Parent and Merger Sub set forth in <u>Section 5.10</u>, taking all actions necessary so that the restrictions on business combinations and stockholder vote requirements contained in Section 203 of
        the DGCL and any other Applicable Law with respect to a &#8220;moratorium,&#8221; &#8220;control share acquisition,&#8221; &#8220;business combination,&#8221; &#8220;fair price&#8221; or other forms of anti-takeover laws or regulations that may purport to be applicable, will not apply to the
        Company with respect to or as a result of this Agreement or the Transactions and (v) agreeing and authorizing that the Merger be governed by Section 251(h) of the DGCL and consummated as soon as practicable following the consummation of the Offer
        (the matters described in clauses (i) through (v), the &#8220;<u>Board Recommendation</u>&#8221;).&#160; Assuming the accuracy of the representations and warranties of Parent and Merger Sub set forth in <u>Section 5.10</u>, and the Merger is effected under Section
        251(h) of the DGCL, no vote of the holders of Company Common Stock or any other equity interests of the Company will be required to adopt this Agreement or to approve and consummate the Transactions.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.04.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Governmental
          Authorization</u>.&#160; The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the Transactions require no action by or in respect of, consent, waiver, approval, authorization or Permit from or
        filing with or notification to, any Governmental Authority, other than (i) the filing of the Certificate of Merger with the Delaware Secretary and appropriate corresponding documents with the appropriate authorities of any other states in which the
        Company is qualified as a foreign corporation to transact business, (ii) compliance with and filings pursuant to any applicable requirements of the HSR Act and any other applicable Antitrust Laws, (iii) the filing with the SEC of (A) the Offer
        Documents and the Schedule 14D-9 and (B) any other filings and reports that may be required in connection with this Agreement and the Transactions under the Exchange Act, (iv) compliance with any rule or regulation of Nasdaq and (v) any other
        actions by or in respect of, consent, approval, authorization, or Permit from or filing with or notification </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">29</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%30%%%-->
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">to, any Governmental Authority, the absence of which have not had, and would not reasonably be expected to have, a Company Material Adverse
        Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.05.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Non-contravention</u>.&#160;














        The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the Transactions do not and will not (i) contravene, conflict with or result in any violation or breach of any provision of the
        Organizational Documents of the Company, (ii) assuming compliance with the matters referred to in <u>Section 4.04</u> and the accuracy of the representations and warranties of Parent and Merger Sub set forth in <u>Section 5.10</u>, contravene,
        conflict with or result in a violation or breach of any provision of any Applicable Law or Order, (iii) require any consent or approval under, violate, conflict with, result in any breach of or any loss of any benefit under, constitute a default
        under, or result in the termination or cancellation of, or give to others any right to receive any payment, right to purchase (including any right of first refusal or right of first offer or the like) or any right of termination, vesting,
        amendment, modification, acceleration (including any acceleration payments) or cancellation (in each case, with or without notice or lapse of time or both) under any Specified Contract or Lease Agreement to which the Company or any Company
        Subsidiary is a party, or by which they or any of their respective properties or assets may be bound or affected or any Permits affecting, or relating in any way to, the property, assets or business of the Company or any of the Company Subsidiaries
        or (iv) result in the creation or imposition of any Lien (other than Permitted Liens) on any rights, property or asset of the Company or any of the Company Subsidiaries, with such exceptions, in the case of each of clauses (ii), (iii) and (iv), as
        have not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.06.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Capitalization</u>.</font></div>
    <div style="margin: 0px 0px 12pt; line-height: 1.25; text-indent: 0px;">
      <div style="margin-bottom: 12pt; text-indent: 108pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman',Times,serif;"></font>The authorized capital stock of the Company consists of (i)&#160;187,500,000 shares of Company Common Stock and (ii)
        5,000,000 shares of preferred stock, par value $1.00 per share (the &#8220;<font style="font-family: 'Times New Roman',Times,serif;"><u>Company Preferred Stock</u></font>&#8221;).&#160; The rights and privileges of the Company Common Stock and the Company Preferred
        Stock are as set forth in the Company&#8217;s Third Amended and Restated Certificate of Incorporation, as filed with the Delaware Secretary on August 11, 2000 (as amended).&#160; At the close of business on November 21, 2019 (the &#8220;<font style="font-family: 'Times New Roman',Times,serif;"><u>Capitalization Date</u></font>&#8221;), (i) 82,946,319 Shares were issued, (ii) 79,933,176 Shares were outstanding, including an aggregate of 235,387 Company Restricted Shares, and 3,013,143 Shares were held by the
        Company in its treasury, (iii) 10,115,358 Company Stock Options, with a weighted average exercise price of $29.16, representing the right to purchase (subject to the terms thereof) an aggregate of 10,115,358 Shares, were issued and outstanding, of
        which 4,064,600 are subject to performance vesting, and (iv) no shares of Company Preferred Stock were issued and outstanding or held by the Company in treasury.&#160; All outstanding shares of capital stock of the Company have been, and all Shares that
        may be issued pursuant to any Company Stock Plan will be, when issued in accordance with the respective terms thereof, duly authorized and validly issued and are (or, in the case of shares that have not yet been issued, will be fully paid,
        nonassessable and free of preemptive or similar rights.&#160; No Subsidiary of the Company owns any shares of capital stock of the Company.&#160; As of the Capitalization Date, (i) 14,450,117 Shares were reserved for issuance pursuant to the Company Stock
        Plans, (ii) 917,595 Shares were reserved for issuance under the Company ESPP and (iii) the maximum number of Shares subject to issuance pursuant to <br>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25; text-indent: 108pt;"> </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">30</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="line-height: 1.25; text-indent: 0px;"><br>
      </div>
      <div style="line-height: 1.25; text-indent: 0px;">outstanding Convertible Senior Notes to the extent converted in accordance with their terms and giving effect to the Transactions is 27,178,083 assuming the Closing Date is December 31, 2019.<font style="font-family: 'Times New Roman',Times,serif;"> </font></div>
      <font style="font-family: 'Times New Roman', Times, serif;"></font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company has Made Available to
        Parent, as of the Capitalization Date, a complete and correct list of (i) all outstanding Company Stock Options, including the number of shares of capital stock subject to such award, the name or employee identification number of the holder
        thereof, the grant date, vesting schedule and the exercise or purchase price per share, and (ii) all outstanding Company Restricted Shares, including the number of shares subject to each award of Company Restricted Shares, the name or employee
        identification number of the holder, the grant date and vesting schedule.&#160; The Company stock plans set forth on <u>Section 4.06(b)(2)</u> of the Company Disclosure Letter (the &#8220;<u>Company Stock Plans</u>&#8221;) and the Company ESPP are the only plans
        or programs the Company or any of the Company Subsidiaries maintains under which stock options, restricted stock, restricted stock units, stock appreciation rights or other compensatory equity and equity-based awards are outstanding and no awards
        other than Company Stock Options and Company Restricted Shares have been granted under the Company Stock Plans or otherwise, other than options granted under the Company ESPP.&#160; With respect to each grant of a Company Equity Award, (i) each such
        grant was made in accordance with the terms of the applicable Company Stock Plan and Applicable Law (including the rules of Nasdaq or any other applicable stock exchange and the terms of any applicable securities listing agreement), (ii) each such
        grant was properly accounted for in accordance with GAAP in the Company SEC Documents (including financial statements) and all other Applicable Laws and (iii) each Company Stock Option has an exercise price per share of Company Common Stock equal
        to or greater than the fair market value of a share of the Company Common Stock on the date of such grant and a grant date identical to the date the Company Board or the Compensation Committee of the Company Board approved as the grant date for
        such Company Stock Option, which approval was in no case after such grant date.&#160; All Convertible Senior Notes were issued pursuant to, and all the terms and conditions of the Convertible Senior Notes are evidenced by the Convertible Senior Notes
        Indentures, and all Capped Call Transactions were made pursuant to and are evidenced by the Capped Call Documentation, and there are no other agreements or side letters with respect to the Convertible Senior Notes or Capped Call Transactions.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as set forth in this <u>Section
          4.06</u> and for changes since the Capitalization Date resulting from (x) the exercise or settlement of Company Equity Awards outstanding on such date or granted after such date in compliance with the terms of this Agreement or (y) issuances of
        Shares upon conversion of Convertible Senior Notes, there are, as of the date of this Agreement, no outstanding (i) shares of capital stock or other voting securities of or ownership interests in the Company, (ii) securities of the Company or the
        Company Subsidiaries convertible into or exchangeable for shares of capital stock or other voting securities or ownership interests of the Company or any of the Company Subsidiaries, (iii)&#160;options, warrants, calls or other rights or arrangements to
        acquire from the Company or any of the Company Subsidiaries, or other obligations or commitments of the Company or any of the Company Subsidiaries to issue, any capital stock or other voting securities or ownership interests in, or any securities
        convertible into or exchangeable for capital stock or other voting securities or ownership interests in, the Company or any of the Company Subsidiaries, (iv) restricted shares, restricted stock units, stock appreciation rights, performance shares,
        contingent value rights, &#8220;phantom&#8221; stock or similar securities or rights that are derivative of, or provide economic </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">31</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">benefits based, directly or indirectly, on the value or price of, any capital stock of, or other voting securities or ownership interests in,
        the Company or any of the Company Subsidiaries (the items in clauses (i)-(iv) being referred to collectively as the &#8220;<u>Company Securities</u>&#8221;), (v) voting trusts,</font><font style="font-family: 'Times New Roman',Times,serif;"> proxies or other
        similar agreements or understandings to which Company or any of the Company Subsidiaries is a party or by which the Company or any of the Company Subsidiaries is bound with respect to the voting of any shares of capital stock of the Company or any
        of the Company Subsidiaries or (vi) contractual obligations or commitments of any character (whether contingent or otherwise) restricting the transfer of, or requiring the registration for sale of, granting any preemptive or anti-dilution rights
        with respect to or requiring the repurchase, redemption, disposition or acquisition, or containing any right of first refusal with respect to any shares of capital stock or Indebtedness of the Company or any of the Company Subsidiaries.&#160; There are
        no outstanding obligations or commitments of any character of the Company or any of the Company Subsidiaries to repurchase, redeem or otherwise acquire any of the Company Securities or any of the capital stock of the Company Subsidiaries.&#160; All
        Company Stock Options and Company Restricted Shares may, by their terms, be treated in accordance with <u>Section 2.08</u>.&#160; No Company Subsidiary owns any Company Securities.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Other than the Company Common Stock,
        there are no outstanding bonds, debentures, notes or other indebtedness or securities of the Company having the right to vote (or, other than the outstanding Company Stock Options, Company Restricted Shares, Shares under the Company ESPP and the
        Convertible Senior Notes, convertible into, or exchangeable for, securities having the right to vote) on any matters on which stockholders of the Company may vote.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.07.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Subsidiaries</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Subsidiary Capital Stock</u>.&#160;
        Neither the Company nor any of the Company Subsidiaries, (i) owns, directly or indirectly, or has the right to acquire pursuant to any Contract or upon the conversion or exchange of any security, any share capital of, or any partnership interests,
        joint venture or other equity ownership interest of any nature in, any other Person, other than the Company or the Company Subsidiaries or (ii) has agreed or is obligated to make, or is bound by any Contract under which it may become obligated to
        make, any future investment in or capital contribution or loan to any other Person.&#160; All outstanding shares of capital stock or other equity securities of, or other ownership interests in, the Company Subsidiaries have been duly authorized and
        validly issued and are fully paid, nonassessable and are not subject to and have not been issued in violation of any purchase option, call option, right of first refusal, preemptive right, subscription right or similar right, and all such shares,
        securities or interests are owned by the Company or by a Company Subsidiary free and clear of any Liens or limitations or restrictions on transfer (other than pursuant to Applicable Law) or voting rights.&#160; Any dissolution by the Company of any
        Person which was formerly a Company Subsidiary and which the Company dissolved prior to the date of this Agreement was performed in compliance in all material respects with all Applicable Law.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Organization; Qualification</u>.&#160; <u>Section














          4.07(b)</u> of the Company Disclosure Letter identifies each Company Subsidiary and indicates its jurisdiction of organization.&#160; Each Company Subsidiary is a corporation or other business entity duly incorporated or organized (as applicable),
        validly existing and in good standing (to the extent a </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">32</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">concept of &#8220;good standing&#8221; is applicable) under the laws of its jurisdiction of incorporation or organization and has full corporate or other
        organizational power and authority required to own, lease and operate the assets and properties that it purports to own, lease and operate and to carry </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">on its business as now conducted, except where any failure thereof has not had, and would not reasonably be expected to have, a Company
        Material Adverse Effect.&#160; Each such Company Subsidiary is duly qualified to do business and is in good standing (to the extent a concept of &#8220;good standing&#8221; is applicable) in each jurisdiction where such qualification is necessary, except for those
        jurisdictions where the failure to be so qualified or in good standing has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.08.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>SEC Filings
          and the Sarbanes-Oxley Act</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Since January 1, 2018, the Company has
        timely filed with or furnished to the SEC (subject to extensions pursuant to Exchange Act Rule 12b-25) each report, statement, schedule, form, certification or other document (including exhibits and all other information incorporated therein) or
        filing required by Applicable Law to be filed with or furnished by the Company to the SEC (the documents referred to in this <u>Section 4.08(a)</u>, as they may have been supplemented, modified or amended since the initial filing date and together
        with all exhibits thereto and information incorporated by reference therein, the &#8220;<u>Company SEC Documents</u>&#8221;).&#160; The Company has Made Available to Parent true, correct and complete unredacted copies of all documents filed as exhibits to the
        Company SEC Documents filed on or after January 1, 2018 and prior to the date of this Agreement that were the subject of a request to the staff of the SEC for confidential treatment.&#160; No Company Subsidiary is required to file or furnish any report,
        statement, schedule, form, registration statement, proxy statement, certification or other document with, or make any other filing with, or furnish any other material to, the SEC.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As of its filing date (or, if amended,
        supplemented, modified or superseded by a filing prior to the date of this Agreement, on the date of such filing), each Company SEC Document complied, and each such Company SEC Document filed subsequent to the date of this Agreement and prior to
        the Effective Time will comply in all material respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act and the rules and regulations of the SEC promulgated thereunder applicable to those Company
        SEC Documents.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As of its filing date (or, if amended,
        supplemented, modified or superseded by another filing prior to the date of this Agreement, on the date of such filing), each Company SEC Document filed on or prior to the date hereof did not, and, subject to the accuracy of the representations and
        warranties set forth in <u>Section 5.07</u>, each such Company SEC Document filed subsequent to the date of this Agreement and prior to the Effective Time will not, contain any untrue statement of a material fact or omit to state any material fact
        required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.&#160; Each Company SEC Document that is a registration statement, as amended or
        supplemented, if applicable, filed pursuant to the Securities Act, as of the date such registration statement, amendment or supplement became effective, did not, and each such Company SEC Document filed subsequent to the date of this Agreement and
        prior to the Effective Time, as of the date such registration statement, </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">33</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">amendment or supplement becomes effective, will not, contain any untrue statement of a material fact or omit to state any material fact
        required to be stated therein or necessary to make the statements therein not misleading.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As of the date of this Agreement, (i)
        there are no outstanding or unresolved comments in comment letters received by the Company from the SEC with respect to the Company SEC Documents and (ii) to the Company&#8217;s Knowledge, none of the Company SEC Documents is the subject of any ongoing
        review by the SEC.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Neither the Company nor any of the
        Company Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off balance sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or
        among the Acquired Companies, on the one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or person, on the other hand, or any &#8220;off balance sheet arrangements&#8221; (as defined in Item
        303(a) of Regulation S-K under the Exchange Act)).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">With respect to each annual report on
        Form 10-K and each quarterly report on Form 10-Q (and any amendments to such Form 10-K or 10-Q) included in the Company SEC Documents, the chief executive officer and chief financial officer of the Company have made all certifications required by
        the Sarbanes-Oxley Act and any related rules and regulations promulgated by the SEC, and (A) the statements contained in any such certifications were complete and correct and (B) such certification complied with the applicable provisions of the
        Sarbanes-Oxley Act, in each case, in all material respects as of their respective dates.&#160; As of the date of this Agreement, the Company has not received written notice from the SEC challenging or questioning the accuracy, completeness, form or
        manner of filing of such certifications made with respect to the Company SEC Documents filed prior to the date of this Agreement.&#160; The Company is in compliance in all material respects with all current listing and corporate governance requirements
        of Nasdaq and is in compliance in all material respects with all applicable provisions, rules, regulations and requirements of the Sarbanes-Oxley Act.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.09.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Financial
          Statements; Internal Controls</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Audited Financial Statements and
        the Unaudited Financial Statements (i) complied as to form with the published rules and regulations of the SEC applicable thereto, as of their respective filing dates with the SEC, in all material respects, (ii)&#160;were prepared in accordance with
        GAAP applied on a consistent basis during the periods involved and (iii) fairly present in all material respects the consolidated financial position of the Acquired Companies as of the dates thereof and their consolidated results of operations and
        cash flows of the Acquired Companies as of the dates or for the periods presented therein (subject, in the case of the Unaudited Financial Statements, to normal year-end adjustments <font style="color: #000000;">and the absence of notes</font>).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company maintains, and since
        January 1, 2018 has maintained, a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) designed to provide reasonable assurance regarding the reliability of the Company&#8217;s financial
        reporting and the preparation of the Financial Statements </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">34</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">for external purposes in accordance with GAAP, and includes those policies and procedures that: (i) pertain to the maintenance of records
        that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
        conformity</font><font style="font-family: 'Times New Roman',Times,serif;"> with GAAP and that receipts and expenditures are being made only in accordance with authorizations of management and the Board of Directors; and (iii) provide reasonable
        assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the assets of the Company that could have a material effect on the financial statements.&#160; The Company&#8217;s management has completed an assessment of
        the effectiveness of the Company&#8217;s system of internal controls over financial reporting in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act for the fiscal year ended December 31, 2018, and, except as set forth in the
        Company SEC Documents filed prior to the date of this Agreement, that assessment concluded that those controls were effective and disclosed to the Company&#8217;s independent public accounting firm and audit committee of the Company Board (i) all
        significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial
        information and (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal control over financial reporting.&#160; Since December 31, 2018, neither the Company nor, to the
        Company&#8217;s Knowledge, the Company&#8217;s independent registered public accounting firm has identified or been made aware of any &#8220;significant deficiencies&#8221; or &#8220;material weaknesses&#8221; (as such terms are defined by the Public Company Accounting Oversight
        Board) in the design or operation of such internal control over financial reporting utilized by the Company that would reasonably be expected to be adverse to the Company&#8217;s ability to record, process, summarize and report financial information and
        any fraud, whether or not material, that involves management or other employees of the Acquired Companies who have a significant role in the Company&#8217;s internal control over financial reporting.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company&#8217;s &#8220;disclosure controls and
        procedures&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to provide reasonable assurance that (i) all information (both financial and non-financial) required to be disclosed by the Company in the reports that it
        files or submits under the Exchange Act is recorded, processed, summarized and reported to the individuals responsible for preparing such reports within the time periods specified in the rules and forms of the SEC and (ii) all such information is
        accumulated and communicated to the Company&#8217;s management or to other individuals responsible for preparing such reports as appropriate to allow timely decisions regarding required disclosure and to make the certifications of the principal executive
        officer and principal financial officer of the Company required under the Exchange Act with respect to such reports.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Since January 1, 2018, the Company has
        not received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or its
        internal accounting controls, including any material complaint, allegation, assertion or claim that the Company has engaged in questionable accounting or auditing practices.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">35</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: Times New Roman, Times, serif; color: #000000">Section 4.10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: Times New Roman, Times, serif"><u>Disclosure
          Documents</u>.&#160; None of the information supplied, or to be supplied, by the Company specifically for inclusion or incorporation by reference in the Offer Documents or any information contained in any document required to be filed by the Company
        with the SEC or required to be distributed or otherwise disseminated by the Company to the Company&#8217;s stockholders in connection with the Offer (other than any information supplied by Parent or Merger Sub), including the Schedule 14D-9, will, at the
        time such document is filed with the SEC, at any time it is amended or supplemented and at the time it is first published, sent or given to the holders of Shares, contain any untrue statement of a material fact or omit to state any material fact
        required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they are being made, not misleading.&#160; The Schedule 14D-9 and each document required to be filed by the Company with the SEC in
        connection with the Offer will comply as to form in all material respects with the requirements of the Exchange Act and the rules and regulations thereunder.&#160; No representation or warranty is made by the Company with respect to statements made or
        incorporated by reference therein based on information supplied by Parent or Merger Sub in writing specifically for inclusion or incorporation by reference in the Schedule 14D-9.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Absence of
          Certain Changes</u>.&#160; Since the Audited Balance Sheet Date and through the date of this Agreement, (a) the Acquired Companies have conducted their business in all material respects in the ordinary course of business consistent with past practice
        (except with respect to this Agreement and discussions, negotiations and transactions related thereto), (b) there has not been any action taken by any of the Acquired Companies that, if taken during the Pre-Closing Period without Parent&#8217;s consent,
        would constitute a breach of any of clauses (x)-(xvi), (xviii), (xix) or (xxi) of Section 6.01(b) and (c) there has not been any Effect that has had, or would reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>No
          Undisclosed Liabilities</u>.&#160; The Acquired Companies do not have any Liabilities, except for: (i) Liabilities disclosed, reflected or reserved against in the Financial Statements or the notes thereto included in the Company SEC Documents filed
        prior to the date of this Agreement; (ii) Liabilities incurred in connection with the Transactions; (iii) Liabilities for performance of obligations of the Acquired Companies under Contracts binding upon the applicable Acquired Company (other than
        resulting from any breach or acceleration thereof) Made Available to Parent or Contracts (other than Specified Contracts) entered into in the ordinary course of business since the Audited Balance Sheet Date&#894; (iv) Liabilities incurred in the
        ordinary course of business since the Audited Balance Sheet Date; and (v) Liabilities that have not been, and would not reasonably be expected to be, material to the Acquired Companies, taken as a whole.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Litigation</u>.&#160;














        As of the date hereof, (a) there is no Proceeding pending against or, to the Company&#8217;s Knowledge, threatened against the Company or any of the Company Subsidiaries or any of their respective properties or assets and (b) neither the Company nor any
        of the Company Subsidiaries is subject to any Order, and to the Company&#8217;s Knowledge, no such Order is threatened to be imposed, except which, in the case of either of clauses (a) or (b), has not been, and would not reasonably be expected to be,
        material to the Acquired Companies, taken as a whole.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">36</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Compliance
          with Applicable Law</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Since January 1, 2018, the Company and
        each of the Company Subsidiaries are and have been in compliance with all Applicable Law and Orders, except where any instances of non-compliance have not been, and would not reasonably be expected to be, material to the Acquired Companies, taken
        as a whole.&#160; Since January 1, 2018, neither the</font><font style="font-family: 'Times New Roman',Times,serif;"> Company nor any of the Company Subsidiaries has received any written notice (i) of, or to Company&#8217;s Knowledge, any other communication
        regarding, any Proceeding by any Governmental Authority relating to the Company or any of the Company Subsidiaries or (ii) or to the Company&#8217;s Knowledge, any other communication from any Governmental Authority alleging that the Company or any of
        the Company Subsidiaries are not in compliance with any Applicable Law or Order, in either case, except as has not been, and would not reasonably be expected to be, material to the Acquired Companies, taken as a whole.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as has not been, and would not
        reasonably be expected to be, material to the Acquired Companies, taken as a whole, (i)&#160;each of the Company and each Company Subsidiary has in effect all Permits necessary for it to lawfully own, lease or otherwise hold and operate its properties
        and assets and to carry on its businesses and operations as now conducted and (ii) to the Company&#8217;s Knowledge, no event has occurred that, with or without notice or lapse of time or both, would reasonably be expected to result in any right of
        termination, amendment, cancellation, revocation, suspension or limitation of any Permit and there have occurred no defaults (with or without notice or lapse of time or both) under or, violations of, Permits.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Anticorruption














          Matters</u>.&#160; None of the Acquired Companies nor to the Company&#8217;s Knowledge any of their respective officers, employees, contractors, representatives or agents (in each case, acting in the capacity of an employee or representative of any Acquired
        Company) has directly or indirectly (i) used any funds (whether of an Acquired Company or otherwise) for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to
        foreign or domestic government officials or employees or to foreign or domestic political parties or campaigns or accepted such payment or (iii) violated any provision of any Anticorruption Laws or any rules or regulations promulgated thereunder or
        any anti-money laundering laws or any rules or regulations promulgated thereunder or any Applicable Law of similar effect, except, in each case, as has not been, and would not reasonably be expected to be, material to the Acquired Companies, taken
        as a whole.&#160; Since January 1, 2018, none of the Acquired Companies have received any written communication that alleges any of the foregoing, except as has not been, and would not reasonably be expected to be, material to the Acquired Companies,
        taken as a whole.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Specified
          Contracts</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As of the date of this Agreement,
        neither the Company nor any of the Company Subsidiaries is a party to any Contract required to be filed by the Company as a &#8220;material contract&#8221; pursuant to Item 601(b)(10) of Regulation S-K under the Securities Act (a &#8220;<u>Filed Company Contract</u>&#8221;)














        that has not been so filed.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">37</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Section 4.16(b)</u> of the Company
        Disclosure Letter sets forth, as of the date of this Agreement, a true and complete list of:</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman', Times, serif;">each loan and credit agreement,
        note, debenture, bond, indenture and other similar Contract pursuant to which any Indebtedness of the Company or any of the Company Subsidiaries, in each case, in excess of $1,000,000, is outstanding or may be </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">incurred, other than any such Contract between or among any of the Company and any of the Company Subsidiaries;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman', Times, serif;">each Contract to which the Company
        or any of the Company Subsidiaries is a party entered into since January&#160;1, 2018 or with respect to which the Company or any of the Company Subsidiaries has any continuing material obligations, in each case, relating to the acquisition or
        disposition by the Company or any of the Company Subsidiaries of properties or assets for, in each case, aggregate consideration of more than $1,000,000, except for acquisitions and dispositions of properties and assets in the ordinary course of
        business;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each Contract of the Company or any
        of the Company Subsidiaries that (A)&#160;grants a right of exclusivity, right of first offer, right of first refusal or similar right with respect to the Product in any business or geographic region (&#8220;<u>Exclusive Rights</u>&#8221;); or (B)&#160;restricts in any
        way the ability of the Company or any of its Affiliates (including post-Closing) to compete with any business or in any geographical area or to solicit customers; in each case under clauses (A) or (B) (and the defined terms therein) that limits in
        any material respect the operation of the Acquired Companies, taken as a whole, as currently conducted;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each Contract to which the Company or
        any of the Company Subsidiaries is a party pursuant to which the Company or a Company Subsidiary grants or receives a material license, covenant not to sue, or other material right to any Intellectual Property (except for&#160;(A) non-exclusive licenses
        to off-the-shelf&#160; commercially available Software for less than $1,000,000 on an annual basis, (B)&#160;agreements between the Company or any of the Company Subsidiaries, on the one hand, and their employees or consultants, on the other hand, entered
        into in the ordinary course of business and (C)&#160;nonexclusive licenses of Intellectual Property that are entered into in the ordinary course of business consistent with past practice);</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman', Times, serif;">each Contract that grants to any
        person any option, right of first offer or right of first refusal or similar right to purchase, lease, sublease, license, use, possess or occupy any securities, assets or other interest of any Acquired Company;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each Contract of the Company or any of
        the Company Subsidiaries that relates to a partnership, joint venture or similar arrangement;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">each Contract with any Governmental
        Authority, except for clinical study agreements, materials transfer agreements and non-disclosure agreements entered into in the ordinary course of business;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(viii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">(A) the Convertible Senior Notes
        Indentures and (B)&#160;the Capped Call Documentation; and</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">38</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ix)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">each Contract with any of the contract
        manufacturing organizations set forth on Section 4.16(b)(ix) of the Company Disclosure Letter or any of their respective Affiliates.</font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Each Contract of the type described in this <u>Section 4.16(b)</u> and each Filed Company Contract is referred to herein as a &#8220;<u>Specified Contract</u>&#8221;.&#160;














      As of the date of this Agreement, the Company has Made Available to Parent true and complete copies of each Specified Contract, together with all modifications and amendments thereto.&#160; There are no oral Specified Contracts.</div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Each Specified Contract is in full
        force and effect and is a valid and binding agreement enforceable against the Company or any of the Company Subsidiaries party thereto and, to the Company&#8217;s Knowledge, any other party thereto in accordance with its terms, except as such
        enforceability may be limited by the Bankruptcy and Equity Exceptions, except where the failure of such Contract to be valid, binding, enforceable or in full force and effect, has not been, and would not reasonably be expected to be, material to
        the Acquired Companies, taken as a whole.&#160;&#160; None of the Company nor any of the Company Subsidiaries party to any Specified Contract is in breach of or default under, or as of the date of this Agreement has provided or received any written notice of
        any intention to terminate or seek renegotiation of, any Specified Contract, and as of the date hereof and to the Company&#8217;s Knowledge, no other party to any Specified Contract is in breach of or default under, or has provided or received any
        written notice of any intention to terminate or seek renegotiation of, any Specified Contract, except in each case as has not been, and would not reasonably be expected to be, material to the Acquired Companies, taken as a whole.&#160; To the Company&#8217;s
        Knowledge, no event or circumstance has occurred that, with or without notice or lapse of time or both, would (i) constitute a breach of or event of default by the Company, (ii) result in a right of termination, modification or renegotiation for
        the counterparty or (iii) cause or permit the acceleration of or other changes to any right of the counterparty or obligation of the Company under any Specified Contract, except, in the case of clauses (i), (ii) and (iii), as has not been, and
        would not reasonably be expected to be, material to the Acquired Companies, taken as a whole.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;">
      <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">There are no Contracts under which
          the Company is required to bear any royalty, milestone or other payment obligations pursuant to the terms of the Alnylam License Agreement.</font></div>
      <font style="font-family: 'Times New Roman', Times, serif;"></font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Taxes</u>.&#160;
        Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect:</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">(i) the Company and each of the Company
        Subsidiaries have filed all Tax Returns required by Applicable Law to be filed by the Company or any of the Company Subsidiaries with any Taxing Authority when due (taking into account any available extensions) and in accordance with all Applicable
        Law; (ii) all such Tax Returns are accurate and complete in all respects; and (iii) the Company and each of the Company Subsidiaries have paid or withheld (or have had paid or withheld on their behalf) all Taxes required to be paid or withheld
        (whether or not shown on any Tax Return); except in each case of clauses (i), (ii) and (iii) with respect to matters for which adequate reserves, in accordance with GAAP, have been reflected in the Financial Statements;</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">39</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">neither the Company nor any of the
        Company Subsidiaries (i) has requested, granted or agreed to any extension or waiver of the statute of limitations period applicable to any Tax Return of the Company or any of the Company Subsidiaries (whether or not filed), which period (after
        giving effect to such extension or waiver) has not yet expired or </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">(ii) has executed or filed any power of attorney with respect to Taxes which will be in effect after the Closing;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">(i) no deficiencies for Taxes with
        respect to the Company or any of the Company Subsidiaries have been claimed, proposed or assessed in writing or, to the Company&#8217;s Knowledge, otherwise, by any Taxing Authority; (ii) there is no Proceeding in progress, pending or threatened in
        writing against or with respect to the Company or any of the Company Subsidiaries in respect of any Tax; and (iii) no claim has been made in writing or, to the Company&#8217;s Knowledge, otherwise, by a Taxing Authority in a jurisdiction where the
        Company or any of the Company Subsidiaries does not file Tax Returns that the Company or any Company Subsidiary is or may be subject to taxation or required to file Tax Returns in that jurisdiction;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">there are no Liens for Taxes on any
        assets of the Company or any of the Company Subsidiaries, other than Permitted Liens;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">neither the Company nor any of the
        Company Subsidiaries has participated in any &#8220;reportable transaction&#8221; within the meaning of Treasury Regulations Section 1.6011-4(b)(2) (or any similar provision of state, local or foreign law);</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">(i) neither the Company nor any of the
        Company Subsidiaries is or has ever been a member of an affiliated group of corporations (within the meaning of Section 1504(a) of the Code) or any group that has filed a combined, consolidated or unitary Tax Return (other than a group of which the
        Company and/or any Company Subsidiary is or was the common parent) and (ii) neither the Company nor any Company Subsidiary has any liability for the Taxes of any Person (other than the Company or the Company Subsidiaries) under Treasury Regulations
        Section 1.1502-6 (or any similar provision of state, local or non-U.S. Tax law), as a transferee or successor, or by Contract;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">neither the Company nor any of the
        Company Subsidiaries (i) has applied for, been granted, or agreed to any accounting method change for which it will be required to take into account any adjustment under Section 481 of the Code (or any similar provision of state, local or non-U.S.
        Tax law) or (ii) will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of (A)&#160;an installment sale or open
        transaction disposition made on or prior to the Closing Date, (B)&#160;a gain recognition agreement or closing agreement under Section 7121 of the Code (or any similar provision of state, local or non-U.S. Tax law) executed on or prior to the Closing
        Date, or (C) an election pursuant to Section 108(i) of the Code made effective on or prior to the Closing Date;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">there are no Tax sharing agreements or
        similar arrangements, including Tax indemnity arrangements (other than commercial agreements or arrangements not primarily related to Taxes and entered into in the ordinary course of business) with respect to or </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">40</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">involving the Company or any of the Company Subsidiaries, other than, in each case, any agreement or arrangement exclusively between or among
        the Company and the Company Subsidiaries;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman', Times, serif;">none of the Company or any of the
        Company Subsidiaries has been a &#8220;controlled corporation&#8221; or a &#8220;distributing corporation&#8221; in any distribution that was purported or intended to be governed by Section 355 of the Code (or any similar provision of state, local or non-U.S. law) that
        occurred during the two (2)-year period ending on the date hereof;</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(j)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">neither the Company nor any of the
        Company Subsidiaries has been a United States real property holding corporation within the meaning of Section&#160;897(c)(2) of the Code during the applicable period specified in Section&#160;897(c)(1)(A)(ii) of the Code; and</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">neither the Company nor any of the
        Company Subsidiaries has applied for a ruling or determination from a Taxing Authority regarding a past or prospective transaction.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Employee
          Benefit Plans</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Section 4.18(a)</u>&#160;of the Company
        Disclosure Letter contains a correct and complete list identifying each material Company Employee Plan as of the date of this Agreement (excluding any direct agreements with current individual consultants or individual contractors with hourly
        compensation that is less than $100 per hour (or the annual equivalent) and do not provide for any severance or change in control payments).&#160; &#8220;<u>Company Employee Plan</u>&#8221; means each &#8220;employee benefit plan,&#8221; as defined in Section 3(3) of ERISA
        (whether or not subject to ERISA), each employment, individual consulting, change of control, retention, severance or similar contract, plan, program, agreement, arrangement or policy and each other plan, program, agreement, arrangement or policy
        (written or oral) providing for compensation, bonuses, profit-sharing, savings, stock option, stock purchase or other stock-related rights or other forms of incentive or deferred compensation, vacation benefits, welfare benefits including in the
        form of insurance (including any self-insured arrangements), health or medical benefits, employee assistance program, disability or sick leave benefits, workers&#8217; compensation, supplemental unemployment benefits, post-employment or retirement
        benefits (including early retirement or compensation, pension, health, medical or life insurance benefits), supplemental retirement benefits (including termination indemnities and seniority payments), or any other similar fringe, welfare or other
        employee benefit contract, plan, agreement, arrangement or policy that is maintained, administered or contributed to by the Company or any Company Subsidiary for the benefit of or relating to any current or former employee, consultant, independent
        contractor, officer or director of the Company or any Company Subsidiary (collectively, &#8220;<u>Company Employees</u>&#8221;), or with respect to which the Company or any Company Subsidiary has any Liability, other than any plan, policy, program or
        arrangement mandated by Applicable Law.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">With respect to each material Company
        Employee Plan, the Company has Made Available to Parent complete and accurate copies, to the extent applicable to such Company Employee Plan, of: (A) the most recent annual report on Form 5500 required to have been filed with the IRS, including all
        schedules thereto; (B) the most recent determination </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">41</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">letter (or, if applicable, advisory or opinion letter), if any, from the IRS; (C) all material correspondence to or from any Governmental
        Authority received in the last year with respect to any Company Employee Plan and (D) the plan documents and summary plan descriptions and</font><font style="font-family: 'Times New Roman',Times,serif;"> any material modifications thereto, and all
        related trust documents, insurance contracts or other funding vehicles, or a written description of the material terms (if not in writing).</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Neither the Company nor any ERISA
        Affiliate of the Company sponsors, maintains or contributes to (or is obligated to contribute to) or in the last six (6) years has sponsored, maintained or contributed to (or has been obligated to contribute to) any (i)&#160;plan subject to Section 302
        of ERISA, Section 412 of the Code or Title IV of ERISA, (ii)&#160;defined benefit plan (as defined in Section 414 of the Code), whether or not subject to ERISA, (iii)&#160;multiemployer plan within the meaning of Section 4001(a)(3) or 3(37) of ERISA or
        (iv)&#160;multiple employer plan (as defined in Section 4063 or 4064 of ERISA).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Each Company Employee Plan that is
        intended to be qualified under Section 401(a) of the Code has received or is permitted to rely upon a favorable determination or opinion letter to the effect that such Company Employee Plan is qualified and the plans and trusts related thereto are
        exempt from federal income taxes under Sections 401(a) and 501(a), respectively, of the Code, or has pending or has time remaining in which to file an application for such determination from the IRS, no such determination letter has been revoked
        and revocation has not been threatened, and to the Company&#8217;s Knowledge there exists no reason why any such determination or opinion letter would reasonably be expected to be revoked or not be issued or that would otherwise materially adversely
        affect the qualified status of any such Company Employee Plan.&#160; Each Company Employee Plan has been maintained, operated and administered in compliance with its terms and with the requirements prescribed by Applicable Law, except where such
        noncompliance has not been, and would not reasonably be expected to be, material to the Acquired Companies, taken as a whole.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">To the Company&#8217;s Knowledge, neither the
        Company nor any of the Company Subsidiaries or any of their respective directors, officers, employees or agents has, with respect to any Company Employee Plan, engaged in or been a party to any non-exempt &#8220;<u>prohibited transaction</u>,&#8221; as such
        term is defined in Section 4975 of the Code or Section 406 of ERISA, that could reasonably be expected to result in the imposition of a future penalty assessed pursuant to Section 502(i) of ERISA or a tax imposed by Section 4975 of the Code, in
        each case applicable to the Company, any of the Company Subsidiaries or any Company Employee Plan or for which the Company or any of the Company Subsidiaries has any future indemnification obligation, except, in each case, as would not reasonably
        be expected to have a&#160; Company Material Adverse Effect.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">Neither the execution or delivery of
        this Agreement nor the consummation of the Transactions will (either alone or together with any other event), other than on account of such Company Employee&#8217;s holding Shares or any Company Equity Awards or participating in the Company ESPP, (i)
        cause any payment, severance or benefit to become due or payable, or required to be provided, to any Company Employee, (ii) increase the amount or value of any benefit, compensation, severance or other material obligation otherwise payable or
        required to be provided to any such Company Employee, (iii) accelerate the time of payment or vesting of any such benefit or compensation, (iv) accelerate the time of or otherwise trigger any </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">42</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">funding (through a grantor trust or otherwise) of any such compensation or benefits or (v) cause any amount to fail to be deductible by
        reason of Section 280G of the Code.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Neither the Company nor any of the
        Company Subsidiaries has any material liability in respect of post-retirement health, medical or life insurance benefits for retired, former or current employees or directors of the Company or the Company Subsidiaries except as required to comply
        with Section 4980B of the Code or any similar state law provision.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">There is no action, suit,
        investigation, audit or proceeding pending against or involving or, to the Company&#8217;s Knowledge, threatened against or involving, any Company Employee Plan, the assets of any trust under any Company Employee Plan, or the plan sponsor, plan
        administrator or any fiduciary of any Company Employee Plan with respect to the administration or operation of such plans, before any arbitrator or any Governmental Authority, except as has not been, and would not reasonably be expected to be,
        material to the Acquired Companies, taken as a whole.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">To the extent applicable, all Company
        Employee Plans maintained primarily for the benefit of Company Employees outside of the United States comply with Applicable Law, and all such plans that are intended to be funded and/or book-reserved are funded and/or book-reserved, as
        appropriate, based on reasonable actuarial assumptions, except as has not had and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.19.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Labor and
          Employment Matters</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as has not been, and would not
        reasonably be expected to be, material to the Acquired Companies, taken as a whole, the Company and each Company Subsidiary is in compliance with all Applicable Law respecting hiring, employment and employment practices, terms and conditions of
        employment, harassment, retaliation, reasonable accommodations, leaves of absence, occupational safety and health, workers&#8217; compensation, employee classification, wages and hours, engagement of independent contractors (including the appropriate
        classification of the same), payroll taxes, redundancy, &#8220;mass layoffs,&#8221; &#8220;plant closings&#8221; and immigration with respect to Company Employees.&#160; As of the date of this Agreement, except as has not been, and would not reasonably be expected to be,
        material to the Acquired Companies, taken as a whole, (i) there are no charges, complaints, audits or investigations pending or scheduled by any Governmental Authority pertaining to the employment practices or actions of the Company or any Company
        Subsidiary or, to the Company&#8217;s Knowledge, threatened against the Company or any Company Subsidiary and (ii) to the Company&#8217;s Knowledge, no complaints or charges relating to employment practices or actions of the Company or any Company Subsidiary
        have been made to any Governmental Authority or submitted to the Company or any Company Subsidiary.&#160; Since January 1, 2017, neither the Company nor any of the Company Subsidiaries has had, and as of the date of this Agreement does not have, any
        material direct or indirect liability with respect to any misclassification of any person as an independent contractor or contingent worker rather than as an &#8220;<u>employee</u>,&#8221; or with respect to any Company Employee leased from another employer.&#160;
        Neither the Company nor any Company Subsidiary has incurred any material liability or </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">43</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">obligation under the Worker Adjustment and Retraining Notification Act and the regulations promulgated thereunder or any similar state or
        local law that remains unsatisfied.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Neither the Company nor any Company
        Subsidiary is a party to, or otherwise bound by, any collective bargaining agreement, Contract or other agreement or understanding with a labor union, organization, group or association, works council or other employee representative body.&#160; Neither
        the execution or delivery of this Agreement nor the consummation of the Transactions entitle any union, works council or like organization to any information, consent, consultation, renegotiation or other similar rights or entitle any such Person
        to any payments under an applicable labor agreement or Applicable Law.&#160; The Company and the Company Subsidiaries have complied in all material respects with all information, consent, consultation, renegotiation and other similar requirements in
        respect of any applicable labor agreement or Applicable Law with which the Company or the Company Subsidiaries are required to comply in connection with execution or delivery of this Agreement or the consummation of the Transactions.&#160; To the
        Company&#8217;s Knowledge, since the date that is three (3) years prior to the date hereof, no Company Employee has claimed or asserted that the Company or any Company Subsidiary has failed to comply in all material respects with any information,
        consent, consultation, renegotiation or other requirement or obligation in respect of any applicable labor agreement or Applicable Law.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As of the date hereof, (i) to the
        Company&#8217;s Knowledge, there is no organizing activity, Proceeding, election petition, union card signing or other union activity, or union corporate campaigns of or by any labor organization, trade union, or work council directed at the Company or
        any of the Company Subsidiaries and (ii) neither the Company nor any Company Subsidiary is subject to any charge, demand, petition or representation proceeding seeking to compel, require or demand it to bargain with any labor union, organization,
        group or association, works council or other employee representative body.&#160; There is no pending or, to the Company&#8217;s Knowledge, threatened, labor strike, lockout, slowdown or work stoppage involving the Company or any Company Subsidiary or their
        employees, nor have there been any such labor strikes, lockouts, slowdowns or work stoppages since January 1, 2018, to the date hereof.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.20.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Insurance
          Policies</u>.&#160; Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, all insurance policies of the Acquired Companies relating to the business, assets and operations of the Acquired Companies are
        in full force and effect, are sufficient to comply with Applicable Law and provide insurance in such amounts and against such risks as the Company reasonably has determined to be prudent, taking into account the industries in which the Acquired
        Companies operate, no notice of cancellation or modification has been received by the Company or any of the Company Subsidiaries, and there is no existing default or event which and the Acquired Companies have not taken or failed to take any action
        that, with the giving of notice or lapse of time or both, would constitute a default by any insured thereunder.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.21.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Environmental
          Matters</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The operations of the Acquired
        Companies have at all times been in compliance in all material respects with all Environmental Law, which compliance has included obtaining, maintaining and complying with any Permits required under all </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">44</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">Environmental Law necessary to operate its business (&#8220;<u>Environmental Permits</u>&#8221;), and neither the Company nor any Company Subsidiary has
        received any notice of nonrenewal, suspension or termination of any Environmental Permits.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As of the date of this Agreement,
        neither the Company nor any of the Company Subsidiaries is subject to any pending or, to the Company&#8217;s Knowledge, threatened material claim, Proceeding or Order, in each case relating to or arising under Environmental Law or Environmental Permits.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">There has been no Release or presence
        of or exposure to any Hazardous Substance that would reasonably be expected to result in material liability or a material requirement for investigation, notification or remediation by the Company or any of the Company Subsidiaries under any
        Environmental Law.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">As of the date of this Agreement, the
        Acquired Companies have not received any written notice, report or other information of or entered into any legally binding agreement, Order, settlement, judgment, injunction, indemnity or decree involving uncompleted, outstanding or unresolved
        violations, liabilities or requirements on the part of the respective Acquired Companies relating to or arising under Environmental Laws or Environmental Permits.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.22.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Intellectual
          Property</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Section 4.22(a)</u>&#160;of the Company
        Disclosure Letter sets forth a true and complete (in all material respects) list, as of the date of this Agreement, of all issuances, registrations or pending applications for trademarks, patents, copyrights, or Internet domain names with any
        Governmental Authority or domain name registrar, as applicable, in each case, that are included in Company Owned IP, indicating for each such item the record owner, registration or application number, registration or application date and the
        applicable filing jurisdiction (or in the case of an Internet domain name, the applicable domain name registrar).&#160; Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, (i) an Acquired Company is
        the exclusive owner of all right, title and interest in and to (free and clear of any Liens, other than Permitted Liens), or is licensed or otherwise has the right to use, all Intellectual Property used in the conduct of the respective businesses
        of the Acquired Companies as currently conducted and as proposed to be conducted on the date of this Agreement (including any&#160; proposed changes to a supplier of the Product or any intermediary compounds thereof); and (ii)&#160;such ownership, licenses
        or rights of the Acquired Companies to use the Company Intellectual Property will not be affected by the execution, delivery and performance of this Agreement or the consummation of the Transactions.&#160; All of the registrations, issuances and
        applications owned by the Acquired Companies and set forth in <u>Section 4.22(a)</u> of the Company Disclosure Letter are subsisting and, to the Company&#8217;s Knowledge, valid and enforceable and in full force and effect.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Since January 1, 2018, no claims or
        other suits, actions or other Proceedings have been pending or, to the Company&#8217;s Knowledge, threatened against any Acquired Company alleging that an Acquired Company has infringed, misappropriated, diluted or otherwise violated any Intellectual
        Property rights of any other person, or that contest the validity, scope, use, ownership or enforceability of any of the Company Owned IP or, to the </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">45</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">Company&#8217;s Knowledge, the Exclusively Licensed IP, except in each case, as has not had, and would not reasonably be expected to have, a
        Company Material Adverse Effect.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Since January 1, 2018, the Acquired
        Companies&#8217; use of any Company Intellectual Property, the operation of the Acquired Companies&#8217; respective businesses (including to the extent conducted in their respective businesses, their making, use, import, sale or offer for sale of the Product
        (or any intermediary compounds thereof)), have not infringed, misappropriated, diluted or otherwise violated any Intellectual Property of any other person except where such infringement, misappropriation, dilution or other violation has not had,
        and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">To the Company&#8217;s Knowledge, since
        January 1, 2018, no Person has infringed, misappropriated, diluted or otherwise violated the rights of any Acquired Company with respect to any Company Owned IP or the Exclusively Licensed IP, except in each case, where such infringement,
        misappropriation or other violation has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.&#160; The Company Owned IP and, to the Company&#8217;s Knowledge, the Exclusively Licensed IP, are not subject to any outstanding
        consent, settlement, lien, decree, order, injunction, judgment or ruling restricting the use thereof in a manner that would reasonably be expected to materially impair the continued operation of the businesses of the Acquired Companies as currently
        conducted.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Acquired Companies have taken
        commercially reasonable steps to maintain and protect the secrecy and confidentiality of their trade secrets and other material confidential information, except for any instance where a failure to take such steps to maintain and protect has not
        had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Acquired Companies have obtained
        from all parties (including current or former employees, officers, directors, consultants and contractors) who have created or developed material Intellectual Property for or on behalf of an Acquired Company written and valid assignments of such
        parties&#8217; rights in such Intellectual Property to the Acquired Company and that are enforceable against the Acquired Company party thereto and, to the Company&#8217;s Knowledge, the other party thereto in accordance with its respective terms, except for
        any instance where a failure to do so has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as has not had, and would not
        reasonably be expected to have, a Company Material Adverse Effect, no funding, facilities or personnel of any Governmental Authority or any university, college, research institute or other educational institution has been used to create or develop
        any Company Owned IP, or to the Knowledge of the Company, the Exclusively Licensed IP, except for any such funding or use of facilities or personnel that has not resulted in such Governmental Authority or institution obtaining any rights to use or
        exploit such Company Intellectual Property.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Since January 1, 2018, the collection,
        acquisition, use, storage, transfer (including any cross-border transfers), distribution or dissemination by the Acquired Companies of any personally identifiable information of third-party individual natural persons </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">46</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">(including any information that, alone or in combination with any other information held by the Acquired Companies, can be used to
        specifically identify an individual person and any &#8220;individually identifiable health information&#8221; defined under Applicable Law) (collectively,</font><font style="font-family: 'Times New Roman',Times,serif;"> &#8220;<u>Personal Data</u>&#8221;) are and have
        been in compliance in all material respects with (i) all Applicable Law governing the privacy, data protection, processing, transfer or security of Personal Data, including the following and their implementing regulations: (A) the U.S. Health
        Insurance Portability and Accountability Act of 1996, as amended by the U.S. Health Information Technology for Economic and Clinical Health Act of 2009, including the regulations promulgated thereunder, (B) the EU Data Protection Directive 95/46/EC
        of 24 October 1995, the EU General Data Protection Regulation 2016/679/EU of April 27, 2016 (&#8220;<u>GDPR</u>&#8221;), the EU ePrivacy Directive 2002/58/EC of 12 July 2002 and the related implementing legislation of the EU Member States, (C) Section 5 of the
        Federal Trade Commission Act as it applies to the receipt, access, use, disclosure, and security of consumer Personal Data, and (D) the Swiss Federal Act on Data Protection of June 19, 1992 (DPA) and its ordinances, and (ii) the applicable Acquired
        Company&#8217;s contractual obligations and publicly posted privacy policies regarding Personal Data (collectively, such Applicable Law, obligations and privacy policies, the &#8220;<u>Privacy Requirements</u>&#8221;), except where any instances of non-compliance
        have not had, and would not reasonably be expected to have, a Company Material Adverse Effect.&#160; The Acquired Companies maintain commercially reasonable policies, procedures and security measures with respect to the physical and electronic security
        and privacy of Personal Data that are designed to achieve compliance with the Privacy Requirements, and the Acquired Companies are in compliance with such policies and procedures, except as has not had, and would not reasonably be expected to have,
        a Company Material Adverse Effect.&#160; To the Company&#8217;s Knowledge, since January 1, 2018, there have been no material breaches or material violations of any such security measures, or any unauthorized access of any Personal Data by any Third Party.&#160;
        No written claim or other Proceeding is pending against any Acquired Company, nor to the Company&#8217;s Knowledge, threatened, relating to any such obligation, policy, Applicable Law in relation to Personal Data or any breach or alleged breach thereof,
        except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as has not had, and would not
        reasonably be expected to have, a Company Material Adverse Effect, the IT Assets (i) operate and perform as required by the Acquired Companies in connection with the conduct of their respective businesses, (ii) since January 1, 2018, have not
        malfunctioned or failed (except for malfunctions or failures that have been fully remedied) and (iii) are free from bugs and other defects and, to the Company&#8217;s Knowledge, do not contain any &#8220;virus&#8221;, &#8220;worm&#8221;, &#8220;spyware&#8221; or other malicious Software.&#160;
        To the Company&#8217;s Knowledge, no Person has gained unauthorized access to the IT Assets, except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.23.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Real Property</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Neither the Company nor any of the
        Company Subsidiaries owns any real property.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Section 4.23(b)</u> of the Company
        Disclosure Letter sets forth, as of the date of this Agreement, a true and complete list of all real property leased, subleased, licensed or otherwise occupied by the Company or any of the Company Subsidiaries and the </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">47</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">address thereof (each, a &#8220;<u>Leased Property</u>&#8221;) and, with respect to each material Leased Property, each lease, sublease, license,
        sublicense or other occupancy agreement, in each case, including all amendments thereto, demising any such Leased Property to the Company or any Company</font><font style="font-family: 'Times New Roman',Times,serif;"> Subsidiary (each, a &#8220;<u>Lease
          Agreement</u>&#8221;).&#160; Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, the Acquired Companies (i) hold a valid and existing leasehold interest in each Leased Property and (ii) hold good and valid
        title to all material tangible properties and assets, in each case, free and clear of all Liens other than Permitted Liens.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">With respect to each Leased Property,
        neither the Company nor any of the Company Subsidiaries has subleased, licensed, sublicensed or otherwise granted anyone a right to use or occupy such Leased Property or any portion thereof, or otherwise assigned, pledged, hypothecated, mortgaged
        or otherwise transferred any lease, sublease, license, sublicense or other interest therein, except, in each case, as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.24.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Health
          Regulatory Matters</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Acquired Companies (i) have timely
        filed with the applicable regulatory authorities (including the FDA, the European Medicines Agency (the &#8220;<u>EMA</u>&#8221;) or any other Governmental Authority performing functions similar to those performed by the FDA) for all Company Regulatory Permits
        and (ii) have, and to the Company&#8217;s Knowledge, all Third Parties have, timely made all required material filings, declarations, listings, registrations, reports, submissions, applications, amendments, modifications, supplements, notices and other
        documents with respect to the Product, including adverse event reports, with the applicable Governmental Authorities (collectively, the &#8220;<u>Health Care Submissions</u>&#8221;).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">All such Company Regulatory Permits and
        Health Care Submissions were complete and accurate in all material respects and in material compliance with Applicable Law when filed.&#160; The Company has Made Available to Parent true, correct and complete copies of all Health Care Submissions and
        all material correspondence with and from, and contact reports summarizing interactions with regulatory authorities (including the FDA, EMA and any other Governmental Authority performing functions similar to those performed by the FDA), in each
        case since January 1, 2018.&#160; Since January 1, 2018, no deficiencies have been asserted by any applicable Governmental Authority to the Company with respect to any such Company Regulatory Permits or Health Care Submissions, except as would not have,
        and would not reasonably be expected to have, a Company Material Adverse Effect.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">All pre-clinical and clinical studies
        or tests in respect of the Product (i)&#160;conducted or sponsored by (A) the Acquired Companies or (B) any research, development, collaboration or similar commercialization partner of any of the Acquired Companies while acting in such capacity (each, a
        &#8220;<u>Collaboration Partner</u>&#8221;) or (ii) used, or intended to be used, to support any filing or application for a Company Regulatory Permit, have been, or with respect to clause (i)(B), to the Company&#8217;s Knowledge, have been, conducted in material
        compliance with Applicable Law (including applicable Health Care Laws) and applicable rules, regulations and guidances (including the standards for good clinical practices relating to clinical trials for pharmaceuticals under Applicable Law) and
        federal and state laws, </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">48</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">rules, regulations and guidances restricting the use and disclosure of individually identifiable health information).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">No Acquired Company or, to the
        Company&#8217;s Knowledge, any Collaboration Partner has received any written notices or other correspondence from regulatory authorities (including the FDA, EMA and any other Governmental Authority performing functions similar to those performed by the
        FDA) or institutional review board or ethics committee with respect to any ongoing clinical or pre-clinical studies or tests (x) threatening the initiation of any action to place a clinical hold order on any such studies or tests or (y) otherwise
        requiring the termination, suspension or material modification of any such studies or tests.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">No Acquired Company nor any authorized
        Person acting on their behalf has (i) made an untrue statement of a material fact or fraudulent statement to the FDA, EMA or any other Governmental Authority performing functions similar to those performed by the FDA, or with respect to any Company
        Regulatory Permit or Health Care Submission or (ii) failed to disclose a material fact required to be disclosed to the FDA, EMA or any other Governmental Authority performing functions similar to those performed by the FDA, or committed any act,
        made a statement, or failed to make a statement that, at the time such disclosure was made, would reasonably be expected to provide a basis for the FDA, EMA or any other Governmental Authority performing functions similar to those performed by the
        FDA to invoke its policy regarding &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221;, set forth in 56 Fed. Reg. 46191 (September 10, 1991) or any similar policy.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">No Acquired Company and, to the
        Company&#8217;s Knowledge, no Person acting on their behalf is the subject of any pending or, to the Company&#8217;s Knowledge, threatened investigation by the FDA, EMA or any other Governmental Authority performing functions similar to those performed by the
        FDA.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">No Acquired Company has, nor, to the
        Company&#8217;s Knowledge, has any of their respective officers, employees, representatives or agents (in each case, acting in the capacity of an employee or representative of any Acquired Company):</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"> been suspended or debarred or
        convicted of any crime or engaged in any conduct that would reasonably be expected to result in (A) debarment under 21 U.S.C. Section 335a or any similar Applicable Law or (B) exclusion under 42 U.S.C. Section 1320a-7 or any similar Applicable Law;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">been convicted of any other offense
        related to any Federal or State healthcare program;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">been excluded, suspended or otherwise
        declared ineligible for Federal or State healthcare program participation, including without limitation persons identified on the General Services Administration&#8217;s List of Parties Excluded from Federal Programs or the HHS/OIG List of Excluded
        Individuals/Entities;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">been debarred, suspended, or proposed
        for debarment or declared ineligible for the awards of contracts by any Federal agency;</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">49</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">been entered on, or engaged in any
        conduct that would reasonably be expected to result in entry on, on any of the FDA Clinical Investigator </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">enforcement lists, including without limitation, (A) the Disqualified/Totally Restricted List, (B) the Restricted List or (C) the Adequate
        Assurances List; or</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">engaged in any conduct that is not
        compliant in any material respect with applicable Health Care Laws relating to the integrity of data generated or used in any clinical trials or other studies related to the development, use, handling, safety, efficacy, reliability or manufacturing
        of the Product.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">All clinical trials and studies have
        been conducted, all data has been generated, analyzed, reviewed and stored, and manufacturing and distribution has been conducted, in each case with respect to the Product, in compliance with applicable Health Care Laws in all material respects.&#160;
        The Acquired Companies have instituted and maintain policies and procedures reasonably designed to ensure the integrity of data generated or used in any clinical trials or other studies related to the development, use, handling, safety, efficacy,
        reliability or manufacturing of the Product and to encourage employees to report any compliance issues related thereto (and the Company has Made Available copies or written summaries of any such reports).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">No Acquired Company is party to or
        has any ongoing reporting obligations pursuant to or under any Order by any Company Regulatory Authority (including, for the avoidance of doubt, any corporate integrity agreement, monitoring agreement, deferred prosecution agreement, consent
        decrees, settlement orders or other similar agreements) and, to the Company&#8217;s Knowledge, no such Order is currently contemplated, proposed or pending.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman', Times, serif;">Except as has not been, and would not
        reasonably be expected to be, material to the Acquired Companies, taken as a whole, each Acquired Company is, and since January 1, 2018 has been, in compliance with all healthcare laws applicable to the operation of its business as currently
        conducted, including (i) any and all federal, state and local fraud and abuse laws, including the federal Anti-Kickback Statute (42 U.S.C. &#167; 1320a-7(b)), the civil False Claims Act (31 U.S.C. &#167; 3729 et seq.), the administrative False Claims Law (42
        U.S.C. &#167; 1320a-7b(a)) and the regulations promulgated pursuant to such statutes; (ii) the FDCA and the regulations promulgated thereunder; (iii) the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &#167;&#167; 1320d et seq.), as
        amended by the Health Information and Technology for Economic and Clinical Health Act, and the regulations promulgated pursuant thereto; (iv) Applicable Laws which are cause for exclusion from any federal health care program and the regulations
        promulgated pursuant to such statutes; (v) Applicable Laws relating to the billing or submission of claims, collection of accounts receivable, underwriting the cost of, or provision of management or administrative services in connection with, any
        and all of the foregoing, by an Acquired Company; (vi) the Anti-Inducement Law (42 U.S.C. &#167; 1320a-7a(a)(5)); (vii) the Public Health Service Act (42 U.S.C. &#167; 201 et seq.) and the regulations promulgated thereunder; and (viii) all applicable laws,
        rules and regulations, standards, principles, ordinances, judgments, decrees, orders, writs and injunctions administered by the FDA and other Company Regulatory Authorities, including those governing or relating to good, professional clinical and
        laboratory practices, recordkeeping, the manufacture, testing, development, approval, processing, and use of any compounds or products manufactured by or on behalf of the Company, including applicable </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">50</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">regulations at 21 C.F.R. Parts 11, 50, 54, 56, 58, 312, and 314 and the FDA&#8217;s current Good Manufacturing Practice Regulations at 21 C.F.R.
        Parts 210 and 211 for products sold in the</font><font style="font-family: 'Times New Roman',Times,serif;"> United States, each as may be amended from time to time (collectively, the &#8220;<u>Health Care Laws</u>&#8221;).&#160; No Acquired Company or, to the
        Company&#8217;s Knowledge, any of its officers, employees, representatives or agents (in each case, acting in the capacity of an employee or representative of an Acquired Company) is subject to any enforcement, regulatory or administrative proceedings
        against or affecting such Acquired Company relating to or arising under the FDCA, the Anti-Kickback Statute, or similar Applicable Law, and, to the Company&#8217;s Knowledge,&#160; no such enforcement, regulatory or administrative proceeding has been
        threatened, except, in each case, as would not have, and would not reasonably be expected to have, a Company Material Adverse Effect.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company has Made Available to
        Parent complete and accurate copies of (i) each investigational new drug application and all material correspondence relating to material clinical trial applications submitted to regulatory authorities (including the FDA, EMA and any other
        Governmental Authority performing functions similar to those performed by the FDA) by or on behalf of any Acquired Company, including any supplements thereto, relating to the Product, (ii) all final study results and/or reports relating to the
        Product, (iii) all written material correspondence to or from regulatory authorities (including the FDA, EMA and any other Governmental Authority performing functions similar to those performed by the FDA), including meeting minutes and records of
        material contacts, in each case relating to the Product, (iv) all documents in any Acquired Company&#8217;s possession related to inspections by regulatory authorities (including the FDA, EMA and any other Governmental Authority performing functions
        similar to those performed by the FDA), in each case relating to the Product, (v) all material information relating to adverse drug experiences, events or reactions or other safety information obtained or otherwise received by any Acquired Company
        relating to the Product, (vi) all agreements with third parties regarding the Product with respect to pharmacovigilance and (vii) all material and final manufacturing and analytical reports, pre-clinical reports, clinical study reports, trial
        master files, statistical programs and information for ongoing and completed clinical trials and studies in any Acquired Company&#8217;s or, to the Company&#8217;s Knowledge, Collaboration Partner&#8217;s possession, in each case, relating to the Product.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.25.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Sanctions
          Laws</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Since January 1, 2018, no Acquired
        Company nor any of their Representatives or any other Person acting for or on behalf of an Acquired Company has been in violation of or has been or was charged by any Governmental Authority with or made any voluntary disclosure or paid any fine or
        penalty to any Governmental Authority concerning, or, to the Company&#8217;s Knowledge, has been investigated for, a violation of any Sanctions Laws except as has not been, and would not reasonably be expected to be, material to the Acquired Companies,
        taken as a whole.&#160; There are not as of the date hereof nor since January 1, 2018 have there been any Proceedings, allegations, investigations or inquiries pending or, to the Company&#8217;s Knowledge, threatened against the Acquired Companies concerning
        any violations or alleged violations of any Sanctions Law.&#160; The Acquired Companies have instituted and maintain policies and procedures reasonably designed to ensure compliance with all applicable Sanctions Laws.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">51</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">None of the Acquired Companies, nor any
        director or officer of any Acquired Company, is a Sanctioned Person.&#160; To the Company&#8217;s Knowledge, no Sanctioned Person or group of Sanctioned Persons beneficially owns more than five percent (5%) of the Company.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">To the Company&#8217;s Knowledge, since
        January 1, 2018, none of the Acquired Companies has had, directly or indirectly, any transactions with or investments in any Sanctioned Person or Sanctioned Country.</font></div>
    <div style="text-indent: 81pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.26.</font>&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;"><u>Critical
          Technology</u>.&#160; None of the Acquired Companies produce, design, test, manufacture, fabricate or develop a Critical Technology that is (i) utilized in connection with such Acquired Companies&#8217; activity in one or more Pilot Program Industries, or
        (ii) designed by the Acquired Companies specifically for use in one or more Pilot Program Industries.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.27.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Interested
          Party Transactions</u>.&#160; Except as disclosed in the Company SEC Documents, since the Audited Balance Sheet Date through the date hereof, no event has occurred that would be required to be reported by the Company pursuant to Item 404 of Regulation
        S-K.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.28.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Brokers&#8217; Fees</u>.&#160;














        Except for J.P. Morgan Securities LLC and Goldman Sachs &amp; Co. LLC, copies of whose engagement agreements (and all indemnification and other agreements related to such engagements) have been Made Available to Parent, there is no investment
        banker, broker, finder or other agent or intermediary that has been retained by or is authorized to act on behalf of the Company or any of the Company Subsidiaries, their respective Affiliates, or any of their respective executive officers or
        directors in their capacities as executive officers or directors, or who is entitled to any financial advisory, banking, broker&#8217;s, finder&#8217;s or similar fee or commission in connection with the Transactions, including the Offer and the Merger.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.29.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Opinion of
          Financial Advisor</u>.&#160; The Company Board has received the separate opinions of J.P. Morgan Securities LLC and Goldman Sachs &amp; Co. LLC to the effect that, as of the date of such opinion and based upon and subject to the limitations,
        qualifications, assumptions and conditions set forth therein, the Per Share Amount to be received by the holders of Shares (other than Parent, Merger Sub and their respective Affiliates and other than any Dissenting Shares) in the Offer and the
        Merger is fair, from a financial point of view, to such holders. &#160;A signed copy of each such opinion shall be delivered to Parent as soon as practicable following the execution and delivery of this Agreement for information purposes only.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 4.30.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>No Other
          Representations or Warranties</u>.&#160; Except for the representations and warranties expressly set forth in this <u>Article&#160;4</u>, none of the Company or any of its Affiliates nor any other Person on behalf of any of them is making or has made any
        express or implied representation or warranties of any kind or nature whatsoever, including with respect to the Company, the Company Subsidiaries or their respective businesses or with respect to any other information provided, or Made Available,
        to Parent, Merger Sub or their respective Representatives or Affiliates in connection with the Transactions, including the accuracy or</font><font style="font-family: 'Times New Roman',Times,serif;"> </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">52</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">completeness thereof and the Company hereby expressly disclaims any such other representations and warranties.&#160; The Company acknowledges and
        agrees that, except for the representations and warranties made by Parent and Merger Sub in this Agreement (as qualified by the applicable items disclosed in the Parent Disclosure Letter), none of Parent, Merger Sub or any other Person is making or
        has made any representations or warranties, expressed or implied, at law or in equity, with respect to or on behalf of Parent, Merger Sub or any of their Subsidiaries, their businesses, operations, assets, liabilities, financial condition, results
        of operations, future operating or financial results, estimates, projections, forecasts, plans or prospects (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, plans or prospects) or the accuracy or
        completeness of any information regarding Parent, Merger Sub or any of their Subsidiaries or any other matter furnished or provided to the Company or Made Available to the Company or its Representatives in any &#8220;data rooms,&#8221; &#8220;virtual data rooms,&#8221;
        management presentations or in any other form in expectation of, or in connection with, this Agreement or the Transactions.&#160; The Company is not relying upon and specifically disclaims that it is relying upon or has relied upon any such other
        representations or warranties that may have been made by any Person, and acknowledges and agrees that Parent, Merger Sub and their Affiliates have specifically disclaimed and do hereby specifically disclaim any such other representations and
        warranties.</font> </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;5</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Except as set forth in the Parent Disclosure Letter (each section or subsection of which qualifies the correspondingly numbered and
      lettered representation and warranty in this <u>Article&#160;5</u> to the extent specified therein and the representations and warranties in such other applicable sections or subsections of this Agreement to the extent that the disclosure on its face is
      reasonably apparent upon reading the disclosure contained in such section or subsection of the Parent Disclosure Letter that such disclosure is responsive to such other numbered and lettered Section or subsection of this <u>Article&#160;5</u>) delivered
      by Parent and Merger Sub to the Company prior to or simultaneously with the execution of this Agreement (the &#8220;<u>Parent Disclosure Letter</u>&#8221;), each of Parent and Merger Sub hereby represents and warrants to the Company as follows:</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Corporate
          Existence and Power</u>.&#160; Parent is a company duly organized, validly existing and in good standing (to the extent a concept of &#8220;good standing&#8221; is applicable) under the Applicable Law of Switzerland.&#160; Merger Sub is a corporation duly
        incorporated, validly existing and in good standing under the Applicable Law of the State of Delaware.&#160; Each of Parent and Merger Sub is duly qualified to do business in each other jurisdiction where such qualification is necessary for it to carry
        on its business as now conducted, except where the failure to be so qualified would not result in a Parent Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Authorization;














          Enforceability</u>.&#160; Each of Parent and Merger Sub has full power and authority to enter into this Agreement and to consummate the Transactions.&#160; The execution, delivery and performance by Parent and Merger Sub of this Agreement and the
        consummation by Parent and Merger Sub of the Transactions have been duly authorized by all necessary corporate action on the part of Parent and Merger Sub.&#160; Each of Parent and Merger Sub has duly executed and delivered this Agreement, and, assuming
        due authorization, execution </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">53</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">and delivery by the Company, this Agreement constitutes a valid and binding agreement of each of Parent and Merger Sub, enforceable against
        each such Person in accordance with its terms, except as such enforceability may be limited by the Bankruptcy and Equity Exception.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.03.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Governmental
          Authorization</u>.&#160; The execution, delivery and performance by Parent and Merger Sub of this Agreement and the consummation by Parent and Merger Sub of the Transactions require no action by or in respect of, consent, approval, authorization or
        permit from, or filing with or notification to, any Governmental Authority, other than (i) the filing of the Certificate of Merger with the Delaware Secretary and compliance with other applicable requirements of the DGCL in connection therewith and
        the filing of appropriate corresponding documents with the appropriate authorities of any other states in which the Parent and Merger Sub are qualified to transact business, (ii) compliance with and filings pursuant to any applicable requirements
        of the HSR Act and any other applicable Antitrust Laws, (iii) the filing with the SEC of (A) the Offer Documents and (B) any other filings and reports that may be required in connection with this Agreement and the Transactions under the Exchange
        Act, (iv) compliance with any applicable requirements of the Securities Act, the Exchange Act and any other applicable securities laws and stock exchange rules and (v) any other actions by or in respect of, consent, approval, authorization, or
        Permit from or filing with or notification to, any Governmental Authority, the absence of which would not have a Parent Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.04.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Non-contravention</u>.&#160;














        The execution, delivery and performance by Parent and Merger Sub of this Agreement and the consummation by Parent and Merger Sub of the Transactions do not and will not (i) contravene, conflict with, or result in any violation or breach of any
        provision of the Organizational Documents of Parent or Merger Sub, (ii) assuming compliance with the matters referred to in <u>Section 5.03</u>, contravene, conflict with or result in a violation or breach of any provision of any Applicable Law or
        Order or (iii) require any consent or approval under, violate, conflict with, result in any breach of or any loss of any benefit under, constitute a change of control or default under, or result in termination or cancellation or give to others any
        right of termination, vesting, amendment, acceleration or cancellation (in each case, with or without notice or lapse of time or both) of any Contract to which Parent, Merger Sub or any other Subsidiary of Parent is a party, or by which they or any
        of their respective properties or assets may be bound or affected, with such exceptions, in the case of each of clauses (ii) and (iii) above, as would not have a Parent Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.05.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Capitalization














          and Operation of Merger Sub</u>.&#160; As of the date of this Agreement, the authorized capital stock of Merger Sub consists of 1,000 shares of common stock, par value $0.001 per share, all of which shares are validly issued and outstanding.&#160; All of
        the issued and outstanding capital stock of Merger Sub is, and at the Effective Time will be, owned beneficially and of record by Parent, free and clear of all Liens and transfer restrictions except for Liens or transfer restrictions of general
        applicability as may be provided under the Securities Act or applicable securities laws.&#160; Merger Sub has been formed solely for the purpose of engaging in the Transactions and prior to the Effective Time will have engaged in no other business
        activities and will have incurred no Liabilities or obligations other than as contemplated hereby or otherwise incidental or ancillary to the Transactions.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.06.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>No Vote of
          Parent Stockholders; Required Approval</u>.&#160; No vote or consent of the holders of any class or series of capital stock of Parent or the holders of any other </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">54</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">securities of Parent (equity or otherwise) is necessary to adopt this Agreement, or to approve the Merger or the other Transactions.&#160; The
        vote or consent of Parent or a wholly owned Subsidiary of Parent as the sole stockholder of Merger Sub is the only vote or consent of the holders of any class or series of capital stock of Merger Sub necessary to approve the Merger and adopt this
        Agreement, which vote shall be taken or consent shall be given immediately following the execution and delivery of this Agreement.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.07.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Disclosure
          Documents</u>.&#160; None of the information supplied or to be supplied by Parent or Merger Sub specifically for inclusion or incorporation by reference in the Offer Documents or the Schedule 14D-9 will, at the time such document is first filed with
        the SEC, at any time it is amended or supplemented or at the time it is first published, sent or given to the holders of Shares, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or
        necessary to make the statements therein, in light of the circumstances in which they are being made, not misleading.&#160; The Offer Documents and each document required to be filed by Parent or Merger Sub with the SEC in connection with the Offer will
        comply as to form in all material respects with the applicable requirements of the Exchange Act and the rules and regulations thereunder.&#160; No representation or warranty is made by Parent or Merger Sub with respect to statements made or incorporated
        by reference therein based on information supplied by the Company in writing for inclusion or incorporation by reference in the Offer Documents.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.08.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Litigation</u>.&#160;














        As of the date of this Agreement, (a) there is no Proceeding pending against or, to the knowledge of Parent, overtly threatened against, Parent or any of its Subsidiaries and (b) neither Parent nor any of its Subsidiaries is subject to any
        outstanding Order, which, in either case, has had or if resolved adversely would have a Parent Material Adverse Effect.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.09.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Available
          Funds</u>. Parent and Merger Sub have access to, and at all times through the consummation of the Offer and the Effective Time will have access to, all funds necessary for the payment of the aggregate Per Share Amount, as the case may be, as
        provided in <u>Article&#160;2</u> and sufficient for the satisfaction of all of Parent&#8217;s and Merger Sub&#8217;s other obligations under this Agreement.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Ownership of
          Company Common Stock</u>.&#160; </font>None of Parent, Merger Sub or any of their respective controlled Affiliates &#8220;owns,&#8221; and at all times during the last three (3) years, none of Parent, Merger Sub or any of their respective controlled Affiliates
      has &#8220;owned,&#8221; beneficially or otherwise (as such terms are defined in Section 203 of the DGCL), any of the outstanding shares of Company Common Stock (other than pursuant to this Agreement or passive investments for cash management purposes or
      employee benefit plans established or maintained for the benefit of Parent or its controlled Affiliates&#8217; employees in the ordinary course of business).&#160; Neither Parent nor Merger Sub is, or at any time during the last three (3) years has been, an
      &#8220;interested stockholder&#8221; of the Company under Section 203(c) of the DGCL.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Broker&#8217;s Fees</u>.&#160;











      </font>Except for Persons, if any, whose fees and expenses shall be paid by Parent or one of its Affiliates, no broker, finder, investment banker, financial advisor or other Person is entitled to any brokerage, finder&#8217;s, financial advisor&#8217;s or</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">55</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements
        made by or on behalf of Parent, Merger Sub, or any of their respective Subsidiaries.</div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 5.12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>No Other
          Representations or Warranties</u>.&#160; Except for the representations and warranties expressly set forth in this <u>Article&#160;5</u>, none of Parent, Merger Sub or any of their Affiliates nor any other Person on behalf of any of them is making or has
        made any express or implied representation or warranties of any kind or nature whatsoever, including with respect to Parent, its Subsidiaries or their respective businesses or with respect to any other information provided, or made available, to
        the Company, the Company Subsidiaries or any of their respective Representatives or Affiliates in connection with the Transactions, including the accuracy or completeness thereof, and Parent and Merger Sub hereby expressly disclaim any such other
        representations or warranties.&#160; Parent and Merger Sub acknowledge and agree that, except for the representations and warranties made by the Company in this Agreement (as qualified by the applicable items disclosed in the Company Disclosure Letter),
        neither the Company nor any other Company Related Party is making or has made any representations or warranties, expressed or implied, at law or in equity, with respect to or on behalf of the Company or any of the Company Subsidiaries, their
        businesses, operations, assets, liabilities, financial condition, results of operations, future operating or financial results, estimates, projections, forecasts, plans or prospects (including the reasonableness of the assumptions underlying such
        estimates, projections, forecasts, plans or prospects) or the accuracy or completeness of any information regarding the Company or any of the Company Subsidiaries or any other matter furnished or provided to Parent or Merger Sub or Made Available
        to Parent, Merger Sub or their Representatives in any &#8220;data rooms,&#8221; &#8220;virtual data rooms,&#8221; management presentations or in any other form in expectation of, or in connection with, this Agreement or the Transactions.&#160; Parent and Merger Sub are not
        relying and specifically disclaim that they are relying upon or have relied upon any such other representations or warranties that may have been made by any Person, and acknowledge and agree that the Company and its Affiliates have specifically
        disclaimed and do hereby specifically disclaim any such other representations and warranties.&#160; Parent and Merger Sub have conducted their own independent investigation of the Acquired Companies and the Transactions and have had an opportunity to
        discuss and ask questions regarding the Acquired Companies&#8217; businesses with the management of the Company.</font></div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;6</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">COVENANTS</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Conduct of
          the Company</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">During the period commencing on the
        date of this Agreement and ending on the earlier of the termination of this Agreement in accordance with <u>Article&#160;8</u> and the Effective Time (the &#8220;<u>Pre-Closing Period</u>&#8221;), except for matters (w) set forth in <u>Section 6.01</u> of the
        Company Disclosure Letter, (x) required by Applicable Law, (y) expressly required or permitted by this Agreement or (z) undertaken with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed),
        the Company shall, and shall cause each of the Company Subsidiaries to, conduct its business in the ordinary course of business consistent with past practice and use its respective reasonable best efforts to (i) preserve intact </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">56</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">the material aspects of its business organizations and relationships with third parties, and (ii) keep available the services of its officers
        and key employees of the Acquired Companies; <u>provided</u>, <u>however</u>, that no action permitted to be taken by the Company or any Company Subsidiary under clause (i) through (xxi) of <u>Section 6.01(b)</u> without Parent&#8217;s consent shall
        be deemed a breach of the preceding sentence unless such action would constitute a breach of such specific provision.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Without limiting the generality of the
        foregoing in <u>Section 6.01(a)</u> and except for matters (w) set forth in <u>Section 6.01</u> of the Company Disclosure Letter, (x)&#160;required by Applicable Law, (y) expressly required or permitted by this Agreement or (z) undertaken with the
        prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), the Company shall not, nor shall it permit any of the Company Subsidiaries to:</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman', Times, serif;">amend the Organizational Documents of
        the Company or the Organizational Documents of any of the Company Subsidiaries (whether by merger, consolidation or otherwise);</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">issue, sell, grant, pledge, transfer,
        lease, dispose of, grant any Lien or otherwise enter into any Contract or other agreement with respect to the Company Securities or any other capital stock of the Company or any capital stock of the Company Subsidiaries, or grant any options,
        warrants or other rights to acquire or any such capital stock or other interest in or any instrument convertible into or exchangeable or exercisable for any such capital stock or other interest, other than the issuance of shares of Company Common
        Stock (A) upon the exercise of Company Stock Options outstanding as of the date of this Agreement pursuant to existing Company Stock Plans or issued in accordance with <u>Section 6.01(b)(xvii)</u>, or pursuant to the terms of the Company
        Restricted Shares that are outstanding on the date of this Agreement or issued in accordance with <u>Section 6.01(b)(xvii)</u>, in each case, in accordance with the applicable Company Stock Plan&#8217;s and Company Equity Award&#8217;s terms as in effect on
        the date of this Agreement, (B) pursuant to the Company ESPP (subject to <u>Section 2.08(c)</u>), (C) in connection with conversions (in whole or in part) of any of the Convertible Senior Notes pursuant to the terms of the Convertible Senior Notes
        Indentures, or (D) the grant of regular director compensation in the form of Company Equity Awards in the ordinary course of business consistent with past practice in accordance with the terms of the Board Compensation Program previously provided;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">except in connection with actions
        permitted by <u>Section 6.02</u> hereof, take any action to exempt any Person from, or make any acquisition of securities of the Company by any Person not subject to, any state takeover statute or similar statute or regulation that applies to
        Company with respect to an Acquisition Proposal or otherwise, including the restrictions on &#8220;business combinations&#8221; set forth in Section 203 of the DGCL, except for Parent, Merger Sub, or any of their respective Subsidiaries or Affiliates, or the
        Transactions;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">adopt any plan of merger,
        consolidation, reorganization, liquidation or dissolution of the Company or any of the Company Subsidiaries, file a petition in bankruptcy under any provisions of federal or state bankruptcy Applicable Law on behalf of the </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">57</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">Company or any of the Company Subsidiaries or consent to the filing of any bankruptcy petition against the Company or any of the Company
        Subsidiaries under any similar Applicable Law;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">create any Subsidiary of the Company or
        any of the Company Subsidiaries;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">(A) establish a record date for,
        declare, accrue, set aside or pay any dividend or make any other distribution on or in respect of (whether in cash, stock, property or otherwise) the Company&#8217;s or any of the Company Subsidiaries&#8217; capital stock or other securities (other than
        dividends to the Company or from one of the wholly owned Company Subsidiaries) or (B) redeem, repurchase or otherwise reacquire (or offer to redeem, repurchase or otherwise reacquire), split, combine or reclassify any Company Securities or capital
        stock of the Company or any of the Company Subsidiaries, or otherwise change the capital structure of the Company or any of the Company Subsidiaries, other than (1) any repurchases pursuant to the Company&#8217;s or any of the Company Subsidiaries&#8217; right
        (under written commitments in effect as of the date hereof) to purchase Company Securities or capital stock of the Company or any of the Company Subsidiaries held by an officer or other employee, or individual who is an independent contractor,
        consultant or director, of or to the Company or any of the Company Subsidiaries, but only upon termination of such Person's employment or engagement by the Company, (2) for purposes of effecting a net settlement of any Company Stock Option in
        satisfaction of any exercise price or required tax withholdings, or net share withholding in connection with the vesting of any Company Restricted Shares in satisfaction of any required tax withholdings or (3)&#160;between the Company and a wholly owned
        Company Subsidiary or between wholly owned Company Subsidiaries;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">make any material changes in any
        accounting methods, principles or practices, in each case, except as required by a change in GAAP or required by Applicable Law;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(viii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">other than in the ordinary course of
        business: (A)&#160;accelerate, terminate or consent to the termination of, cancel, amend in any material respect, grant a waiver of any material right under or otherwise modify in any material respect any Specified Contract or any Contract that would
        constitute a Specified Contract if in effect as of the date of this Agreement; or (B) enter into any Contract that would constitute a Specified Contract if in effect as of the date of this Agreement;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ix)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">make any capital expenditure other
        than capital expenditures that are no more than $1,000,000 in the aggregate in any fiscal year and are incurred in the ordinary course of business consistent with past practice;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">repurchase, prepay, incur, assume or
        guarantee any Indebtedness to any Person, issue or sell any debt securities of the Company or any of the Company Subsidiaries or guarantee any debt securities of any other Person or enter into any arrangement having the economic effect of any of
        the foregoing (other than (A) settlements (in whole or in part) of any of the Convertible Senior Notes pursuant to the terms of the Convertible Senior Notes Indentures, (B) any such transactions between the Company and one of its wholly owned
        Subsidiaries or (C) borrowings incurred in the ordinary course of business (including any</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">58</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;"> borrowings in respect of letters of credit) that do not, at any time, exceed $2,000,000, in the aggregate;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">grant or suffer to exist any Liens on
        any properties or assets of the Company or any of the Company Subsidiaries that are material to any Acquired Company, other than Permitted Liens;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">make any capital investment in or loan
        or advance to, or forgive any loan to, any other Person except for (A) loans, capital contributions, advances or investments between the Company and any wholly owned Company Subsidiary or between wholly owned Company Subsidiaries and (B) advances
        to employees and consultants for travel and other business-related expenses in the ordinary course of business consistent with past practices and in compliance with the Company&#8217;s policies related thereto;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xiii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">other than in the ordinary course of
        business and other than with respect to Intellectual Property rights of the Acquired Companies (which shall be the subject to and governed by <u>Section 6.01(b)(xix)</u>), sell, lease, sublease, license, sublicense, abandon, waive, relinquish,
        transfer, pledge, abandon, assign, swap, mortgage, hypothecate or otherwise dispose of any of the assets, properties or rights of the Company or any of the Company Subsidiaries that are material to the Acquired Companies, taken as a whole;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xiv)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">purchase or acquire, directly or
        indirectly (including by merger, consolidation, or acquisition of stock or assets or any other business combination), (A)&#160;any corporation, partnership, other business organization or division thereof or any other business or all or substantially
        all of the assets of any Person (other than reorganizations solely among wholly owned Subsidiaries of the Company) or (B) any assets, real property, securities, properties, interests or businesses from any Person (except for a wholly owned Company
        Subsidiary), in each case, other than acquisitions of raw materials, supplies, equipment, inventory and third-party software in the ordinary course of business;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">enter into a new line of business or
        abandon or discontinue any existing line of business;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xvi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">settle, pay, discharge or satisfy any
        Proceeding (or agree to do any of the foregoing), other than any settlement, payment, discharge or satisfaction that (A)&#160;does not relate to any Transaction Litigation (with respect to which any settlements, releases, waivers or compromises shall be
        subject to <u>Section 6.10</u>) and (B) (1) either (x) results solely in a monetary obligation involving only the payment of monies by the Company and/or the Company Subsidiaries of not more than $2,000,000, individually or in the aggregate for
        all such Proceedings (excluding any settlements made under the following clause (y)), or (y) results solely in a monetary obligation that is funded by an indemnity obligation to, or an insurance policy of, any Acquired Company and the payment of
        monies by the Acquired Companies that are not more than $2,000,000, individually or in the aggregate (not funded by an indemnity obligation or through insurance policies) and (2) does not involve any admission of guilt or impose any restrictions or
        limitations upon the operations or business of or other conduct remedy or injunctive relief applicable to the Company or any of the Company Subsidiaries, whether before, on or after the Effective Time;</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">59</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xvii)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">except as required by Applicable Law,
        expressly required or permitted by this Agreement or required by the terms of any Company Employee Plan as in effect as of the date of this Agreement, (A)&#160;increase the compensation payable by the Company or any of the Company Subsidiaries to
        directors, officers, employees, consultants or independent contractors, other than increases with respect to Company Employees who are not directors or executive officers in the ordinary course of business in connection with the Company&#8217;s or any
        Company Subsidiary&#8217;s annual merit-based compensation review process or job promotions that do not exceed 3% individually or in the aggregate, (B) establish, adopt, enter into, amend, terminate, or take any action to accelerate rights under any
        Company Employee Plans or any plan, agreement, program, policy, trust, fund or other arrangement that would be a Company Employee Plan if it were in existence as of the date of this Agreement, other than amendments made to Company Employee Plans in
        the ordinary course of business that do not materially increase costs, (C) grant or amend any equity or equity-based awards except as required by existing Company Stock Plans, (D) hire any officer, employee, independent contractor or consultant,
        other than individuals with an annual base salary less than $200,000 or (E) other than in the ordinary course of business consistent with past practice for Company Employees who are not directors or executive officers, terminate the employment or
        services (other than for cause) of any officer, employee, independent contractor or consultant with an annual base salary more than $200,000;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xviii)</font>&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">become a party to, establish, adopt,
        amend, commence participation in or terminate any collective bargaining agreement or other agreement with a labor union, works council or similar organization;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xix)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">sell, license, sublicense, abandon,
        assign, transfer, create any Lien on (other than Permitted Liens), or otherwise grant any rights under any material Company Owned IP or the Exclusively Licensed IP, other than the grant of nonexclusive licenses in the ordinary course of business
        consistent with past practice;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xx)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">make, rescind or change any material
        Tax election, settle or compromise any claim relating to a material amount of Taxes, waive or extend the statute of limitations in respect of a material amount of Taxes, enter into any closing agreement with respect to a material amount of Taxes,
        amend any Tax Return relating to a material amount of Taxes or make any material change in any of the methods, principles or practices used by it for Tax accounting except as required by Applicable Law;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xxi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">enter into any material transaction or
        Contract with any Affiliate, holder of five percent (5%) or more of the Shares, director or executive officer of the Company or any of the Company Subsidiaries or enter into any other material transaction or Contract with any other Person that
        would be required to be reported by the Company pursuant to Item 404 of Regulation S-K under the Exchange Act; or</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(xxii)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">authorize any of, or agree or commit to
        take, any of the actions described in the foregoing clauses (i) through (xxi) of this <u>Section 6.01(b)</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Product Matters</u>.&#160; In furtherance
        and not in limitation of any other provision of this Agreement, to the extent permitted by Applicable Law, the Company shall keep </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">60</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Parent informed on a reasonably current basis of any material developments (including the occurrence of any serious adverse event), discussions or negotiations relating to
        the Product.&#160; Without limiting the generality of the foregoing, to the extent permitted by Applicable Law, the Company shall (i) consult with Parent and promptly inform Parent, and provide Parent with a reasonable opportunity to review, as
        reasonably in advance as practicable under the circumstances, and consider in good faith Parent&#8217;s comments to or in connection with any material meetings, filings, submissions, correspondence or other activities or communications made by or on
        behalf of any Acquired Company to, between or with the FDA, EMA or any other Governmental Authority performing functions similar to those performed by the FDA relating to the Product, and (ii) promptly inform Parent and provide Parent or Merger Sub
        with a reasonable opportunity (but no fewer than five (5) Business Days) to comment, in each case, prior to making any material change to any study protocol, adding any new trial, making any material change to a manufacturing plan or process,
        making any material change to a development timeline or initiating, or making any material change to, promotional or marketing materials or activities relating to the Product.</div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding anything to the
        contrary in this <u>Section 6.01</u>, the parties hereto acknowledge and agree that nothing contained in this Agreement shall give Parent or Merger Sub, directly or indirectly, the right to control or direct the Company&#8217;s operations (including for
        purposes of the HSR Act) prior to the consummation of the Offer.&#160; Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions hereof, complete control and supervision over its operations.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Acquisition
          Proposals; Change in Recommendation</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as permitted by this <u>Section
          6.02</u>, during the Pre-Closing Period, the Acquired Companies and their respective directors and officers shall not, and shall not authorize their other Representatives to, and shall direct them not to (i) initiate, solicit, propose, knowingly
        induce or knowingly encourage or knowingly facilitate the making of any Acquisition Proposal, (ii) other than informing Third Parties of the existence of the provisions contained in this <u>Section 6.02</u>, engage in, continue or otherwise
        participate in negotiations or discussions with, or furnish any non-public information (or access thereto) concerning the Company or any of the Company Subsidiaries to, any Third Party in connection with, or for the purpose of knowingly encouraging
        or knowingly facilitating, an Acquisition Proposal, (iii)&#160;recommend or enter into any Contract, letter of intent, acquisition agreement, agreement in principle, memorandum of understanding or similar agreement with respect to any Acquisition
        Proposal or (iv) approve, authorize or agree to do any of the foregoing.&#160; Promptly following the execution of this Agreement, and in any event within one (1) Business Day of the date of this Agreement, the Acquired Companies shall, and shall direct
        their respective Representatives to, (A) cease and cause to be terminated any solicitation and any and all existing discussions or negotiations with any Person conducted heretofore with respect to any Acquisition Proposal or any inquiry or request
        for information that could reasonably be expected to lead to, or result in, an Acquisition Proposal and (B) terminate access by any Third Party to any physical or electronic data room relating to any potential Acquisition Transaction.&#160;
        Notwithstanding anything in this Agreement to the contrary, the Company shall be permitted to grant waivers of, and not enforce, any standstill provision or similar provision that has the effect of prohibiting the counterparty thereto from making
        an Acquisition Proposal to the Company Board to the extent </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">61</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">that the Company Board determines in good faith that the failure to grant such waiver or to not</font><font style="font-family: 'Times New Roman',Times,serif;"> enforce such provision would reasonably be expected to constitute a breach of the Company Board&#8217;s fiduciary duties under Applicable Law.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding anything to the
        contrary contained in this Agreement, if prior to the consummation of the Offer the Company receives a <font style="font-style: italic;">bona fide</font> written Acquisition Proposal (which Acquisition Proposal was made after the date of this
        Agreement and did not result from a material breach of this <u>Section 6.02</u>), and the Company Board determines in good faith, after consultation with its financial advisors and outside legal counsel, that such Acquisition Proposal constitutes,
        or could reasonably be expected to lead to, a Superior Proposal, then the Company and its Representatives may: (i) furnish any information with respect to the Acquired Companies and access thereto to any Third Party making such Acquisition Proposal
        (and its Representatives and financing sources); <u>provided</u> that (A) prior to furnishing any such information, the Company receives from such Third Party an executed Acceptable Confidentiality Agreement and (B) any such non-public information
        so furnished has been previously provided or Made Available to Parent or is provided or Made Available (including through the Data Room) to Parent promptly (and in any event no later than twenty-four (24) hours) after it is so furnished to such
        Third Party or (ii)&#160;participate or engage in negotiations or discussions with the Third Party making such Acquisition Proposal and its Representatives and financing sources regarding such Acquisition Proposal.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as set forth in this <u>Section
          6.02</u> (including <u>Sections 6.02(d), (e)</u> and <u>(g)</u>),&#160; neither the Company Board nor any committee thereof shall (i) (A) withdraw (or modify, amend or qualify in a manner adverse to Parent or Merger Sub), or propose publicly to
        withdraw (or modify, amend or qualify in a manner adverse to Parent or Merger Sub), the Board Recommendation, (B) approve, recommend or declare advisable, or propose publicly to approve, recommend or declare advisable, any Acquisition Proposal or
        (C) fail to include the Board Recommendation in the Schedule 14D-9 when disseminated to the Company&#8217;s stockholders (any action described in this clause (i) being referred to as a &#8220;<u>Change in Recommendation</u>&#8221;) or (ii)&#160;approve, recommend,
        declare advisable or enter into any Contract, letter of intent, acquisition agreement, agreement in principle, memorandum of understanding or similar agreement with respect to any Acquisition Proposal, other than an Acceptable Confidentiality
        Agreement (an &#8220;<u>Alternative Acquisition Agreement</u>&#8221;).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding anything to the
        contrary contained in this Agreement, at any time prior to the consummation of the Offer, the Company Board may make a Change in Recommendation in response to an Intervening Event if (i) the Company Board determines in good faith, after
        consultation with its outside legal counsel, that the failure to do so would reasonably be expected to constitute a breach of the Company Board&#8217;s fiduciary duties under Applicable Law, (ii)&#160;(A) the Company shall have provided Parent five (5)
        Business Days&#8217; prior written notice (<u>provided</u> that such notice shall not constitute a Change in Recommendation) advising Parent that the Company intends to make a Change in Recommendation (and specifying, in reasonable detail, the
        Intervening Event) (<u>provided</u> that Parent shall be required to keep all such information confidential in accordance with the terms of the Confidentiality Agreement), and (B):</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">62</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">(1) during such five (5) Business Day period, if requested by Parent in good faith, the Company and its Representatives shall
      negotiate with Parent regarding any changes to the terms </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">of this Agreement and any other proposals made by Parent so that a failure to effect a Change in Recommendation would no longer constitute a breach of the
      Company Board&#8217;s fiduciary duties under Applicable Law; and</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">(2) following such five (5) Business Day period, the Company Board shall have determined in good faith (after consultation with its
      outside legal counsel and financial advisors) that the failure to effect a Change in Recommendation in response to such Intervening Event would reasonably be expected to constitute a breach of the Company Board&#8217;s fiduciary duties under Applicable
      Law.&#160;</div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">In the event of any material change in any event, occurrence or fact relating to such Intervening Event (other than in respect of any revisions proposed
      or proposals made by Parent as referred to above), a new notice shall be required from the Company pursuant to <u>Section 6.02(d)(ii)</u>, except that the references to five (5) Business Days in this <u>Section 6.02(d)</u> shall be deemed to be
      three (3) Business Days, and the provisions of this <u>Section 6.02(d)</u> shall otherwise apply to the Intervening Event as modified thereby.</div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding anything to the
        contrary contained in this Agreement, at any time prior to the consummation of the Offer if, in response to a <font style="font-style: italic;">bona fide</font> written Acquisition Proposal made by a Third Party after the date of this Agreement
        which does not arise from a material breach of this <u>Section 6.02 </u>and has not been withdrawn, the Company Board determines in good faith (after consultation with its outside legal counsel and financial advisors) that (i) such Acquisition
        Proposal constitutes a Superior Proposal and (ii) the failure to take an action set forth in clause (x) or (y) would reasonably be expected to constitute a breach of the Company Board&#8217;s fiduciary duties under Applicable Law, then (x) the Company
        Board may make a Change in Recommendation or (y) the Company may terminate this Agreement pursuant to <u>Section 8.01(d)(i)</u> in order to enter into an Alternative Acquisition Agreement with respect to such Superior Proposal; <u>provided</u>
        that in either such case (A) the Company shall have provided to Parent three (3) Business Days&#8217; prior written notice (the &#8220;<u>Superior Proposal Notice</u>&#8221;) (<u>provided</u> that such notice shall not constitute a Change in Recommendation) advising
        Parent that the Company intends to take such action (and specifying, in reasonable detail, the material terms and conditions of any such Superior Proposal, including the identity of the Third Party making any such Superior Proposal) and providing
        Parent with a complete copy of any written request, proposal or offer, including any proposed Alternative Acquisition Agreement, and any other documents containing the material terms of such Superior Proposal (<u>provided</u> that Parent shall be
        required to keep all such documents and their terms confidential in accordance with the terms of the Confidentiality Agreement), and (B):</font></div>
    <div style="text-indent: 108pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">during such three
        (3) Business Day period, if requested by Parent in good faith, the Company and its Representatives shall negotiate with Parent regarding changes to the terms of this Agreement and any other proposals made by Parent intended by Parent to cause such
        Acquisition Proposal to no longer constitute a Superior Proposal; and</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">63</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">following such three
        (3) Business Day period, the Company Board shall have determined in good faith (after consultation with its outside legal counsel and financial advisors) that (x) such Acquisition Proposal continues to </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">constitute a Superior Proposal, and (y) the failure to make the Change in Recommendation or terminate this Agreement
        pursuant to <u>Section 8.01(d)(i)</u> would reasonably be expected to constitute a breach of the Company Board&#8217;s fiduciary duties under Applicable Law.</font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Any material revisions to such Acquisition Proposal shall constitute a new Acquisition Proposal and shall in each case require the Company to deliver to
      Parent a new Superior Proposal Notice, except that the references to three (3) Business Days in this <u>Section 6.02(e)</u> shall be deemed to be two (2) Business Days.</div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">During the Pre-Closing Period, the
        Company shall promptly (and in any event no later than twenty-four (24) hours after receipt) advise Parent orally or in writing in the event that the Company receives any Acquisition Proposal and in connection with such notice provide to Parent the
        material terms and conditions of any such Acquisition Proposal (including the identity of the Third Party making any such Acquisition Proposal).&#160; During the Pre-Closing Period, the Company shall (i) keep Parent reasonably informed of the status,
        material details and material terms of any such Acquisition Proposal (including, prior to initially furnishing any information or to commencing any discussions or negotiations pursuant to <u>Section 6.02(b)</u>, advising Parent of any
        determination by the Company Board pursuant to <u>Section 6.02(b)</u>) and any discussions and negotiations concerning the material terms and conditions thereof and (ii) promptly provide to Parent (and in any event no later than twenty four (24)
        hours after receipt or delivery thereof) any written proposal, indication of interest (or amendment thereto) or any other written material that constitutes an Acquisition Proposal (or amendment thereto) including copies of any proposed Alternative
        Acquisition Agreements and any other material agreements (or drafts thereof) and any financing commitments related thereto.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;">
      <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Nothing contained in this Agreement
          shall prohibit the Company or the Company Board, directly or indirectly, through their respective Representatives, from (i)&#160;taking and disclosing to the stockholders of the Company any position contemplated by Rule 14d-9, Rule 14e-2(a) or Item
          1012(a) of Regulation M-A promulgated under the Exchange Act, (ii) making any &#8220;stop, look and listen&#8221; communication to the Company&#8217;s stockholders pursuant to Rule 14d-9(f) promulgated under the Exchange Act or (iii) making any disclosure to the
          stockholders of the Company that the Company has determined in good faith (after consultation with its outside legal counsel) is required by Applicable Law; <u>provided</u> that this <u>Section 6.02(g)</u> shall not be deemed to permit the
          Company Board to make a Change in Recommendation except to the extent permitted by <u>Section 6.02(d)</u> - <u>(e)</u>; <u>provided</u>, <u>further</u>, that nothing in this <u>Section 6.02</u> shall prohibit the Company from contacting and
          engaging in a discussion with any Person or group or their respective Representatives who has made an Acquisition Proposal solely for the purpose of clarifying such Acquisition Proposal and the terms thereof so long as the Company promptly
          provides Parent with a reasonably detailed summary of such discussion.</font></div>
      <font style="font-family: 'Times New Roman', Times, serif;"></font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.03.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Approval of
          Merger</u>.&#160; The Merger shall be governed by Section 251(h) of the DGCL and shall be effected by Parent, Merger Sub and the Company as soon as </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">64</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">practicable following the consummation of the Offer, without a vote of the stockholders of the Company, pursuant to Section 251(h) of the
        DGCL.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.04.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Access to
          Information</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Upon reasonable notice to the Company,
        the Acquired Companies shall, and shall cause their respective officers, directors, employees and other Representatives to, afford Parent&#8217;s and Merger Sub&#8217;s officers and Parent&#8217;s and Merger Sub&#8217;s other authorized Representatives reasonable access
        as reasonably requested by Parent, during normal business hours throughout the Pre-Closing Period, to their respective Representatives, officers, employees, properties, facilities, books, Contracts, records (including Tax Returns), reports,
        correspondence and any other documents and information of the Acquired Companies that is in the possession, custody or control of any of the Acquired Companies or their respective Representatives (whether in physical or electronic form) and shall
        furnish Parent and Merger Sub all financial, operating and other data and information, in each case, as Parent and Merger Sub through their officers, employees or other Representatives, may reasonably request, in each case, for reasonable business
        purposes related to the consummation of the Transactions; <u>provided</u>, <u>however</u>, that any such access shall be conducted at Parent&#8217;s expense, at a reasonable time, under the supervision of appropriate personnel of the Acquired Companies
        and in such a manner as not to unreasonably interfere with the normal operation of the business of the Acquired Companies.&#160; Nothing in this Agreement shall require any of the Acquired Companies to disclose any information to Parent to the extent
        such disclosure would, in the Company&#8217;s reasonable discretion (i) jeopardize any attorney-client or other legal privilege or (ii) contravene any Applicable Law, fiduciary duty or binding confidentiality obligation of any Acquired Company or its
        Affiliate (so long as the Company has used reasonable best efforts to make appropriate substitute arrangements to permit reasonable disclosure not in violation of such Applicable Law, agreement or duty); <u>provided</u>, <u>further</u>, that
        information shall be disclosed subject to the execution of a joint defense agreement in customary form, and disclosure may be limited to external counsel for Parent, in each case, to the extent that the Company determines that doing so may be
        reasonably required for the purposes of complying with applicable Antitrust Laws.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">No information or knowledge obtained by
        Parent or Merger Sub pursuant to <u>Section 6.02</u>, this <u>Section 6.04</u> or otherwise shall affect or be deemed to affect or modify any representation, warranty, covenant or agreement contained in this Agreement, the conditions to the
        obligations of the parties to consummate the Transactions, including the Offer and the Merger, in accordance with the terms and provisions of this Agreement or otherwise prejudice in any way the rights and remedies of Parent or Merger Sub
        hereunder, nor shall any such information, knowledge or investigation be deemed to affect or modify Parent&#8217;s or Merger Sub&#8217;s reliance on the representations, warranties, covenants and agreements made by the Company in this Agreement.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">With respect to all information
        provided to Parent or any of its Representatives by the Company or any of its Representatives in connection with this Agreement and the consummation of the Transactions (including any information disclosed pursuant to this <u>Section 6.04</u>)
        Parent shall comply with and shall instruct its Representatives to comply with, all of its obligations under the Confidentiality Agreement.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">65</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.05.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Employee
          Benefit Plan Matters</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">From and after the Effective Time,
        Parent shall honor, and shall cause the Surviving Corporation to honor all Company Employee Plans in effect immediately before the Effective Time that by their terms provide a contractual entitlement to any employee or service provider party to or
        participating in such arrangements.&#160; Notwithstanding the foregoing, nothing herein, other than <u>Section 6.05(b)</u> and the terms of such arrangements, including the contractual rights of such participants, shall prevent Parent from amending or
        terminating any Company Employee Plan or providing compensation or benefits in its discretion.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;">
      <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">For a period of one (1) year
          following the Effective Time, Parent shall provide, or shall cause to be provided, to each Continuing Employee who remains employed (i) base salary and base wages and short-term cash incentive compensation opportunities that are no less favorable
          than those in effect for such Continuing Employee as of the date hereof, (ii) severance payments and severance benefits, in each case, in accordance with the severance plans and guidelines in effect as of the date hereof and described on <u>Section











            6.05(b)</u> of the Company Disclosure Letter, (iii) health and welfare benefits that are substantially comparable in the aggregate to the health and welfare benefits provided to such Continuing Employee as of the Effective Time and (iv) other
          benefits that have been Made Available (excluding long-term incentive, equity and equity-based compensation and deferred compensation) that are substantially comparable in the aggregate to the other such benefits provided to such Continuing
          Employees immediately prior to the execution of this Agreement.</font></div>
      <font style="font-family: 'Times New Roman', Times, serif;"></font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Each Continuing Employee who
        participates in the annual bonus program in respect of the Company&#8217;s 2019 fiscal year shall, to the extent not paid prior to the Closing Date, receive a cash bonus in respect of 2019 based on actual performance against 2019 corporate goals as
        determined by the Compensation Committee consistent with past practices, with individual performance assessed at one-hundred percent (100%); <u>provided</u> that, if the Closing occurs prior to the end of 2019, the cash bonuses payable to the
        Continuing Employees shall be prorated based on the number of days elapsed in the 2019 fiscal year through the Closing Date.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">From and after the Closing Date, with
        respect to Continuing Employees, Parent shall use its reasonable best efforts to cause the service of each such Continuing Employee with the Acquired Companies prior to the Closing Date to be recognized for purposes of eligibility to participate,
        levels of benefits (but not for benefit accruals or participation eligibility under any defined benefit pension plan or plan providing post-retirement medical benefits, subsidized early retirement benefits, or any other similar benefits) and
        vesting under each compensation, vacation, fringe or other welfare benefit plan, program or arrangement of the Surviving Corporation or any of its Affiliates (collectively, the &#8220;<u>Parent Benefit Plans</u>&#8221;) in which any Continuing Employee is or
        becomes eligible to participate, but solely to the extent that service was credited to such employee for such purposes under a comparable Company Employee Plan immediately prior to the Closing Date and to the extent that such credit would not
        result in a duplication of benefits.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">From and after the Closing Date, with
        respect to each Parent Benefit Plan that is an &#8220;employee welfare benefit plan&#8221; as defined in Section 3(1) of ERISA in </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">66</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">which any Continuing Employee is or becomes eligible to participate, Parent shall use its</font><font style="font-family: 'Times New Roman',Times,serif;"> reasonable best efforts to cause each such Parent Benefit Plan to waive all limitations as to pre-existing conditions, waiting periods, required physical examinations and exclusions with respect to participation and coverage
        requirements applicable under such Parent Benefit Plan for such Continuing Employees and their eligible dependents to the same extent that such pre-existing conditions, waiting periods, required physical examinations and exclusions would not have
        applied or would have been waived under the corresponding Company Employee Plan in which such Continuing Employee was a participant immediately prior to his commencement of participation in such Parent Benefit Plan.</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Prior to the Effective Time, if
        requested by Parent in writing not less than ten (10) Business Days prior to the Closing Date, to the extent permitted by Applicable Law and the terms of the applicable plan or arrangement, the Company shall cause the Company 401(k) Plan (the &#8220;<u>Company














          401(k) Plan</u>&#8221;) to be terminated effective immediately prior to the Effective Time.&#160; In the event that Parent requests that the Company 401(k) Plan be terminated, (i) the Company shall provide Parent with evidence that such plan has been
        terminated (the form and substance of which shall be subject to review and approval by Parent) not later than the day immediately preceding the Effective Time and (ii) Parent shall cause a tax-qualified defined contribution retirement plan
        designated by Parent (the &#8220;<u>Parent 401(k) Plan</u>&#8221;) to permit each Continuing Employee to make rollover contributions of &#8220;eligible rollover distributions&#8221; (within the meaning of Section 401(a)(31) of the Code, including loans) in the form of
        cash, shares of Parent stock, notes or a combination thereof, in an amount equal to the full account balance distributed or distributable to such Continuing Employee from the Company 401(k) Plan to the Parent 401(k) Plan.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Parent, the Company and the Surviving
        Corporation acknowledge and agree that all provisions contained in this <u>Section 6.05</u> are included for the sole benefit of the respective parties to this Agreement and shall not create any right in any other Person, including any Company
        Employee, any participant in any Company Employee Plan or Parent Benefit Plan or any beneficiary thereof or any right to continued employment with Parent, Company, the Surviving Corporation or any of their Affiliates.&#160; Nothing in this <u>Section
          6.05</u> shall be deemed to amend any Company Employee Plan, any Parent Benefit Plan or to require Parent, the Surviving Corporation or any of their Affiliates to permit any Person to participate in any particular benefit plan sponsored or
        maintained by Parent or any of its Affiliates, or to continue or amend any particular benefit plan, before or after the consummation of the Transactions, and any such plan may be amended or terminated in accordance with its terms and Applicable
        Law.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.06.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>State
          Takeover Laws</u>.&#160; If any &#8220;control share acquisition,&#8221; &#8220;business combination,&#8221; &#8220;fair price,&#8221; &#8220;moratorium&#8221; or other anti-takeover Applicable Law may become or is deemed or purports to be applicable to any Transaction, then each of the Company,
        Parent, Merger Sub, and their respective Boards of Directors shall use their respective reasonable best efforts to (i) take such actions with respect thereto as are necessary so that the Transactions may be consummated as promptly as practicable on
        the terms contemplated hereby and (ii) otherwise act to render such anti-takeover Applicable Law (or, in the case of Section 203 of the DGCL, the restrictions on business combinations provided therein) inapplicable to, or to minimize the effects of
        the foregoing on, the Transactions.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">67</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.07.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Obligations
          of Parent</u>.&#160; Parent shall cause Merger Sub to perform its obligations under this Agreement and to consummate the Transactions, including the Offer and the Merger, on the terms and conditions set forth in this Agreement.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.08.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Director and
          Officer Liability</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">From and after the Effective Time,
        Parent shall (and shall cause the Surviving Corporation to) indemnify, defend and hold harmless, to the fullest extent permitted under Applicable Law (and shall advance expenses as incurred to the fullest extent permitted under Applicable Law,
        provided the Person to whom expenses are advanced provides an undertaking to repay such advances if a court of competent jurisdiction determines in a final, nonappealable judgment that such Person is not entitled to be indemnified hereunder), each
        present and former director and officer of the Acquired Companies and each of their employees who serves as a fiduciary of a Company Stock Plan, as the case may be, (in each case, when acting in such capacity) (each, an &#8220;<u>Indemnified Party</u>&#8221;)
        against any costs or expenses (including reasonable attorneys&#8217; fees), judgments, settlements, fines, losses, claims, damages or Liabilities (whether civil, criminal, administrative, investigative or other), arising out of or pertaining to matters
        existing or occurring at or prior to the Effective Times, including the Transactions.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Prior to the Closing, the Company shall
        use its reasonable best efforts to purchase a &#8220;tail&#8221; or &#8220;runoff&#8221; officers&#8217; and directors&#8217; liability insurance policy in respect of acts or omissions occurring prior to the Effective Time covering each Indemnified Party on terms with respect to
        coverage, deductibles and amounts no less favorable than those of such policy in effect on the date of this Agreement (the &#8220;<u>Current Policy</u>&#8221;) for the six (6) year period following the Closing and at a price not to exceed three hundred fifty
        percent (350%) of the amount per annum the Company paid or required to be paid for a twelve (12)-month period under the Current Policy (the &#8220;<u>Current Premium</u>&#8221;).&#160; If the Company or, pursuant to the immediately following sentence, Parent
        obtains prepaid &#8220;tail&#8221; or &#8220;runoff&#8221; policies in accordance with this <u>Section 6.08(b)</u>, the Surviving Corporation shall, and Parent shall, and shall cause the Surviving Corporation to, maintain such policies in full force and effect for their
        full term, and they shall continue to honor the obligations thereunder.&#160; If the Company fails to purchase such &#8220;tail&#8221; or &#8220;runoff&#8221; policy prior to Closing, then either (i) Parent may purchase such &#8220;tail&#8221; or &#8220;runoff&#8221; policy on behalf of the Company
        or the Surviving Corporation or (ii) the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, maintain an officers&#8217; and directors&#8217; liability insurance policy in respect of acts or omissions occurring prior to the
        Effective Time covering the Indemnified Parties on terms with respect to each of coverage and amount no less favorable than those of such policy in effect as of the date of this Agreement for a period of six (6) years after the Effective Time; <u>provided</u>&#160;<u>further</u>,
        that in satisfying its obligation under this <u>Section 6.08(a)(ii)</u>, neither Parent nor the Surviving Corporation shall be obligated to pay annual premiums in excess of three hundred fifty percent (350%) of the Current Premium and if such
        premiums for such insurance would at any time exceed three hundred fifty percent (350%) of the Current Premium, then Parent or the Surviving Corporation shall cause to be maintained such policies of insurance described above that provide the
        maximum dollar amount of coverage available at an annual premium equal to three hundred fifty percent (350%) of the Current Premium.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">68</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">From and after the Effective Time,
        Parent shall cause the Surviving Corporation to fulfill and honor in all respects the obligations of the Acquired Companies pursuant to (i) each indemnification agreement that has been Made Available and is in effect between the Company or any of
        the Company Subsidiaries and any individual who at the Effective Time is, or at any time prior to the Effective Time was, a director or officer of the Company or of a Company Subsidiary; and (ii) any indemnification provision and any exculpation
        provision set forth in the certificate of incorporation or bylaws or other Organizational Documents of the Company or any Company Subsidiary as in effect on the date of this Agreement.&#160; From the Effective Time through the sixth (6th) anniversary of
        the date on which the Effective Time occurs, the certificate of incorporation and bylaws of the Surviving Corporation shall contain, and Parent shall cause the certificate of incorporation and bylaws of the Surviving Corporation to so contain,
        provisions no less favorable with respect to indemnification, advancement of expenses and exculpation than are set forth in the Organizational Documents of the Company as in effect on the date of this Agreement.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">If Parent or the Surviving Corporation
        or any of their respective successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers or conveys all or
        substantially all of its properties and assets to any Person, then, and, in each such case, proper provision shall be made so that the successors and assigns of the Parent or the Surviving Corporation, as applicable, shall assume the obligations
        set forth in this <u>Section 6.08</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding anything in this
        Agreement to the contrary, the provisions of this <u>Section 6.08</u> (i) shall survive the acceptance of the Shares for payment pursuant to the Offer and the consummation of the Merger, (ii) are intended to be for the benefit of, and shall be
        enforceable by, each indemnified or insured party (including each Indemnified Party), his or her heirs and his or her or their trustees or administrators or persons acting in similar capacities and (iii) are in addition to, and not in substitution
        for, any other rights to indemnification or contribution that any such individual may have under the certificate of incorporation or bylaws, or comparable Organizational Documents of the Company or any Company Subsidiary, under any applicable
        Contract or Applicable Laws, or otherwise.&#160; Unless required by Applicable Law, this <u>Section 6.08</u> may not be amended, altered, or repealed after the acceptance of the Shares for payment pursuant to the Offer in such a manner as to adversely
        affect any of the rights of any Person indemnified by this <u>Section 6.08</u> without the prior written consent of the affected Person.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.09.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Best Efforts</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Subject to the terms and conditions of
        this Agreement, including the proviso to the first sentence of <u>Section 6.09</u>(d),the Company and Parent shall (and shall cause their respective Subsidiaries to) each use their best efforts to take, or cause to be taken, all actions and to do,
        or cause to be done, and to assist and cooperate with the other parties in doing all things necessary, proper or advisable under Applicable Law to (i) obtain all necessary actions, waivers, registrations, permits, authorizations, orders, consents
        and approvals from Governmental Authorities, the expiry or early termination of any applicable waiting periods, and make all necessary registrations and filings (including filings with Governmental Authorities, if any) and take all steps as may be
        reasonably necessary to obtain an approval or waiver from, or </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">69</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">to avoid an action or proceeding by, any Governmental Authorities, in order to consummate the Transactions as promptly as practicable and in
        any event prior to the End Date and (ii) deliver required notices or any necessary additional instruments to, and obtain required consents, waivers or any additional instruments necessary from, Third Parties in order to consummate the Transactions
        as promptly as practicable and in any event prior to the End Date.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">In furtherance and not in limitation of
        the undertakings pursuant to this <u>Section 6.09</u>, each of Parent and the Company shall (i) prepare and file any notification and report forms and related material required under the HSR Act and any other applicable Antitrust Laws with respect
        to the Transactions (if any), and any additional filings or notifications and related material that are necessary, proper or advisable to permit consummation of the Transactions, as promptly as reasonably practicable (but in no event later than ten
        (10) Business Days from the date of this Agreement for the filing of the notification and report forms and related material required under the HSR Act), (ii)&#160;provide or cause to be provided as promptly as reasonably practicable any information and
        documentary material that may be requested by the DOJ or FTC under the HSR Act or by other Governmental Authorities under applicable Antitrust Laws (if any) and (iii) promptly take such actions as are necessary or advisable to obtain prompt
        expiration or termination of any applicable waiting period or other approval of consummation of the Transactions by the DOJ or FTC or other applicable Governmental Authorities, including to cause to be lifted or vacated any restraint, injunction or
        other legal impediment to any of the Transactions, so as to enable the parties hereto to consummate the Transactions prior to the End Date.&#160; Parent shall pay all filing fees payable pursuant to the HSR Act or other applicable Antitrust Laws (if
        any).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Subject to Applicable Law, the Company
        and Parent and their respective counsel shall (i) cooperate in all respects with each other in connection with any filing or submission with a Governmental Authority in connection with the Transactions and in connection with any investigation or
        other inquiry by or before a Governmental Authority relating to the Transactions, including any proceeding initiated by a private person, (ii) have the right to review in advance, and to the extent practicable each shall consult the other on, any
        material filing made with, or written materials to be submitted to, any Governmental Authority in connection with the Transactions and of any material communication received or given in connection with any proceeding by a private Person, in each
        case regarding any of the Transactions, (iii) promptly inform each other of any material communication (or any other material correspondence or memoranda) received from, or given to, the DOJ or the FTC or any other applicable Governmental Authority
        and (iv) promptly furnish each other with copies of all correspondence, filings and written communications between them or their Subsidiaries or Affiliates, on the one hand, and any Governmental Authority or its respective staff, on the other hand,
        with respect to the Transactions.&#160; In furtherance of the foregoing, the Company and Parent shall (with respect to any in-person discussion or meeting), and shall to the extent practicable (with respect to any telephonic discussion or meeting),
        provide the other party and its counsel with advance notice of and the opportunity to participate in any material discussion or meeting with any Governmental Authority in respect of any filing, investigation or other inquiry in connection with the
        Transactions; <u>provided</u> that each of the parties hereto shall have the right to review in advance, and to the extent practicable each will consult the other on, all the information relating to the other parties and their respective
        Subsidiaries, as the case may be, that appears in any filing made with, or written materials (including correspondence) submitted to, </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">70</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">any Third Party and/or any Governmental Authority in connection with any governmental inquiry, investigation or proceeding with respect to
        the Transactions.&#160; Neither Parent nor the Company shall commit to or agree with any Governmental Authority to stay, toll or extend any applicable waiting period under the HSR Act without the prior written consent of the other.&#160; Without limiting the
        foregoing, each of Parent and the Company shall request and shall use reasonable best efforts to obtain early termination of the waiting period under the HSR Act.&#160; The Company and Parent may, as each deems advisable and necessary, reasonably
        designate any competitively sensitive material provided to the other under this <u>Section 6.09</u> as &#8220;Antitrust Counsel Only Material.&#8221;&#160; Notwithstanding anything to the contrary in this <u>Section 6.09</u>, materials provided to the other party
        or its counsel may be redacted to remove references concerning the valuation of the Acquired Companies and as necessary to address reasonable attorney-client or other privilege or confidentiality concerns.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">In furtherance of the undertakings of
        Parent pursuant to <u>Section 6.09(a)</u> and <u>Section 6.09(b)</u>, but subject to the proviso to this sentence, Parent shall take, or cause to be taken, any and all steps necessary to avoid or eliminate each and every impediment under any
        Antitrust Law that may be asserted by any Governmental Authority or any other Person so as to enable the parties hereto to consummate the Transactions as promptly as practicable, and in any event prior to the End Date, including proposing,
        negotiating, committing to and effecting, by consent decree, hold separate orders, or otherwise, the sale, divestiture, license or other disposition of such of its and its Subsidiaries&#8217; assets, properties or businesses or of the assets, properties
        or businesses to be acquired by Parent pursuant hereto, and entering into such other arrangements, as are necessary or advisable in order to avoid the entry of, and the commencement of litigation seeking the entry of, or to effect the dissolution
        of, any injunction, temporary restraining order or other Order in any Proceeding by a Governmental Authority or any other Person under Antitrust Laws that would otherwise have the effect of preventing or materially delaying the consummation of the
        Transactions; <u>provided</u> that, notwithstanding the foregoing provisions of this <u>Section 6.09(d)</u> or any other provision of this Agreement, in no event shall Parent or any of its Subsidiaries be required (i) to agree to (nor shall the
        Company or any Company Subsidiaries be permitted to agree unless Parent so directs them (and they shall, if Parent so directs, agree to, so long as such agreements are conditioned upon the Closing)) any action, concession or undertaking, unless
        such action, concession or undertaking is conditioned on the Closing or (ii) to effect or offer or commit to effect any sale, divestiture, license or other disposition of any assets, properties or businesses, or to take or make or commit to take or
        make any other action, concession or undertaking, to the extent that any such sale, divestiture, license, disposition, action, concession or undertaking would constitute or result in a Substantial Detriment.&#160; In addition, Parent shall defend
        through litigation on the merits any claim asserted in court by any Governmental Authority or any other person under Antitrust Laws in order to avoid entry of, or to have vacated or terminated, any Order (whether temporary, preliminary or
        permanent) that would prevent the Closing occurring prior to the End Date.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding the foregoing, Parent
        shall, following consultation with the Company and after considering the Company&#8217;s views in good faith, and subject to Parent&#8217;s and Merger Sub&#8217;s obligations under this <u>Section 6.09</u>, direct and control all aspects of the parties&#8217; efforts
        with respect to the HSR Act and other applicable Antitrust Laws with respect to the Transactions, and the Company shall cooperate in good faith with Parent and Merger Sub in the parties&#8217; efforts to obtain any clearance, approval, waiver or expiry
        or early termination of </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">71</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">any applicable waiting periods with respect to any Antitrust Laws; <u>provided</u>, that each of the parties shall (i) have the right to
        review in advance, and to the extent practicable each will consult the other on, all the information relating to the other party and its respective Subsidiaries, as the case may be, that appears in any filing made with, or written materials
        (including correspondence) submitted to, any Third Party and/or any Governmental Authority in connection with any governmental inquiry, investigation or proceeding with respect to the Transactions, (ii) promptly inform each other of any material
        communication (or any other material correspondence or memoranda) received from, or given to, the DOJ or the FTC or any other applicable Governmental Authority and (iii) promptly furnish each other with copies of all correspondence, filings and
        written communications between them or their Subsidiary, on the one hand, and any Governmental Authority or its respective staff, on the other hand, with respect to the Transactions.&#160; The parties shall (with respect to any in-person discussion or
        meeting), and shall to the extent practicable (with respect to any telephonic discussion or meeting), provide the other party and its counsel with advance notice of and the opportunity to participate in any material discussion or meeting with any
        Governmental Authority in respect of any filing, investigation or other inquiry in connection with the Transactions.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Neither Parent nor Merger Sub (nor any
        other Subsidiary of Parent) shall enter into any agreement, transaction or any agreement to effect any transaction (including any merger or acquisition) that would reasonably be expected to prevent or materially delay Parent&#8217;s or Merger Sub&#8217;s
        ability to: (i)&#160;obtain the timely expiration or termination of the waiting period under the HSR Act, or the authorizations, consents, Orders and approvals required under any other applicable Antitrust Law, applicable to the Transactions, (ii)&#160;avoid
        the entry of, the commencement of litigation seeking the entry of, or to effect the dissolution of, any injunction, temporary restraining order or other Order that would prevent or materially delay the consummation of the Transactions, or
        (iii)&#160;obtain all other authorizations, consents, Orders and approvals of Governmental Authorities necessary for the consummation of the Transactions in accordance with the terms and conditions of this Agreement.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Transaction
          Litigation</u>.&#160; During the Pre-Closing Period, the Company shall control the defense of any Transaction Litigation; <u>provided</u>, <u>however</u>, that the Company shall promptly notify Parent in writing of any such Transaction Litigation.&#160;
        The Company shall (a) give Parent the right to review and comment on all material filings or responses to be made by the Company and shall discuss in advance any material discussions or communications proposed to be held by the Company with any
        Third Party in connection with any such Transaction Litigation (and the Company shall in good faith take any comments or feedback provided by Parent into account), and the opportunity to participate in the defense and settlement of, any such
        Transaction Litigation and (b) if Parent does not exercise such right to participate (subject to the Company&#8217;s control right), keep Parent reasonably and promptly informed with respect to the status of such Transaction Litigation; <u>provided</u>,
        <u>however</u>, that the disclosure of information in connection therewith shall be subject to the provisions of <u>Section 6.04</u>, including regarding attorney-client privileges and other applicable legal privileges.&#160; No compromise or full or
        partial settlement of any Transaction Litigation shall be agreed to by the Company without Parent&#8217;s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed).</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">72</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Public
          Announcements</u>.&#160; Parent and the Company shall consult with each other before issuing any press release, or scheduling a press conference or conference call with investors or analysts, and shall use reasonable best efforts to consult with each
        other before making any other public statement, in each case, with respect to this Agreement or the Transactions, and shall not issue any such press release or make any such other public statement relating to this Agreement or the Transactions
        without the consent of the other party, which consent shall not be unreasonably withheld, conditioned or delayed, except for any such release or announcement that Parent or the Company determines, after consultation with outside legal counsel, is
        required by Applicable Law or any listing agreement with or rule of any national or foreign securities exchange or association upon which the securities of the Company or Parent, as applicable, are listed, in which case the party required to make
        the release or announcement shall provide notice to and, to the extent reasonably practicable, consult with the other party about, and shall use its reasonable best efforts to allow the other party reasonable time (taking into account the
        circumstances) to comment on, such release or announcement in advance of such issuance, and the party will consider any such reasonable comments that are timely provided in good faith; <u>provided</u>, <u>however</u>, each party may, without such
        consultation or consent, make any public statement in response to questions from the press, analysts, investors or those attending industry conferences, make internal announcements to employees and make disclosures in Company SEC Documents and any
        documents, reports, statements, forms or other filings required to be made by Parent with the SEC, so long as such statements, announcements and disclosures substantially reiterate (and are not inconsistent with) previous press releases, public
        disclosures or public statements approved in advance by the other party; and <u>provided</u>, <u>further</u>, that, notwithstanding the foregoing, neither Parent nor the Company shall be required to consult with or obtain consents from the other
        parties hereto before issuing any press release or making any other public statement with respect to any Change in Recommendation, Acquisition Proposal or Intervening Event or any action taken in response thereto.</font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt; text-indent: 72pt;"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">Section 6.12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif;"><u>Convertible
          Senior Notes; Capped Call Transaction</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Prior to the Effective Time, the
        Company shall take all actions as may be required in accordance with, and subject to the terms of, the applicable provisions of the Convertible Senior Notes Indentures and the Capped Call Documentation, including the giving of any notices required
        by the Convertible Senior Notes Indentures and/or the Capped Call Documentation in connection with the Transactions and any repurchases or conversions of the Convertible Senior Notes occurring as a result of or in connection with the Transactions
        constituting a Fundamental Change (as defined in the respective Convertible Senior Notes Indentures).&#160; In addition, the Company shall, at Parent&#8217;s request prior to the Effective Time, provide all notices and take all other actions reasonably
        requested by Parent in connection with the delivery of a notice of optional redemption of the 2.50% Convertible Senior Notes due 2022 at or after the Effective Time; <u>provided</u>, that the Company shall not be required to deliver any notice of&#160;
        optional redemption prior to the Effective Time.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company shall, prior to the
        effective date of the Fundamental Change (as defined in the Convertible Senior Notes Indentures), prepare any supplemental indentures required in connection with the Transactions and the consummation thereof to be executed and delivered to the
        Trustee (as defined in the respective Convertible Senior Notes </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">73</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">Indentures) at or prior to the Effective Time, which supplemental indentures shall be satisfactory in form and substance to the Trustee and
        Parent.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company shall, prior to the Closing
        Date, use reasonable best efforts to have the restrictive legends removed from the Convertible Senior Notes and have unrestricted CUSIP numbers assigned to the Convertible Senior Notes, and shall take all actions as may be required in accordance
        with, and subject to the terms of, the applicable provisions of the Convertible Senior Notes Indentures, to accomplish the same, including the delivery of any officers&#8217; certificates and opinions of counsel.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company shall, prior to the Closing
        Date, take all such further actions, including the delivery of any officers&#8217; certificates and opinions of counsel required by the Convertible Senior Notes Indentures as may be necessary, as reasonably determined by Parent to comply with all of the
        terms and conditions of the Convertible Senior Notes Indentures in connection with the Transactions.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company shall provide Parent and
        its counsel (i) copies of any notices or other communications, promptly after the receipt thereof, from the trustees or holders of notes under the Convertible Senior Notes Indentures or the counterparties under the Capped Call Transactions, (ii)
        prompt updates on any Convertible Senior Notes surrendered for conversion prior to the Effective Time, and (iii) reasonable opportunity (and in any event at least two (2) Business Days to the extent reasonably practicable)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>to review and comment on any written notice or communication and any notices, certificates, press releases, supplemental indentures, legal opinions, officers&#8217;
        certificates or other documents or instruments, including those referred to in clauses (a) through (d) of this <u>Section 6.12</u> deliverable pursuant to or in connection with the Convertible Senior Notes Indentures or Capped Call Documentation
        prior to the dispatch or making thereof, and the Company shall consult with Parent or its counsel with respect to such notices or actions and give due consideration to any recommendations made by Parent or its counsel prior to the dispatch or
        making thereof; <u>provided</u>, that any notices or actions (including the specific substance and/or content thereof) that are not required by the terms of the applicable Convertible Senior Notes Indenture or the Capped Call Documentation and any
        time periods for conversion or other aspects of the conversion process or capped call settlement that are determined by the Company pursuant to the applicable Convertible Senior Notes Indenture or Capped Call Documentation, respectively, shall be
        subject to the prior approval of Parent (such approval not to be unreasonably withheld, conditioned or delayed).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company agrees (A) to use its
        reasonable best efforts to cooperate with Parent, at Parent&#8217;s written request, to enter into arrangements with the counterparties of each Capped Call Transaction to cause such Capped Call Transaction to be exercised, settled, terminated and/or
        canceled as of the Effective Time, <u>it</u>&#160;<u>being</u>&#160;<u>understood</u> that the calculation and settlement of any amounts payable thereunder shall be payable only in cash, and subject to the mutual agreement of Parent, the Company and the
        respective counterparties of each Capped Call Transaction in accordance with the terms of the Capped Call Documentation or pursuant to such other written agreement relating to the termination of the Capped Calls Transactions as agreed between the
        Company and the applicable counterparty and (B) not to amend, modify or terminate the Capped Call Documentation without the prior written consent of Parent, which consent shall not be unreasonably withheld, conditioned or delayed (<u>it</u>&#160;<u>being</u>&#160;<u></u></font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">74</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;"><u>understood</u>, for the avoidance of doubt, that such limitations shall not apply to any modification or adjustment made unilaterally by
        the counterparty to a Capped Call Transaction pursuant to the terms of the applicable Capped Call Documentation).</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding anything in this
        Agreement to the contrary, it is understood and agreed that nothing in this <u>Section 6.12</u> shall require the Company to (i) other than with respect to any fees, costs, expense or liabilities expressly provided under the Convertible Senior
        Notes Indentures or Capped Call Documentation (including as a result of any conversions that are required to be settled prior to the Closing and interest payments required to be paid prior to the Closing), pay any fees, incur or reimburse any costs
        or expenses, or make any payment prior to the occurrence of the Effective Time for which it has not first received full reimbursement or is not otherwise indemnified and held harmless to its reasonable satisfaction by or on behalf of Parent&#894; (ii)
        enter into any instrument or agreement, or agree to any change or modification to any instrument or agreement, that is effective prior to the occurrence of the Effective Time or that would be effective if the Effective Time did not occur&#894; (iii) be
        required to provide access to or disclose information that would reasonably be expected to jeopardize attorney-client privilege or other privilege or contravene Applicable Law or violate any Contract&#894; or (iv) compromise any prior Tax or accounting
        position.&#160; For the avoidance of doubt, and without limiting the obligations in this <u>Section 6.12</u>, each of Parent and Merger Sub acknowledge and agree that its obligations to consummate the transactions contemplated by this Agreement are not
        conditioned upon either (1)&#160;the execution of supplemental indentures pursuant to each Convertible Senior Notes Indenture by the relevant trustee thereunder or (2) the exercise, settlement, termination and/or cancellation of the Capped Call
        Transactions.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Each of Parent and Merger Sub (i) shall
        promptly, upon request by the Company, reimburse the Acquired Companies, for all fees, costs and expenses (including attorneys&#8217; fees) incurred by the Acquired Companies, as applicable, in connection with the actions of the Company, the Company
        Subsidiaries and their respective Representatives contemplated by this <u>Section 6.12</u> and (ii) acknowledges and agrees that the Company, the Company Subsidiaries and their respective Representatives shall not be required to incur any
        liability to any Person prior to the Closing with respect to any actions of the Company, the Company Subsidiaries and their respective Representatives contemplated by this <u>Section 6.12</u>;<u> provided</u> that clauses (i) and (ii) shall not,
        prior to the occurrence of the Effective Time, apply to any fees, costs, expenses or liabilities expressly provided under the Convertible Senior Notes Indentures or Capped Call Documentation (including as a result of any conversions that are
        required to be settled prior to the Closing and interest payments required to be paid prior to the Closing).&#160; Parent and Merger Sub shall indemnify and hold harmless the Company, the Company Subsidiaries and their respective Representatives from
        and against any and all liabilities, losses, damages, claims, costs, expenses, interest, awards, judgments and penalties suffered or incurred by any of them in connection with the actions contemplated by this <u>Section 6.12</u>, in each case,
        other than to the extent any of the foregoing was suffered or incurred prior to the occurrence of the Effective Time as a result of the bad faith, gross negligence or willful misconduct of the Company, any of the Company Subsidiaries or their
        respective Representatives or that is expressly provided under the Convertible Senior Notes Indentures or Capped Call Documentation (including as a result of any conversions that are required to be settled prior to the Closing and interest payments
        required to be paid prior to the Closing).</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">75</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Section 16
          Matters</u>.&#160; Prior to the consummation of the Offer, the Company and the Company Board shall take all actions to the extent necessary or as may be reasonably requested by any party hereto in connection with this Agreement to cause the
        transactions contemplated by <u>Section 2.08</u> and any and all dispositions or cancellations of equity securities of the Company (including any deemed dispositions or cancellations and any derivative securities with respect to any equity
        securities of the Company) held by each individual who is subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to the Company, and who would otherwise be subject to Rule 16b-3 under the Exchange Act, to be exempt
        under Rule 16b-3 under the Exchange Act.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Rule 14d-10
          Matters</u>.&#160; Prior to the consummation of the Offer, to the extent required, the Compensation Committee of the Company Board will take such steps to cause each employment compensation, severance or other employee benefit arrangement pursuant to
        which consideration is payable to any officer, director or employee who is a holder of any security of the Company to be approved by the Compensation Committee of the Company Board in accordance with the requirements of Rule 14d-10(d)(2) under the
        Exchange Act and the instructions thereto as an &#8220;employment compensation, severance or other employee benefit arrangement&#8221; within the meaning of Rule 14d-10(d)(2) under the Exchange Act and satisfy the requirements of the non-exclusive safe harbor
        set forth in Rule 14d-10(d) of the Exchange Act.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 6.15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Stock </u><u>Exchange














          De-listing</u>.&#160; Parent shall cause (and the Company shall reasonably cooperate with Parent to cause) the Company&#8217;s securities to be de-listed from Nasdaq and de-registered under the Exchange Act as promptly as practicable following the Effective
        Time.</font></div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;7</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CONDITIONS TO THE MERGER</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 7.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Conditions to
          the Obligations of Each Party</u>.&#160; The obligation of each party hereto to consummate the Merger is subject to the satisfaction or, to the extent permitted by Applicable Law, waiver, on or prior to the Closing, of the following conditions:</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Merger Sub (or Parent on Merger Sub&#8217;s
        behalf) shall have consummated the Offer; and</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">no Governmental Authority having
        jurisdiction over any party hereto shall have issued any Order, nor any Applicable Law or other legal restraint, injunction or prohibition shall be in effect, that makes consummation of the Merger illegal or otherwise prohibited; <u>provided</u>
        that a party shall not be permitted to invoke this <u>Section 7.01(b)</u> if the issuance of such Order, Applicable Law or other legal restraint, injunction or prohibition is principally caused by the material breach by such party of any covenant
        or obligation of such party set forth in this Agreement.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">76</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;8</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">TERMINATION</div>
    <div style="line-height: 1.25; text-indent: 36pt;">
      <div style="text-indent: 72pt;"> Section 8.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination</u>. This Agreement may be terminated and the Transactions may be abandoned at any time prior to the Effective Time:</div>
      <div style="text-indent: 72pt;"> <br>
      </div>
      <div style="text-indent: 72pt;">
        <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">by mutual written agreement of the
            Company and Parent;</font></div>
        <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">by either the Company or Parent,
            if:</font></div>
        <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;">
          <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">the Offer shall not have been
              consummated in accordance with the terms of this Agreement on or before 11:59 p.m., Eastern Time, on February 23, 2020 (the &#8220;<u>End Date</u>&#8221;); <u>provided</u>, <u>however</u>, that in the event that on the original End Date all of the
              Non-Minimum Tender Offer Conditions, other than the Offer Conditions set forth in clauses (b) or (c) of Annex A and those conditions that by their nature are to be satisfied at the Offer Expiration Time, shall have been satisfied or waived,
              then the End Date shall be automatically extended to August 23, 2020 (and all references to the End Date herein and in Annex A shall be as so extended); <u>provided</u>, that, notwithstanding the foregoing, the right to terminate this
              Agreement under this <u>Section 8.01(b)(i)</u> shall not be available to any party whose material breach of any provision of this Agreement has been a principal cause of, or resulted in, the failure of the Offer to be consummated by such
              time; or</font></div>
          <font style="font-family: 'Times New Roman', Times, serif;"></font></div>
        <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">any Governmental Authority having
            jurisdiction over any party hereto shall have issued a final, non-appealable Order, or any Applicable Law or other legal restraint, injunction or prohibition shall be in effect, that makes consummation of the Offer or the Merger illegal or
            otherwise prohibited; <font style="background-color: #FFFFFF;"><u>provided</u></font><font style="background-color: #FFFFFF;"> that the party seeking to terminate this Agreement pursuant to this </font><font style="background-color: #FFFFFF;"><u>Section











                8.01(b)(ii)</u></font><font style="background-color: #FFFFFF;"> shall have taken all actions required under this Agreement to have any such Order, </font>Applicable Law<font style="background-color: #FFFFFF;"> or other legal restraint</font>,
            injunction or prohibition<font style="background-color: #FFFFFF;"> lifted; </font><font style="background-color: #FFFFFF;"><u>provided</u></font><font style="background-color: #FFFFFF;">, </font><font style="background-color: #FFFFFF;"><u>further</u></font><font style="background-color: #FFFFFF;">, that </font>a party shall not be permitted to terminate this Agreement pursuant to this <font style="background-color: #FFFFFF;"><u>Section 8.01(b)(ii)</u></font> if the issuance of such final and
            non-appealable Order, Applicable Law or other legal restraint, injunction or prohibition is principally caused by the material breach by such party of any covenant or obligation of such party set forth in this Agreement; or</font></div>
      </div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">by Parent, prior to the consummation of
        the Offer, if:</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">a Change in Recommendation shall have
        occurred; or</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">the Company shall have breached any of
        its representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform (A) would give rise to the failure of any of the Offer Conditions contained in condition &#8220;(e)&#8221; or &#8220;(f)&#8221; in <u>Annex A</u>
        and (B) is incapable of being cured by the End Date or, if capable of being cured in such time frame, has not been cured by the Company within</font><font style="font-family: 'Times New Roman',Times,serif;"> thirty (30) days after written notice
        has been given by Parent to the Company of such breach or failure to perform; <u>provided</u>, <u>however</u>, that Parent may not terminate this Agreement pursuant to this <u>Section 8.01(c)(ii)</u> if, at the time such termination would
        otherwise take effect in accordance </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">77</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">with the foregoing, Parent or Merger Sub is in material breach of any provision of this Agreement; or</font> </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">by the Company, prior to the
        consummation of the Offer, if:</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">(w) the Company Board has determined
        that an Acquisition Proposal constitutes a Superior Proposal; (x) the Company has complied with its obligations under <u>Section 6.02(f)</u>; (y) the Company pays, or causes to be paid, to Parent the Termination Fee payable pursuant to <u>Section
          9.04(b)</u> prior to or concurrently with such termination; and (z) substantially concurrently with such termination, the Company enters into a definitive Alternative Acquisition Agreement in respect of such Superior Proposal;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Parent shall have breached or failed
        to perform any of its representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform (A) would have a Parent Material Adverse Effect and (B) is incapable of being cured by the End Date or,
        if capable of being cured in such time frame, has not been cured by Parent within thirty (30) days after written notice has been given by the Company to Parent of such breach or failure to perform; <u>provided</u>, <u>however</u>, that the
        Company may not terminate this Agreement pursuant to this <u>Section 8.01(d)(ii)</u> if, at the time such termination would otherwise take effect in accordance with the foregoing, the Company is in material breach of any provision of this
        Agreement;</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Merger Sub fails to commence the
        Offer by December 5, 2019; <u>provided</u>, <u>however</u>, that the Company may not terminate this Agreement pursuant to this <u>Section 8.01(d)(iii)</u> if such failure to commence the Offer is principally caused by the material breach by the
        Company of any covenant or obligation of the Company set forth in this Agreement; or</font></div>
    <div style="text-indent: 144pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Merger Sub fails to consummate the
        Offer within two (2) Business Days following the Offer Expiration Time and, as of such Offer Expiration Time, all of the Offer Conditions have been satisfied or (to the extent permitted by Applicable Law) waived (other than those conditions that by
        their nature are to be satisfied at the time Merger Sub consummates the Offer, but subject to such conditions being able to be satisfied).</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">The party desiring to terminate this Agreement pursuant to this <u>Section 8.01</u> (other than pursuant to <u>Section 8.01(a)</u>)
      shall give written notice of such termination to each other party hereto and specify the applicable provision or provisions hereof pursuant to which such termination is being effected.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 8.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Effect of
          Termination</u>.&#160; If this Agreement is terminated pursuant to <u>Section 8.01</u>, this Agreement shall become void and of no effect without liability of any party (or any Representative of such party) to each other party hereto; <u>provided</u>,
        <u>however</u>, that the last sentence of <u>Section 6.09(b)</u>, <u>Section 6.12(h)</u>, this <u>Section 8.02</u> and <u>Article&#160;9</u> shall survive any termination hereof pursuant to <u>Section 8.01</u>; <u>provided</u>, <u>further</u>,
        that, subject to <u>Section 9.04(h)</u>, no</font><font style="font-family: 'Times New Roman',Times,serif;"> such termination shall relieve any party from liability for any Willful Breach of this Agreement prior to such termination.&#160; The
        Confidentiality Agreement shall not be affected by the </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">78</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">termination of this Agreement and shall continue in full force and effect in accordance with its terms.</font> </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ARTICLE&#160;9</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">MISCELLANEOUS</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Notices</u>.&#160;
        Any notices or other communications required or permitted under, or otherwise given in connection with, this Agreement shall be in writing and shall be deemed to have been duly given (i) when delivered, if delivered in person, (ii) on the next
        Business Day if transmitted by national overnight courier (with confirmation of delivery) or (iii) on the date transmitted if sent by email (<u>provided</u> no &#8220;bounce back&#8221; or similar message of non-delivery is received with respect thereto), in
        each case, as follows:</font></div>
    <div style="line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;"> </font>
      <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">if to the Company:</div>
      <div style="margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">The Medicines Company<br>
        8 Sylvan Way</div>
      <div style="margin-left: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Parsippany, New Jersey 07054<br>
        Attention: Stephen Rodin, General Counsel<br>
        Email: stephen.rodin@THEMEDCO.com</div>
      <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">with a copy (which shall not constitute notice) to:</div>
      <div style="margin-left: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP<br>
        1285 Avenue of the Americas<br>
        New York, New York 10019<br>
        Attention: Scott A. Barshay, Jeffrey D. Marell and Justin Rosenberg<br>
        Email: sbarshay@paulweiss.com, jmarell@paulweiss.com and jrosenberg@paulweiss.com</div>
      <div style="margin-left: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">if to Parent or Merger Sub (or, following the Effective Time, the Surviving Corporation):</div>
      <div style="margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Novartis AG<br>
        Lichtstrasse 35</div>
      <div style="margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4056 Basel</div>
      <div style="margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Switzerland<br>
        Attention: Jonathan Emery, Head Legal M&amp;A, Novartis International AG<br>
        Email: jonathan.emery@novartis.com</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">with a copy (which shall not constitute notice) to:</div>
      <div style="margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Sullivan &amp; Cromwell LLP<br>
        125 Broad Street</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">79</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="margin-left: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">New York, New York 10004<br>
        Attention: Francis J. Aquila, Matthew G. Hurd and Melissa Sawyer<br>
        Email: aquilaf@sullcrom.com, hurdm@sullcrom.com and sawyerm@sullcrom.com</div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Notwithstanding anything in this Agreement to the contrary, any notice given in accordance with the foregoing clauses (i) or (ii) of this <u>Section
        9.01</u> shall only be effective if a duplicate copy of such notice is also given by email in the method described in this <u>Section 9.01</u>.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.02.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Survival of
          Representations and Warranties</u>.&#160; None of the representations and warranties contained in this Agreement or in any certificate or other writing delivered pursuant hereto shall survive the Effective Time.&#160; Any covenant or agreement of the
        parties contained in this Agreement which, by its terms, contemplates performance after the Effective Time, shall survive in accordance with its terms.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.03.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Amendments
          and Waivers</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Prior to the consummation of the Offer,
        any provision of this Agreement may be amended or waived by the parties hereto only by action taken or authorized by or on behalf of their respective Boards of Directors (or duly authorized committee thereof), but only if such amendment or waiver
        is in writing and is signed, in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by each party against whom the waiver is to be effective; <u>provided</u>, <u>however</u>, that without the further approval of
        the Company&#8217;s stockholders, no such amendment or waiver shall be made or given that requires the approval of the stockholders of the Company under the DGCL unless the required further approval is obtained.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Any failure of any of the parties to
        comply with any obligation, covenant, agreement or condition in this Agreement (including <u>Annex A</u>) may be waived at any time prior to the Effective Time by any of the parties entitled to the benefit thereof only by a written instrument
        signed by each such party granting such waiver.&#160; No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further
        exercise thereof or the exercise of any other right, power or privilege.&#160; Subject to <u>Section 9.04(h)</u>, the rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by Applicable Law or in
        equity.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.04.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Fees;
          Expenses</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Except as otherwise expressly provided
        in this Agreement, all costs and expenses incurred in connection with this Agreement and the Transactions shall be paid by the party incurring such costs or expenses.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">If this Agreement is terminated by the
        Company pursuant to <u>Section 8.01(d)(i)</u>, prior to or concurrently with such termination, the Company shall pay (or cause to be paid to) Parent a fee in the amount of $290,000,000 (the &#8220;<u>Termination Fee</u>&#8221;).</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">80</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">If this Agreement is terminated by
        Parent pursuant to <u>Section 8.01(c)(i)</u>, then the Company shall promptly, but in no event later than two (2) Business Days after termination of this Agreement, pay (or cause to be paid to) Parent the Termination Fee.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">If this Agreement is terminated (i) (A)
        by Parent or the Company pursuant to <u>Section 8.01(b)(i)</u> (but in the case of a termination by the Company, only if at such </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">time Parent would not be prohibited from terminating this Agreement pursuant to the proviso in <u>Section 8.01(b)(i)</u>) or (B) by Parent
        pursuant to <u>Section 8.01(c)(ii)</u>, (ii) at any time on or after the date of this Agreement and prior to such termination a <font style="font-style: italic;">bona fide</font> Acquisition Proposal&#160;shall have been publicly made or otherwise
        become publicly known and not publicly withdrawn prior to such termination, and (iii) within twelve (12) months after the date of such termination, (A) the Company enters into an Alternative Acquisition Agreement providing for an Acquisition
        Transaction or (B) an Acquisition Transaction is consummated, then, the Company shall pay (or cause to be paid to) Parent the Termination Fee concurrently with the consummation of any such Acquisition Transaction; <u>provided</u>, <u>however</u>,
        that, for purposes of this <u>Section 9.04(d)</u>, all references to &#8220;twenty percent (20%)&#8221; in the definition of Acquisition Transaction shall be deemed to be references to &#8220;fifty percent (50%)&#8221;.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">For the avoidance of doubt, any payment
        made by the Company under this <u>Section 9.04</u> shall be payable only once with respect to this <u>Section 9.04</u> and not in duplication even though such payment may be payable under one or more provisions hereof.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">The Company acknowledges that the
        agreements contained in this <u>Section 9.04</u> are an integral part of the Transactions and that without such provisions Parent and Merger Sub would not have entered into this Agreement.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">If the Company fails to pay the
        Termination Fee or any portion thereof and Parent or Merger Sub commences a suit which results in an Order against the Company for the Termination Fee or any portion thereof, the Company shall pay Parent and Merger Sub their costs and expenses
        (including reasonable attorney&#8217;s fees and disbursements) in connection with such suit, together with interest on the Termination Fee (or any portion thereof that has not been paid timely in accordance with this Agreement) and on the amount of such
        costs and expenses, in each case, from and including the date payment of such amount was due to through the date of actual payment at the prime rate set forth in <font style="font-style: italic;">The Wall Street Journal</font> in effect on the
        date such payment was required to be made.&#160; Any amounts payable pursuant to this <u>Section 9.04</u> shall be paid to Parent by wire transfer of immediately available funds.&#160; Parent shall promptly provide the Company upon request therefor the wire
        transfer information required to make any payments pursuant to this <u>Section 9.04</u>.</font></div>
    <div style="text-indent: 108pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Notwithstanding anything in this
        Agreement to the contrary, if Parent receives payment from the Company of the Termination Fee pursuant to <u>Sections 9.04(b)</u> - <u>(d)</u> (i) Parent&#8217;s right to receive payment from the Company of the Termination Fee pursuant to <u>Sections
          9.04(b)</u> - <u>(d)</u> and any payments pursuant to <u>Section 9.04(g)</u> shall be the sole and exclusive remedy of any of Parent, Merger Sub or any of their respective Affiliates or representatives against the Company and any of its former,
        current or future officers, directors, partners, stockholders, Company Stock Option holders, Company Restricted Share holders, managers, members or Affiliates (collectively, the &#8220;<u>Company Related Parties</u>&#8221;) for any loss </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">81</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">suffered as a result of the failure of the Transactions to be consummated or for a breach or failure to perform hereunder or otherwise, and
        upon payment of the Termination Fee, none of the Company Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Transactions and (ii) if Parent (or its designee) received any payments from
        the Company in respect of any breach of this Agreement, and thereafter Parent (or its designee) is entitled to receive the Termination Fee under this <u>Section 9.04</u>, the amount of such</font><font style="font-family: 'Times New Roman',Times,serif;"> Termination Fee shall be reduced by the aggregate amount of any payments made by the Company to Parent (or its designee) in respect of any such breaches of this Agreement.</font> </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.05.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Assignment;
          Benefit</u>.&#160; Neither this Agreement nor any of the rights, interests or obligations herein may be assigned by any party hereto&#160; without the prior written consent of the other parties and any purported assignment in violation hereof shall be null
        and void <font style="font-style: italic;">ab initio</font>.&#160; Notwithstanding anything contained in this Agreement to the contrary, nothing in this Agreement, expressed or implied, is intended to confer on any Person other than the parties hereto
        and their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except (i) from and after the consummation of the Offer, the provisions of <u>Article&#160;2</u> relating to
        the payment of the Per Share Amount, which shall be enforceable by the holders of Shares immediately prior to the consummation of the Offer who validly tendered and did not withdraw Shares pursuant to the Offer, (ii) from and after the Effective
        Time, (A) the provisions of <u>Article&#160;2</u> relating to the payment of the Per Share Amount, the Merger Consideration and the Option Consideration, which shall be enforceable by the holders of Company Common Stock and Company Equity Awards, as
        applicable, as of immediately prior to the Effective Time and (B) the provisions of <u>Section 6.08</u>, which shall be enforceable by the Persons or entities benefiting therefrom and (iii)&#160;the provisions of <u>Section 9.04(h)</u>, which shall be
        enforceable by the Company Related Parties.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.06.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Governing Law</u>.&#160;














        This Agreement and any Proceedings arising out of or related hereto or the Transactions or to the inducement of any party hereto to enter into this Agreement (whether for breach of contract, tortious conduct or otherwise and whether predicated on
        common law statute or otherwise) shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules of such state.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.07.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Jurisdiction</u>.&#160;














        The parties hereto hereby irrevocably agree (i) that any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the Transactions shall be brought in the Chancery Court of the
        State of Delaware and any state appellate court therefrom, or, if no such state court has proper jurisdiction, the Federal District Court for the District of Delaware located in Wilmington, Delaware, and any appellate court therefrom and (ii) not
        to commence any such Proceeding in any court except such courts.&#160; Each party hereby irrevocably submits to the exclusive jurisdiction of such court in respect of any legal or equitable Proceeding arising out of or relating to this Agreement or the
        Transactions, or relating to enforcement of any of the terms of this Agreement, and hereby waives, and agrees not to assert, as a defense in any such Proceeding, any claim that it is not subject personally to the jurisdiction of such court, that
        the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper or that this Agreement or the Transactions may not be enforced in or by such courts.&#160; Each party agrees that notice or the </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">82</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">service of process in any Proceeding arising out of or relating to this Agreement or the Transactions shall be properly served or delivered
        if delivered in the manner contemplated by <u>Section 9.01</u> or in any other manner permitted by Applicable Law.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.08.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Waiver of
          Jury Trial</u>.&#160; EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMITTED BY </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">APPLICABLE LAW ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING DIRECTLY OR INDIRECTLY OUT OF OR RELATED TO THIS AGREEMENT OR THE
        TRANSACTIONS CONTEMPLATED HEREBY.&#160; EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO
        ENFORCE EITHER OF SUCH WAIVERS, (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (III) IT MAKES SUCH WAIVERS VOLUNTARILY AND (IV) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS
        AND CERTIFICATIONS IN THIS <u>SECTION 9.08</u>.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.09.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Specific
          Performance; Remedies</u>.&#160; The parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur and that the parties would not have any adequate remedy at law in the event that any
        of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.&#160; It is accordingly agreed that (a) the parties shall be entitled to an injunction or injunctions, specific performance, or
        other equitable relief, to prevent breaches or threatened or anticipated breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the courts described in <u>Section 9.07</u>, without proof of damages or
        otherwise, and (b) the right of specific performance is an integral part of the Transactions and without that right, neither the Company nor Parent would have entered into this Agreement.&#160; Each of the parties agrees that it waives the defense of
        adequacy of a remedy at law and will not oppose the granting of an injunction or injunctions, specific performance or other equitable relief on the basis that the other parties have an adequate remedy at law or equity.&#160; The parties acknowledge and
        agree that any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this <u>Section 9.09</u> shall not be required to provide any
        bond or other security in connection with any such order or injunction.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Severability</u>.&#160;














        If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction or other Governmental Authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions
        of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance of the Offer, the Merger and the other Transactions is not affected in any manner materially
        adverse to any party.&#160; Upon such a holding, the parties agree to negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner, in order that the Offer, the Merger
        and the other Transactions be consummated as originally contemplated to the fullest extent possible.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">83</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Entire
          Agreement</u>.&#160; This Agreement, including the exhibits and annexes to this Agreement, the Company Disclosure Letter and the Parent Disclosure Letter and any documents delivered by the parties in connection herewith and the Confidentiality
        Agreement constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, among the parties with respect thereto; <u>provided</u>, <u>however</u>,
        that, the Confidentiality Agreement shall not be </font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">superseded, shall survive any termination of this Agreement and shall continue in full force and effect until the earlier to occur of (a) the
        Effective Time and (b) the date on which the Confidentiality Agreement expires in accordance with its terms or is validly terminated by the parties thereto.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Rules of
          Construction</u>.&#160; Each of the parties hereto acknowledges that it has been represented by counsel of its choice throughout all negotiations that have preceded the execution of this Agreement, and that it has executed the same with the advice of
        said independent counsel.&#160; Each party and its counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred to in this Agreement, and any and all drafts relating thereto exchanged among the parties
        shall be deemed the work product of all of the parties and may not be construed against any party by reason of its drafting or preparation.&#160; Accordingly, any rule of law or any legal decision that would require interpretation of any ambiguities in
        this Agreement against any party that drafted or prepared it is of no application and is hereby expressly waived by each of the parties hereto.&#160; Any matter set forth on the Company Disclosure Letter shall not be deemed to constitute an admission by
        the Company or any Company Subsidiary, or to otherwise imply, that any such matter is material, is required to be disclosed by the Company under this Agreement or falls within relevant minimum thresholds or materiality standards set forth in this
        Agreement, nor shall be construed as an admission or indication to any Third Party that any breach or violation exists or has actually occurred.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; color: #000000;">Section 9.13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"><u>Counterparts;
          Effectiveness</u>.&#160; This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.&#160; This Agreement shall become effective
        when each party hereto shall have received a counterpart hereof signed by all of the other parties hereto, <u>it</u>&#160;<u>being</u>&#160;<u>understood </u>and agreed that all parties hereto need not sign the same counterpart.&#160; Until and unless each
        party has received a counterpart hereof signed by each other party hereto, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other
        communication).&#160; Signatures to this Agreement transmitted by electronic mail in PDF form, or by any other electronic means designed to preserve the original graphic and pictorial appearance of a document, will be deemed to have the same effect as
        physical delivery of the paper document bearing the original signatures.</font></div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</div>
    <br>
    <div style="line-height: 1.25; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">84</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 24pt; font-family: 'Times New Roman',Times,serif; text-indent: 27pt;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the
      day and year first above written.</div>
    <div style="line-height: 1.25; margin-bottom: 24pt; font-family: 'Times New Roman',Times,serif;">
      <table style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td colspan="3" rowspan="1" style="width: 4%;" valign="top">NOVARTIS AG<br>
            </td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 4%;" valign="top">&#160;</td>
            <td colspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td style="width: 30%;" valign="top">&#160;</td>
            <td style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" align="left" valign="top">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;" align="left"><br>
              </div>
            </td>
            <td style="width: 4%; padding-bottom: 2px;" valign="top">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;" align="left">By: </div>
            </td>
            <td rowspan="1" colspan="2" style="width: 4%; border-bottom: 2px solid rgb(0, 0, 0);" valign="top">/s/ Nigel Sheail<br>
            </td>
            <td style="width: 10%; padding-bottom: 2px;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 4%;" valign="top">&#160;</td>
            <td colspan="1" style="width: 4%;" valign="top">Name:<br>
            </td>
            <td style="width: 30%;" align="left" valign="bottom">Nigel Sheail</td>
            <td style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 4%;" valign="top">&#160;</td>
            <td colspan="1" style="width: 4%;" valign="top">Title: <br>
            </td>
            <td style="width: 30%;" valign="top">As Attorney<br>
            </td>
            <td style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 4%;" valign="top">&#160;</td>
            <td colspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td style="width: 30%;" valign="top">&#160;</td>
            <td style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; padding-bottom: 2px;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%; padding-bottom: 2px;" valign="top">By:<br>
            </td>
            <td rowspan="1" colspan="2" style="width: 4%; border-bottom: 2px solid rgb(0, 0, 0);" valign="top">/s/ Jonathan Emery&#160; <br>
            </td>
            <td rowspan="1" style="width: 10%; padding-bottom: 2px;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" colspan="1" style="width: 4%;" valign="top">Name:<br>
            </td>
            <td rowspan="1" style="width: 30%;" valign="top">Jonathan Emery</td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" colspan="1" style="width: 4%;" valign="top">Title: <br>
            </td>
            <td rowspan="1" style="width: 30%;" valign="top">As Attorney<br>
            </td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" colspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 30%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td colspan="3" rowspan="1" style="width: 4%;" valign="top">MEDUSA MERGER CORPORATION &#160; <br>
            </td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" colspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 30%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; padding-bottom: 2px;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%; padding-bottom: 2px;" valign="top">By:<br>
            </td>
            <td rowspan="1" colspan="2" style="width: 4%; border-bottom: 2px solid rgb(0, 0, 0);" valign="top">/s/ Peter Louwagie&#160; <br>
            </td>
            <td rowspan="1" style="width: 10%; padding-bottom: 2px;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" colspan="1" style="width: 4%;" valign="top">Name:<br>
            </td>
            <td rowspan="1" style="width: 30%;" valign="top">Peter Louwagie</td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 4%;" valign="top">&#160;</td>
            <td rowspan="1" colspan="1" style="width: 4%;" valign="top">Title:<br>
            </td>
            <td rowspan="1" style="width: 30%;" valign="top">Authorized Signatory<br>
            </td>
            <td rowspan="1" style="width: 10%;" valign="top">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif;"></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif;">
      <div><br>
      </div>
      <div style="text-align: center; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25;">
        <div><br>
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25;">
        <div><br>
        </div>
      </div>
      <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 24pt;">
        <div style="line-height: 1.25;"> <br>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25;">[<font style="font-style: italic;">Signature Page to Agreement and Plan of Merger</font>]</div>
        </div>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif;"><br>
      <div style="line-height: 1.25; text-indent: 0px;">
        <div style="text-align: center; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: center; line-height: 1.25;">
          <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" border="0" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td rowspan="1" colspan="3" style="vertical-align: top;">
                  <div>THE MEDICINES COMPANY</div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td style="width: 4%; vertical-align: top;">&#160;</td>
                <td colspan="1" style="width: 4%; vertical-align: top;">&#160;</td>
                <td style="width: 30%; vertical-align: top;">&#160;</td>
                <td style="width: 10%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
                  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By:</div>
                </td>
                <td rowspan="1" colspan="2" style="width: 4%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Mark Timney </td>
                <td style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td style="width: 4%; vertical-align: top;">&#160;</td>
                <td colspan="1" style="width: 4%; vertical-align: top;">Name: <br>
                </td>
                <td style="width: 30%; vertical-align: top;">
                  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Mark Timney<br>
                  </div>
                </td>
                <td style="width: 10%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                <td colspan="1" style="width: 4%; vertical-align: top;">Title:<br>
                </td>
                <td style="width: 30%; vertical-align: top;">
                  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chief Executive Officer<br>
                  </div>
                </td>
                <td style="width: 10%; vertical-align: top;">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div>[<font style="font-style: italic;">Signature Page to Agreement and Plan of Merger</font>] </div>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin-top: 4px; margin-bottom: 4px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-weight: bold;"><font style="font-weight: bold;"><u>Annex A</u></font></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold; font-family: 'Times New Roman',Times,serif;">Conditions of the Offer</div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">The obligation of Merger Sub to accept for payment and pay for Shares validly tendered (and not validly withdrawn) pursuant to the
      Offer is subject to the satisfaction of the conditions set forth in clauses &#8220;(a)&#8221; through &#8220;(h)&#8221; below.&#160; Accordingly, notwithstanding any other term of the Offer or the Agreement to the contrary, Merger Sub shall not be required to accept for payment
      or, subject to any applicable rules and regulations of the SEC, including Exchange Act Rule 14e-l(c) (relating to Merger Sub&#8217;s obligation to pay for or return tendered Shares promptly after the termination or withdrawal of the Offer), pay for, and
      may delay the acceptance for payment of or, subject to such rules and regulations, the payment for, any tendered Shares: (i) if the Merger Agreement has been validly terminated in accordance with <u>Section 8.01</u>; and (ii) at any scheduled Offer
      Expiration Time (as the Offer may have been extended pursuant to, and subject to any requirements to extend the Offer pursuant to, <u>Section 2.01(c)</u> of the Merger Agreement), if: (x) the Minimum Tender Condition or the Termination Condition
      shall not be satisfied by the Offer Expiration Time; or (y) any of the additional conditions set forth below shall not be satisfied or (to the extent permitted by Applicable Law) waived in writing by Parent:</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">there shall have been validly tendered
        in the Offer and not withdrawn that number of Shares that (together with any Shares owned by Parent and its Affiliates and excluding any Shares tendered pursuant to guaranteed delivery procedures that have not yet been &#8220;received&#8221; (as such term is
        defined in Section 251(h)(6)(f) of the DGCL)) represent at least a majority of the Shares outstanding at the Offer Expiration Time (the &#8220;<u>Minimum Tender Condition</u>&#8221;);</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">any waiting period (or any extension
        thereof) under the HSR Act applicable to the Transactions shall have expired or been terminated;</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">no Governmental Authority having
        jurisdiction over any party hereto shall have issued any Order, nor any Applicable Law or other legal restraint, injunction or prohibition shall be in effect, that (i) makes consummation of the Offer or the Merger illegal or otherwise prohibited or
        (ii) imposes a Substantial Detriment; <u>provided</u> that Parent and Merger Sub shall not be permitted to invoke this clause (c) if the issuance of such Order, Applicable Law or other legal restraint, injunction or prohibition is principally
        caused by the material breach by Parent or Merger Sub of any of its covenants or obligations set forth in this Agreement;</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">since the date of the Merger Agreement,
        there shall not have been any Effect that has had or would reasonably be expected to have a Company Material Adverse Effect;</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">(i) the representation and warranty of
        the Company set forth in <u>Section 4.11(c)</u> shall be true and correct as of the date of the Merger Agreement, (ii) each of the representations and warranties of the Company set forth in <u>Section 4.01</u>, <u>Section 4.02</u>, <u>Section
          4.03</u> and <u>Section 4.24(g)(vi)</u> of the Merger Agreement shall be true and correct in all material respects as of the consummation of the Offer, as if made at such time, except to the extent such </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">representation or warranty expressly relates to a specific date (in which case on and as of such specific date), (iii) the representations
        and warranties of the Company set forth in <u>Section 4.06(a)</u> shall be true and correct except for <font style="font-style: italic;">de minimis</font> inaccuracies as of the consummation of the Offer, as if made at such time, except to the
        extent any such representation or warranty expressly relates to a specific date (in which case on and as of such specific date), and (iv) each of the other representations and warranties of the Company set forth in the Merger Agreement shall be
        true and correct as of the consummation of the Offer, as if made at such time, except to the extent any such representation or warranty expressly relates to a specific date (in which case on and as of such specific date), other than in the case of
        clause (iv) for such failures to be true and correct that have not had or would not reasonably be expected to have a Company Material Adverse Effect (<u>it</u>&#160;<u>being</u>&#160;<u>understood</u> that for this purpose all references to the term &#8220;Company
        Material Adverse Effect&#8221; and other qualifications based on the word &#8220;material,&#8221; set forth in any such representations and warranties shall be disregarded);</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;"> the Company shall have complied in all
        material respects with each of the covenants, obligations and agreements it is required to comply with or perform at or prior to the Effective Time;</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Parent and Merger Sub shall have
        received a certificate of the Company, signed by an officer of the Company, dated the date on the which the Offer expires certifying that the conditions specified in clauses (d), (e) and (f) have been satisfied; and</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">the Merger Agreement shall not have been
        terminated in accordance with its terms (the &#8220;<u>Termination Condition</u>&#8221;).</font></div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">The foregoing conditions are for the sole benefit of Parent and Merger Sub and, except for the Minimum Tender Condition and the
      Termination Condition (each of which may only be waived with the prior written consent of the Company), may be waived by Parent or Merger Sub in whole or in part at any time and from time to time and in the sole discretion of Parent or Merger Sub,
      subject in each case to the terms of the Merger Agreement and Applicable Law.&#160; The foregoing conditions shall be in addition to, and not a limitation of, the rights and obligations of Parent and Merger Sub with respect to extending, terminating
      and/or modifying the Offer pursuant to the terms and conditions of the Merger Agreement or Applicable Law.&#160; The failure by Parent, Merger Sub or any other Affiliate of Parent at any time to exercise any of the foregoing rights shall not be deemed a
      waiver of any such right, the waiver of any such right with respect to particular facts and circumstances shall not be deemed a waiver with respect to any other facts and circumstances and each such right shall be deemed an ongoing right that may be
      asserted at any time and from time to time.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Capitalized terms used in this <u>Annex A</u> but not defined herein shall have the meanings set forth in the Agreement to which it
      is attached, except that the term &#8220;<u>Merger Agreement</u>&#8221; shall be deemed to refer to the Agreement to which this <u>Annex A</u> is attached.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; text-align: center;">2<br>
      <hr style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
